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ABSTRACT 
The ability to engineer noble-metal nanostructures (NMNSs) in a controllable manner and 
to understand the structure-dependent properties greatly boost our knowledge in rational design of 
biosensing technologies. In particular, as a type of highly efficient peroxidase mimics, NMNSs 
hold promising potential to break through the bottleneck of conventional enzyme-based in vitro 
diagnostics. 
During the time of my Ph.D. study, I have successfully: 1) directed a two-step method 
involving seed-mediated growth and chemical etching for the synthesis of Ru nanoframes (RuNFs) 
with face-centered cubic crystal phase and enhanced catalytic activities; 2) demonstrated, for the 
first time, the inherent  peroxidase-like activity of RuNFs as a type of efficient peroxidase mimics, 
opening up possibilities for their bioapplications; 3) developed an enzyme-free signal 
amplification technique for ultrasensitive colorimetric assay of disease biomarkers by using Pd-Ir 
nanooctahedra encapsulated gold vesicles as labels; 4) prepared polyvinylpyrrolidone (PVP)-
capped Pt nanocubes with superior peroxidase-like catalytic activity and record-high specific 
catalytic activity; 5) developed a facile colorimetric method for the detection of Ag(I) ions with 
picomolar sensitivity by using the PVP-capped Pt nanocubes as the probes; 6) developed a non-
enzyme cascade amplification strategy for colorimetric assay of disease biomarkers by taking 
advantage of the interaction between the Ag(I) ions and PVP-capped Pt nanocubes; and 7) 
established a highly sensitive colorimetric lateral flow assay platform by using Au@Pt core-shell 
nanoparticles as the labels that possess both plasmonic and catalytic properties. 
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CHAPTER 1 GENERAL INTRODUCTION 
1.1 General Introduction 
1.1.1 Viewpoints of Noble-metal: Traditional vs. Modern 
Noble metals nowadays refer to a group of metals including gold (Au), silver (Ag), 
palladium (Pd), platinum (Pt), ruthenium (Ru), rhodium (Rh), iridium (Ir), and osmium (Os). The 
word “noble” traditionally comes from these metals’ high value and rarity in the Earth's crust, as 
well as their highly resistance of oxidation and corrosion in moist air and being not easily attacked 
by acids. As such, the jewelry, coinage, and historical artifacts made of noble metals (mostly, Au 
and Ag) are able to maintain their glossiness for centuries without fading. 
Modern scientific evaluation of noble metals could be traced back to 1850s when Michael 
Faraday first created a colloidal Au solution with ruby red color and conjectured that the color was 
generated by the light scattering property of the Au species with “finely divided metallic state”.1 
Following this revolutionary discovery, Au played a prominent role in the field of colloid science, 
where theoretical and experimental knowledge was steadily increasing during the 20th century. As 
a remarkable milestone to the materials in modern era, Richard Feynman gave a famous talk 
entitled “There's Plenty of Room at the Bottom” at the American Physical Society meeting in 1959, 
wherein he foresaw a more powerful matter that could be operated at atomic and molecular level.2 
Since then, the emerging of advanced microscopy methods, such as scanning tunneling microscope 
(IBM’s Zurich lab, 1981)3 and atomic force microscopy (Gerd Binnig, Calvin Quate, and 
Christoph Gerber, 1986),4 allowed the scientists to visually measure and manipulate individual 
atoms, eventually leading to the establish of nanotechnology.5 Again, noble metals played a unique 
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role as metallic features in the evolving of “the world of nano dimensions”6 due to their high 
stability as pure metals.  
The goal of nanotechnology is to create materials with at least one dimension in the range 
of approximately 1-100 nm (defined as nanomaterials),7 explore the fundamentally new properties 
and functions at that scale that are different with single atoms or molecules or bulk behavior, and 
build systems and devices that are applicable to cross-disciplinary domains of relevance.8 To date, 
the art of handling noble-metal nanostructures (NMNSs) has fascinated mankind for centuries due 
to their exceptional physicochemical properties and remarkable applications in the fields of 
catalysis,9 electronics,10 and photonics.11 For instance, Au and Ag nanostructures have been used 
as colorants in ancient time, typically in glass and ceramic or enamel potteries, though being 
unknowingly. The earliest example is the Lycurgus Cup that could be dated back to Roman times 
in about 290-325 AD.12 In spite of the high price, Pd, Pt, Rh, Ru, and Ir were heavily used as 
catalysts in the chemical industries for almost two centuries because of their superior catalytic 
performance.13 Nevertheless, in the light of nanotechnology, these old phenomena and applications 
have been revisited in recent decades, which advances the synthetic strategies for NMNSs, 
enriches the insights of their physicochemical properties, and upgrades the applications even to 
the sensing,14 imaging,15 and biomedicine.16 
1.1.2 Enriched Insights of the Physicochemical Properties for NMNSs 
When matter is divided into the nanolength, its physical features will be changed 
drastically, such as increased surface-to-volume-ratio, decreased coordination number of surface 
atoms, and quantum-confinement effects.17 When applied to noble metals, unusual optical 
phenomena and catalytic activities will arise in the nanostructures.18 These emerging properties 
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grant a new division for the noble metals, wherein the Au and Ag are assigned as plasmonic metals, 
while the rest as the catalytic metals (Figure 1.1).19 Excitingly, both theoretical and experimental 
results indicate these physicochemical properties are chiefly dependent on the physical parameters 
of a noble-metal nanostructure, including size, geometric shape, internal structure (solid or 
hollow), and elemental composition. That is, we are able to tailor the properties of a noble-metal 
nanostructure by controlling one or a combination of those parameters.  
 
Figure 1.1 A section of the periodic table showing the noble-metals. These metals can be divided 
into two major groups according to their distinctive properties. Note that due to the pyrophoricity 
of Os nanostructure and extreme toxicity of its oxide, this metal is rarely studied.20 
1.1.2.1 Modelling the Optical Response of the Plasmonic-metal Nanostructures 
The optical properties of the plasmonic-metal nanostructures mainly arise from a 
phenomenon called the Localized Surface Plasmon Resonance (LSPR). In principle, when 
irradiated by an incident light, free electrons in metal particle will be excited and create a collective 
oscillation away from their equilibrium positions. Such oscillation of electrons is analogous to that 
of gaseous plasma so as to be defined as Surface Plasmons (SPs) and the light-particle interaction 
is called Surface Plasmon Resonance (SPR). Specifically, when the metal is transformed into 
nanostructure, the frequency of electronic oscillation will match with that of the incident light, 
4 
 
resulting in the absorption of photons and confinement of the SPR by the geometrical boundary of 
the metal nanostructure, which is furthered as LSPR (Figure 1.2a).21 During the course, a portion 
of these absorbed photons will be coherently released in all directions that is known as scattering, 
meanwhile some of them will be transferred into phonons or vibrations of the lattice known as 
absorption. Therefore, the LSPR peak of a metal structure combines both light absorption and 
scattering at specific wavelength, which indeed is an extinction peak (Figure 1.2b).22 By taking 
advantage of the LSPR, plasmonic-metal nanostructures are capable to i) span the extinction peak 
in the ultraviolet (UV), full visible (Vis), and near-infrared (NIR) regions of spectrum (Figure 
1.2c);23 ii) enhance the cross-section of extinction peak, whose molar extinction coefficient could 
reach at level of 108~1011 M-1‧cm-1, approximately 3~6 orders of magnitude higher than that of 
conventional organic dyes;24 and iii) finely tune the spectral features, such as the resonant modes 
and peak positions, by changing the abovementioned physical parameters of a nanostructure18, 25. 
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Figure 1.2 (a) Schematic illustration of LSPR for a metal nanosphere induced by an external 
electric field (e.g., incident light). Adapted with permission from ref 21. Copyright 2003 American 
Chemical Society. (b) Scattering, absorption and extinction cross-section of a 100 nm Au 
nanosphere. Adapted with permission from ref 22. Copyright 2015 Optical Society of America. 
(c) The range of LSPR peaks for a variety of Au and/or Ag nanostructures. Adapted with 
permission from ref 23. Copyright 2007, Springer Nature. 
The theoretically modelling of optical response for small metal spheres was first 
accomplished by Gustav Mie in 1908.26 His solutions to the Maxwell’s electromagnetic field 
equations described the extinction spectra of metal spheres with varied size in a homogenous 
medium. Following this work, Richard Gans modified the Mie’s solutions for metal ellipsoids.27 
Later, “Lorenz-Mie theory” and “Lorenz-Mie-Debye theory” were also proposed to expand the 
calculated models.28 However, these theories were marginalized at that time because it was hardly 
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to obtain metal nanostructures with regular shapes. It was until the end of last century when the 
advance in nanotechnology blossomed the synthetic methods for plasmonic-metal nanostructures 
with various sizes and shapes, theoretical calculations were recalled to understand the underlying 
mechanism of the spectacular colors induced by size and/or shape of a noble-metal nanostructure 
(Figure 1.3).  
 
Figure 1.3 Optical properties of Au nanostructures with different size and shape. (a) Commercial 
Au nanospheres (AuNSs) dispersed in water. Copyright and image from Nanocomposix. (b) 
Corresponding LSPR extinction peaks of AuNSs as a function of the size. Copyright and image 
from Nanocomposix. (c) Au nanorods, (d) SiO2-Au core-shell nanostructures, and (e) Au nanocage 
model and colors of aqueous solutions containing these nanostructures that have different (c) 
aspect ratio, (d) shell thickness, and (e) degree of galvanic replacement by Au. Adapted with 
permission from ref 16. Copyright 2012 Royal Society of Chemistry. 
Despite the prediction of Mie’s theory and its derivatives succeeded in a number of simple 
systems, such as spheres, ellipsoids, and infinite cylinders, they were no longer valid for other 
asymmetric nanostructures. Therefore, discrete dipole approximation (DDA) was proposed in 
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1973, which can be applied to nanostructures of any arbitrary shape.29-31 In DDA calculations, a 
nanostructure is approximated as a three-dimensional array of polarizable elements considered as 
point dipoles.21 When this array is irradiative by an incident light, a dipole moment will be induced 
by the external electric field and the surrounding dipoles. The contribution from each dipole can 
then be used to determine the overall optical response (e.g., scattering and absorption cross-
sections) of the metal nanostructure with respect to the wavelength. Making use of this simulation, 
Prof. Xia presented a series of DDA calculations for the Ag nanoparticles of 2- and 3-dimentional 
(2D and 3D) structures, successfully correcting the relationship between the morphology and the 
spectral features (Figure 1.4).32 So far, methods like the finite difference in the time domain 
(FDTD) and the boundary element method (BEM) were also established as driven by the 
demanding to explain the LSPR properties of nanostructures subjected to a more complex 
environment.33 
Taken together, the classical Mie’s theory and modern numerical analyses are able to 
describe many optical properties of plasmonic-metal nanostructures of different size, shape, and 
etc. Theoretical modeling is of great importance to bridge the experimental observations and the 
physics behind plasmonics, and thus predicting unique optical responses of novel structures yet to 
be obtained. Nevertheless, this progress boosts our confidence in the design of spectroscopic 
techniques and colorimetric sensing platforms based on plasmonic-metal nanostructures that 
mature to both practical fabrication and theoretical guidance.34  
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Figure 1.4 The DDA simulations of the optical response for Ag nanoparticles with a variety of 
shapes in water. Absorption peak is shown in red, scattering peak in blue, and LSPR extinction 
peak in black. Adapted with permission from ref 32. Copyright 2006 American Chemical Society. 
1.1.2.2 Renovating the Cost-efficiency of Catalytic-metal Nanostructures 
The catalytic metals locate at the second and third row of VIII group on the periodic table 
that possess d-electrons and d-orbital to spare as the reaction proceeding, of which the ability to 
transit electrons is the key for them to serve as catalysts in oxidation, cross-coupling, electron-
transfer, and hydrogenation reactions.35 In traditional industries and modern automobile, these 
catalytic metals used to be employed as heterogeneous catalysts, among which the Pt-based 
particles are the most popular candidates.36-37 Moreover, these catalytic metals share many 
similarities in chemical, physical, and anatomical properties, therefore, they are also categorized 
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as platinum group metals (PGMs).38 Not surprisingly, taking the high price and demand of PGMs 
as catalysts into consideration, we have to face to a foremost challenge: how to maximize the cost-
efficiency of PGMs? 
A promising answer was given by the nanotechnology. Recent landmark achievements in 
the syntheses of nanostructures, mostly on the basis of a colloidal chemistry, ensure the 
employment of PMG-based nanocatalysts to meet the technological demands.18 A notable example 
is that the size of nanostructures can be maneuvered in the regimes of 1-10 nm with high 
uniformity. As a result, these extremely small nanostructures could have high fractions of the 
surface atoms to the whole (also called dispersion) along with the surface-to-volume-ratio. 
Considering the heterogeneous reaction occurs on the surface of a catalyst, shrinking the size of a 
nanostructure could ensure as many atoms to be exposed on the surface, which is a straightforward 
yet efficient way to improve its cost-efficiency.39 Coincidently, the high uniformity of the PGMs 
nanostructures makes the surface atoms almost identical from particle to particle, enabling the 
reaction to be catalyzed in a consistent pathway, yielding the desired products with reduced 
number of byproducts. For example, Prof. Somorjai reported a study on the size effect of Pt 
nanoparticles (PtNPs) supported on SBA-15 silica toward the hydrogenation of pyrrole.40 
Representative transmission electron microscopy (TEM) images of PtNPs of 2 nm and 5 nm was 
provided in Figure 1.5a, b, respectively. It was found that unique selectivity came out as the PtNPs 
size increasing above 2 nm, favoring for the ring opening to n‐butylamine while the formation of 
pyrrolidine was retarded (Figure 1.5c). The reason was that n‐butylamine is a more electron‐rich 
structure than pyrrolidine, which is more likely to poison the smaller PtNPs that possess more 
unsaturated surface bonds. 
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Figure 1.5 Size-dependent selectivity of Pt nanoparticles (PtNPs) toward pyrrole hydrogenation. 
TEM images of (a) 2.0 nm and (b) 5.0 nm PtNPs. (c) Reaction selectivity as a function of Pt size. 
Inset shows the strategy of size control for PtNPs. Adapted with permission from ref 38. Copyright 
2008 American Chemical Society.  
 Now that we know the surface atoms of PGM nanostructures are the key component to a 
heterogeneous-catalytic process, we can also tailor both catalytic activity and selectivity by means 
of shape control of PGM nanostructures. For example, Prof. Yang reported a study on the benzene 
hydrogenation over Pt nanostructures of cubic and cuboctahedral shapes (Figure 1.6).41 It has been 
shown that Pt nanocubes with (100) facets only could produce cyclohexene as the product, while 
Pt cuboctahedra with a mixture of (100) and (111) facets produced both cyclohexane and 
cyclohexene. The result is in consistency with the reaction selectivity catalyzed by bulk Pt (111) 
and Pt (100) single crystals and gives a hint on the relationship between the well-defined shape of 
a nanostructure and the catalytic performance. It worth pointing out that other than the facets, 
11 
 
edges and corners in a given shape can also serve as intrinsically active centers for catalysis due 
to the low coordination numbers.42 
 
Figure 1.6 Shape-dependent selectivity of Pt nanoparticles (PtNPs) toward benzene 
hydrogenation. TEM images of PtNPs of (a) cubic shape and (b) cuboctahedral shape. Insets show 
the model of cube covered by (100) facets and cuboctahedron covered by a mixture of (100) and 
(111) facets. (c) Turnover rate and (d) corresponding Arrhenius plots of benzene hydrogenation 
reaction for cyclohexane and cyclohexene in presence of Pt cubes and Pt cuboctahedra as catalysts, 
wherein the Pt cubes exhibited selectivity for cyclohexane. Adapted with permission from ref 39. 
Copyright 2007 American Chemical Society. 
 In addition, depositing active metals on a supported material made of other metals that are 
more abundant and/or less expensive used to be a prevalence strategy. In a sense, the “ideal” 
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situation should be only a single layer of the active atoms is formed on the outer surface. Thanks 
to the substantial achievement made by Prof. Xia’s group, it is now technically feasible to grow a 
shell within one to several atomic layers on a template. Recent examples based on Pd-Pt core-shell 
nanostructures have been reported, where Xia and co-workers implemented seed-mediated growth 
for the conformal coating of Pt layers on Pd cubes as seeds.43 They demonstrated the growth of Pt 
atoms was following a layer-by-layer mode, where the thickness of Pt shell could be precisely 
controlled from 1 to 6 atomic layers, as shown in Figure 1.7a, b. Using the oxygen reduction 
reaction (ORR) as a model reaction, the Pd-Pt nanocubes showed enhancements in electrocatalytic 
performance (e.g., specific and mass activity and durability) when compared to a commercial Pt/C 
catalyst (Figure 1.7c, d). However, it may be argued that the interior of this type of nanostructures 
is still occupied by the seeds (Pd, in this case), which in fact has little contribution to the catalytic 
reaction yet much to the material cost. To avoid this, a logical solution is to engineer a cage-like 
nanostructure with hollow interior. Following this idea, by selectively removal of the interior of 
Pd-Pt core-shell nanostructures, Pt nanocages with subnanometer-thick walls and cubic or 
octahedra shape could be obtained (Figure 1.8a, b).44 The electrocatalytic performance of the Pt 
nanocages toward ORR was substantially improved, which may be originated from the shortened 
atomic distance in the Pt layer compared to the pure Pt nanostructures (Figure 1.8c, d). 
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Figure 1.7 Low-magnification high-angle annular dark-field scanning TEM (HAADF-STEM) 
images of (a) Pd-PtnL core-shell nanocubes, from left to right: n=1, 2-3, 4, and 6; (b) high-
magnification HAADF-STEM images of individual nanocubes corresponding to (a). Mass (left) 
and specific (right) ORR performance of (c) activity and (d) durability of the Pd-PtnL/C catalysts 
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against a commercial Pt/C catalyst and/or Pt nanocubes of 9 nm in edge length. Adapted with 
permission from ref 40. Copyright 2014 American Chemical Society.  
 
Figure 1.8 TEM images of Pt (a) cubic and (b) octahedral nanocages. Insets in (a) and (b) are the 
high-magnification HAADF-STEM images of an individual nanocage. Electrocatalytic properties 
and stability tests of the two types of Pt nanocages compared to a commercial Pt/C catalyst. Mass 
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(left) and specific (right) ORR performance of (c) activity and (d) durability of the cage-based 
catalysts against a commercial Pt/C catalyst at 0.9 VRHE. Adapted with permission from ref 41. 
Copyright 2015, American Association for the Advancement of Science. 
The rationale behind fabrication of PGM-based nanocatalysts again stems from the fact 
that a large portion of atoms are exposed on surface in a nanostructure and the electrons are 
confined to spaces (e.g., edge and corner) only a few of nanometers across, giving rise to more 
active sites for reactions and thus greatly improve the cost-efficiency of the PGMs. Perhaps most 
importantly, many studies in the past decades showed that the catalytic performance (e.g., activity, 
selectively, and durability) have strong relationship with the physical parameters and elemental 
composition of PGM-based nanostructures, which can be precisely controlled at atomic and 
molecular level.18  
1.1.2.3 NMNSs as Artificial Enzymesa 
The rising development of controllable syntheses of NMNSs not only maintains their 
dominance in traditional industries, but also raises them as appealing stars in the field of artificial 
enzymes as alternatives to natural enzymes.45-46 As well known, enzymes are virtually biocatalysts 
of great efficiency and specificity at mild conditions (e.g., room temperature, ambient pressure, 
and aqueous solutions), which are very important to the living systems and beyond.47 However, 
these natural enzymes made of proteins or ribonucleic acids have several drawbacks like gradual 
denaturation, high expense, and sophisticated recycling, which inevitably limited their practical 
usage. To tackle these issues, artificial enzymes made of nanostructures have been developed. 
                                                          
aUnder review by ChemNanoMat. Expected to be accepted on May 2019. 
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Though essentially different, nanostructure-based enzyme mimics display many advantages over 
the conventional artificial enzymes and natural enzymes (see Table 1.1 for detail comparison).45-
46, 48  
Table 1.1 Comparison between artificial enzymes and natural enzymes. Reprinted with permission 
from ref 48. Copyright © The Author(s) 2016. 
 Features 
Artificial enzymes of nanostructure Low cost 
 Easy for mass production 
 Robustness to harsh environments 
 High stability 
 Long-term storage 
 Tunable activity 
 Structure-dependent properties 
 Multifunction 
 Easy for further bioconjugation 
 Smart response to external stimuli 
 Self-assembly 
Conventional artificial enzymes Low cost 
 Easy for mass production 
 Robustness to harsh environments 
 High stability 
 Long-term storage 
 Tunable activity 
 Established methods for preparation  
 Uniform size and defined structures  
 Smaller size (compared with nanostructures) 
Natural enzymes High catalytic efficiency 
 High substrate specificity 
 High selectivity 
 Sophisticated three-dimensional structures 
 Wide range of catalytic reactions 
 Tunable activity 
 Good biocompatibility 
 Rational design via protein engineering  
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Taking peroxidases as an example, they are a group of enzymes that act as catalysts to the 
oxidation of certain compounds with peroxides (e.g., H2O2).
49-50 They have been found in plants 
and animals, where their main role is to break down the oxidizing agents into harmless substances, 
helping prevent damage.51-52 Technologies for isolation and purification of peroxidases from 
organisms allow for their industrial applications.53 Horseradish peroxidase (HRP), as a typical 
model, has been used as labels in medical diagnostic kits, where they are conjugated to antibodies 
and specifically produce detection signal by catalyzing substrates.54 HRPs have also been utilized 
for treatment of wastewater as they are able to eliminate phenolic contaminants through catalysis.55 
Despite of these demonstrations, the intrinsic limitations of peroxidases greatly inhibit broader 
applications. For instance, peroxidases are relatively unstable under harsh conditions (e.g., 
temperatures above 50 °C or pH below 4.5).56 Their catalytic efficiencies are confined to certain 
levels, which are determined by the inherent molecular structures of peroxidases. Moreover, the 
isolation and purification of peroxidases are complicated and costly. 
To circumvent those issues, much effort has been made to develop peroxidase mimics as 
the natural counterparts.45-46 Since the first report of ferromagnetic nanoparticles with intrinsic 
peroxidase-like activity in 2007,57 a variety of peroxidase mimics made of inorganic 
nanomaterials, including carbon materials,58-59 noble metals,48, 60 metal oxides,61-63 and a 
combination of them64-65 have been actively reported in recent years. Among them, NMNSs as 
peroxidase mimics are of great interest due to their higher peroxidase-like efficiencies than most 
other types of peroxidase mimics with similar dimensions. For example, our group reported a new 
type of peroxidase mimics made of Pd-Ir core-shell nanocubes, featuring record-high peroxidase-
like activity at a level as high as 106-107 s-1, which is approximately 1000-fold higher than that of 
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HRP.57, 66 In addition, they have several other distinctive features that make them strong candidates 
among peroxidase mimics: i) they are made of inert noble metals with excellent stabilities, 
enabling them survive harsh environments; ii) their surfaces can be conveniently labeled with 
chemical ligands and biomolecules (e.g., antibodies and nucleic acids) through physical adsorption 
or metal-thiolate bonding; and iii) they can be prepared in high quality and large quantities in 
common chemical laboratories,18, 67-68 ensuring good reproducibility in certain applications. 
In addition to peroxidase, the NMNSs can also mimic enzymes like RNase, DNase, 
superoxide dismutase, catalase, etc. Detail information can be found in many recent reviews.45-46, 
48 
1.2 Applications of NMNSs in Biomedicine 
Integrating NMNSs into the fields of biomedicine is a huge breakthrough that benefits from 
the nanotechnology. In essential, the unique physicochemical properties of NMNSs form the basis 
for a variety of applications. The capacity of structural engineering for NMNSs like controllable 
synthesis and surface modification, indeed bridges the gap between theoretical direction and the 
practical use, such as in vitro diagnostics, in vivo imaging, therapy and medicine (Figure 1.9). For 
example, taking advantage of the strong electromagnetic enhancement by the LSPR of plasmonic-
metal nanostructures, surface-enhanced Raman scattering (SERS) could achieve ultrasensitive 
detection by molecular fingerprinting.69-70  
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Figure 1.9 A summary of the properties of engineered NMNSs that fit for the biomedicine 
applications.  
1.2.1 In Vitro Diagnosticsa 
In vitro diagnostics (IVDs) refer to tests on biological samples that are taken from the 
human body, including, but not limited to, blood, urine, saliva, and tissues.71-74 IVD tests are 
usually performed to detect and monitor disease in an individual (in most cases, through the 
determination of molecular biomarkers), intending to provide valuable medical information for 
disease treatment, management, and prevention. IVDs represent a crucial component in modern 
healthcare. They influence more than 60% of clinical decision making, while accounting for only 
∼2% of total healthcare spending.75 IVDs reduce cost by diminishing subsequent health issues, 
avoiding unnecessary treatment, and reducing hospitalization. In addition to cost-effectiveness, 
IVDs are featured by low patient risk. Most IVDs do not come into direct contact with the human 
                                                          
aReprinted with permission from Chem. Mater. 2018, 30, 8391-8414.  
Copyright © 2018, American Chemical Society. 
Haihang Ye contributed the review of literature, collection of figures, and preparation of the article. 
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body, involving no more than minimal risk for a patient.76-78 
Today, IVDs go far beyond simply telling a doctor whether a patient has certain diseases 
or not. They are able to spot early warning signs, provide quantitative data on relevant biomarkers, 
and evaluate individual risk factors.79-80 This information greatly enhances doctors’ ability to make 
an optimized decision at the right time. The versatile capabilities of IVDs make them an integral 
part of decision making during the entire continuum of patient care. For instance, in dealing with 
cancers, IVDs can guide physicians to make clinical decisions on both treatment and recovery. 
Prior to any invasive treatments, IVD tests (e.g., blood tests for prostate cancer and core-needle 
biopsy for breast cancer) need to be performed to obtain detailed information about cancer, such 
as the exact kind of cancer, the stage of cancer, and how fast it is expanding. After treatment, IVDs 
help physicians monitor possible cancer recurrence by measuring the level of specific biomarkers 
in a patient’s blood or tissue.81-85  
The increasing demand of IVDs and their significance in biomedicine drive the 
development of new IVD technologies toward higher sensitivity, greater simplicity, and lower cost. 
In particular, high sensitivity is critical in early detection of life-threatening diseases such as 
cancers, infectious diseases, and cardiovascular disease, creating opportunities for early 
intervention and prevention.86-88 Great simplicity and low cost allow IVDs to extend beyond the 
clinical laboratory and doctor’s office, empowering patients to self-monitor and manage their own 
health conditions and ultimately achieving sustainable healthcare.89-90 
Technological advancement is oftentimes motivated by scientific discoveries. Taking 
advantages of the functional nanostructures for the revolution of IVD technologies is an exciting 
task for scientists worldwide. However, the path from lab experiments to clinical use is long and 
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fraught with pitfalls. The lack of in-depth fundamental understanding and difficulties in dealing 
with complicated clinical samples make the translational period of these nanostructures in IVDs 
rather arduous. Nevertheless, a few of them have already made it through. For example, Au 
nanoparticles-based test strip technology has successfully been brought to the market since the 
1980s and become a powerful tool to solve real-world problems (e.g., tests for pregnancy and 
malaria).91-93 It is worth mentioning that facile and scalable synthesis of quality colloidal Au 
nanoparticles can be traced back to the work by Turkevich et al. in the early 1950s94-96 — only 
∼30 years behind their practical use. Over the past two decades, great progress has been made on 
both the fundamental and practical sides of nanostructures. It is now feasible to manufacture 
nanostructures with good uniformities and commercial scales.97-99 Taken together, this niche field 
is primed to make the transition from scientific findings to clinical realities. 
1.3 Engineered NMNSs for In Vitro Diagnosticsa 
NMNSs as a group of emerging functional materials have received increasing interest in 
IVDs over the past several decades due to their unique and intriguing physicochemical 
properties.76, 100-103 For example, (i) they offer a vast of signal transduction principles that are suited 
for efficient IVD tests, including optical,104 plasmonic,105 electrochemical,64, 106 SERS,107-108 
fluorescent,109-110 and colorimetric signals.111 Notably, a very small amount of NMNSs are required 
to yield a strong signal, allowing for sensitive detection. (ii) Owing to the great efforts by many 
research groups in the past, they can now be produced in high quality and large quantities, ensuring 
                                                          
aReprinted with permission from Chem. Mater. 2018, 30, 8391-8414.  
Copyright © 2018, American Chemical Society. 
Haihang Ye contributed the review of literature, collection of figures, and preparation of the article. 
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good reproducibility for associated IVDs.97-99 (iii) Their surface can be conveniently modified with 
functional groups such as amino and carboxyl groups by means of metal-thiolate bonding, 
allowing for facile labeling of biomolecules.112-115 (iv) They are made of noble metals with 
excellent stability and mechanical flexibility, enabling them to easily survive from complex and 
harsh environments.116-118 This feature is particularly desired for point-of-care IVDs, where 
environmental conditions such as temperature, humidity, and air quality are less predictable and 
controllable than those in a clinical laboratory.119-120 Finally, it should be noted that the cost of 
noble metals should not be an issue in this particular application because of the tiny amount of 
materials usage in IVDs. 
The term “engineered” refers to noble-metal nanomaterials “with controlled physical 
parameters, including size, shape, elemental composition, and internal structure (e.g., hollow vs. 
solid).” As mentioned in Section 1.1.2, the physicochemical properties of a noble-metal 
nanostructure have strong dependence on these physical parameters.34, 121-128 Therefore, for a given 
application, the engineered NMNSs would more likely to express the optimized properties, as well 
as the expected performance. In the past decades, many examples clearly told us the critical 
importance of “engineered” to the effective utilization of NMNSs. Nevertheless, compared to other 
fields (e.g., catalysis and in vivo biomedicine), engineered NMNSs have not been extensively 
studied in IVDs. Only within the past few decades have they been applied to IVD tests. In the 
following couple of sections, a comprehensive literature review will be given by introducing the 
impacts of size, shape, elemental composition, and internal structure of a noble-metal nanoparticle 
on its performance in IVDs within the recent decade. 
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1.3.1 Impact of Size 
The size of a noble-metal nanostructure not only has a great impact on signal transduction 
but also affects the way a nanostructure interacts with biomolecules and/or other components of 
an IVD platform. For example, Špringer et al. quantitatively investigated how the size of Au 
nanoparticles (AuNPs) influences their capability in enhancing the response of SPR biosensors.129 
The study involved both experimental work and theoretical simulations. As a model system 
(Figure 1.10a), neutravidin-functionalized AuNPs (N-AuNPs) were used in the last step of a 
sandwich assay of carcinoembryonic antigen (CEA) to enhance the SPR sensor response to 
biotinylated secondary antibody against CEA. AuNPs with diameters of 10, 15, 21, 33, and 52 nm 
were tested in this system to investigate the size effect. The sensor response (shift in the SPR 
wavelength, Δλr) is determined by two factors—the surface density of captured AuNPs (Δσ) and 
the sensor sensitivity to AuNP surface density (Sσ), which are related as Δλr = Δσ × Sσ. Herein, the 
first factor (Δσ) is defined as the ability of the N-AuNPs to bind to the SPR sensor surface through 
the interaction between a biotinylated antibody and neutravidin on the AuNP surface (Figure 
1.10a). The second factor (Sσ) is defined only by the optical properties of both the N-AuNPs and 
the properties of the sensor. This factor measures the ratio between changes in the sensor response 
to changes in the N-AuNP surface density. Significantly, Δλr and Δσ could be experimentally 
determined through SPR instrument readout and scanning electron microscopy (SEM) imaging, 
respectively. Therefore, the value of Sσ can be experimentally derived through following equation: 
               𝑆𝜎 =
∆𝜆𝑟
∆𝜎⁄      (1) 
The data of Δλr and Δσ for different sized AuNPs are summarized in Figure 1.10b, c, 
respectively. On the basis of these data and equation 1, the values of Sσ were derived (symbol ■ in 
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Figure 1.10d). This set of experimental data was well correlated to the results from a theoretical 
model (lines in Figure 1.10d) that relates the enhancement generated by various characteristics of 
the AuNPs (e.g., size, composition, and concentration). It can be concluded that, while Sσ increases 
with the size of the N-AuNP, the ability of the bioreceptor-functionalized surface of the sensor to 
bind the N-AuNPs is affected by steric effects and thus decreases with the size of N-AuNP. This 
study provides a quantitative understanding on the impact of particle size, allowing for the design 
and development of SPR biosensors with optimized analytical performance. 
 
Figure 1.10 (a) Schematics showing the sandwich assay of carcinoembryonic antigen (CEA) by a 
neutravidin-functionalized AuNP (N-AuNP)-enhanced SPR sensor. N-AuNPs with Au cores of 
five different sizes are evaluated in the sensor. (b) Sensor responses (Δλr) for N-AuNPs with 
different sizes. (c) Surface densities (Δσ) for N-AuNPs with different sizes. (d) Theoretical and 
experimental sensor sensitivity to surface density (Sσ) as a function of N-AuNP size. The dotted 
line represents a cubic dependence of Sσ on the AuNP size. Adapted with permission from ref 129. 
Copyright 2014 American Chemical Society. 
Size also plays a decisive role in other signal transduction principles. For example, AuNPs 
can effectively generate a color signal (through absorption/scattering of incident light) and thermal 
contrast signal (through the photothermal effect.130-131 The size of AuNPs has been recognized to 
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have a great impact on both types of signal and associated IVD platforms. In a recent work by 
Zhan et al., such impacts have been understood from both theoretical and experimental aspects 
using a lateral flow assay (LFA) as a model IVD platform.132 In a typical sandwich LFA test 
(Figure 1.11a), analyte flows through a paper-based strip by capillary force and is first captured 
by detection antibody-labeled AuNPs to form a complex.133 The complex is then captured by 
antibodies precoated on the test zone of the membrane. The accumulation of AuNPs at the test 
zone results in a visible red color, indicating a positive test. In conventional LFA, AuNPs of 30-40 
nm in diameter are used as colorimetric labels. To improve the sensitivity of LFA, Zhan et al. 
carefully studied the impact of AuNP size (30, 60, and 100 nm in diameter). The nitrocellulose 
membrane is conceptually simplified as a bundle of cylindrical pores of radius R (Figure 1.11a). 
The Peclet number (Pe) and the Damkohler number (Da) were scaled to assess the importance of 
diffusion to convection and reaction in LFA (Figure 1.11b). Particularly, in the formula of Da, the 
effective forward reaction rate constant (kon′) for antibody-labeled AuNP is assumed to be  
                  𝑘𝑜𝑛
′ = 𝑛𝑘𝑜𝑛    (2) 
Here, kon is the forward rate constant for a single antibody-antigen interaction in the LFA 
setting, and n is the effective number of antibodies per AuNP. A COMSOL model was developed 
to analyze the system and predict LFA performance prior to experiments. The model shows that 
reaction and convection have a higher impact on AuNP capture in the test zone than diffusion, with 
the reaction being the rate-limiting factor in AuNP capture. In this system, the reaction is largely 
determined by kon′. Therefore, on the basis of equation 2, larger sized AuNPs would have greater 
kon′ due to the larger number of antibodies per AuNP (n) and thus could improve AuNP capture. 
Figure 1.11c shows the modeling results for a sandwich LFA of C-reactive protein (CRP, a 
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biomarker of inflammation) achieved by the COMSOL model. Figure 1.11d shows the modeling 
results-guided experimental results where both thermal and color signals were measured for the 
CRP LFAs. It can be seen that the modeling results agreed well with experimental results, including 
the observation of the “hook effect” (reduction in signal at excessively high analyte 
concentrations).134-135 The two sets of data quantitatively demonstrate that larger sized AuNPs 
having a higher effective forward rate constant (kon′) could increase AuNP capture and therefore 
LFA sensitivity. In particular, under thermal signal detection mode, 100 nm AuNPs yield a 256-
fold sensitivity enhancement relative to conventional 30 nm AuNP-based colorimetric LFA. It 
should be mentioned that AuNP capture will be rate-limited by diffusion when the size is beyond 
100 nm. Modeling results show that larger AuNPs (e.g., 400 nm) will settle in the membrane pores 
within 50 s, the time necessary for a AuNP to migrate from conjugate pad to test zone. Therefore, 
further increasing particle size will decrease AuNP capture and thus the sensitivity of LFA because 
larger AuNPs have slower diffusion rates. 
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Figure 1.11 (a) Schematics showing the architecture of a typical AuNP-based LFA with test line 
width L, where the nitrocellulose membrane is conceptually simplified as bundles of cylindrical 
pores with radius R. Ctrl represents the control line of LFA. AuNPs of 30, 60, and 100 nm in 
diameter are studied in the LFA. (b) Pe and Da that were used to assess the factors of convection, 
diffusion, and reaction in LFA. Reaction is recognized to be the rate-limiting step of AuNP capture 
in the test zone. (c) COMSOL modeling result showing the capture of 100 nm AuNP in the test 
zone of sandwich LFA of C-reactive protein (CRP). (d) Experimental thermal (solid symbols) and 
visual (hollow symbols) signals of CRP LFAs. a/a′, b/b′, and c/c′ denote the results for 100 nm, 60 
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nm, and 30 nm AuNPs, respectively.  Adapted with permission from ref 132. Copyright 2017 
American Chemical Society. 
These examples demonstrate the importance of size control in AuNP-based IVD 
technologies. In fact, the profound impact of particle size on IVDs was also observed in a number 
of other NMNSs. For instance, for Ag nanoparticle-based SERS detection, the optimal size of Ag 
nanoparticles for providing a maximum SERS signal of adsorbed R6G was found to be ∼50-60 
nm.136 In a Pt nanoparticle-based colorimetric assay, among Pt nanoparticles with diameters in the 
range of 50-280 nm, ∼150 nm Pt nanoparticles gave the highest signal intensity.137 
1.3.2 Impact of Shape 
Compared to size control, shape control is even more effective and versatile in enhancing 
the properties of a noble-metal nanostructure and thus its performance in IVDs. For instance, the 
LSPR peak of a Au or Ag nanostructure is more sensitive to its shape relative to size.126, 138 Steric 
effect in interaction with biomolecules caused by the increase of particle size can be minimized in 
the case of shape control. Moreover, shape control is more cost-efficient since it avoids the increase 
of materials usage. 
In the SPR biosensor (see a model in Figure 1.10a), the signal enhancement and detection 
sensitivity have a strong dependence on the shape of Au nanostructures as enhancers. Kwon et al. 
studied the shape effect in the SPR biosensor by comparing the performance of Au nanostructures 
with quasi-spherical and rod-like shapes (Figure 1.12a, b).139 Both Au nanostructures possess at 
least one dimension in the 40-50 nm range. Thrombin was chosen as a model biomarker, which 
was captured by the DNA aptamer probe attached to the SPR-chip surface and the specific antibody 
conjugated on the Au nanostructures to form a sandwich complex during an assay. As shown by 
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the spectra in Figure 1.12a, b, the major LSPR peaks for the Au quasi-spherical nanoparticles and 
nanorods were located at ∼640 nm and ∼530 nm, respectively. This difference in LSPR peak can 
be ascribed to the difference in particle shape. Under the same assay conditions, the minimum 
thrombin concentrations detected by the Au quasi-spherical nanoparticles and nanorods were 1 and 
10 aM, respectively (see Figure 1.12c, d). This difference in signal generation and thus detection 
sensitivity originated from the changes in the real and imaginary components of the refractive 
index of the film at the chip-solution interface that were induced by the adsorbed Au nanostructures. 
The poorer detection performance of the Au nanorods relative to the Au quasi-spherical 
nanoparticles could be ascribed to that fact that (i) the nanorods induced a smaller change in the 
real component of the refractive index, since the volume of the nanorods is ∼3-fold lower than 
that of the quasi-spherical nanoparticles with the same particle number, and (ii) near-field 
plasmonic coupling occurred in the case of nanorods due to the overlap between the particle LSRP 
profile and the wavelength of light source in the sensor device (760 nm), which affected the 
imaginary component of the refractive index. The shape-dependent performance of the SPR 
biosensor was extensively investigated in other studies, where Au nanostructures with various 
shapes were examined.140-142 
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Figure 1.12 (a, b) UV-vis spectra taken from aqueous suspensions of (a) Au nanorods and (b) Au 
quasi-spherical nanoparticles before (dashed lines) and after (solid lines) they had been conjugated 
with antithrombin antibodies. Insets show TEM images of corresponding Au nanostructures. (c, d) 
SPR sensorgrams for the detection of thrombin using (c) Au nanorods and (d) Au quasi-spherical 
nanoparticles as the signal enhancers. NC1 and NC2 represent nonspecific signal recorded from 
antithrombin conjugated Au nanostructures in the absence of thrombin and anti-BSA conjugated 
Au nanostructures in the presence of thrombin, respectively. Adapted with permission from ref 139. 
Copyright 2012 American Chemical Society. 
In recent years, artificial enzymes (or enzyme mimics) made of NMNSs have emerged as 
a new type of functional material for IVDs.143-145 In a typical IVD test, the enzyme mimics are 
conjugated to bioreceptors and specifically generate a detection signal by catalyzing enzyme 
substrates. Compared to their natural counterparts, enzyme mimics are more stable owing to the 
excellent stabilities of noble metals. In this niche field, the major challenge is to enhance the 
catalytic efficiency of mimics since it largely determines the intensity of detection signal and thus 
the assay sensitivity. It has been demonstrated that the catalytic efficiency of an enzyme mimic has 
a strong dependence on the arrangement of atoms on the surface, which is correlated to the 
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geometric shape of the mimic. For example, the catalase-like activity (e.g., decomposition of H2O2 
into O2) of {111}-covered Pd octahedrons was measured to be much higher than that of {100}-
covered Pd nanocubes under the same conditions (Figure 1.13a).146 As revealed by theoretical 
simulations, this difference in catalytic activity can be ascribed to the difference in reaction energy 
(Er) of the rate-limiting step (Er = -2.81 for Pd{111} vs. Er = -2.64 for Pd{100}). It is worth noting that 
the catalase-like activity of NMNSs enables the translation of molecular recognition events into 
easily measurable physical parameters such as volume and pressure of oxygen gas. On the basis 
of these signal-transducer principles, simple and sensitive point-of-care IVD tests were 
established.147-148 In a recent work by Gao et al. (Figure 1.13b), Pt concave nanocubes encased by 
high index facets were demonstrated to possess a peroxidase-like activity that was ∼1500- and 4-
times higher than those of natural peroxidases and Pt nanospheres, respectively.149 The peroxidase-
like property of Pt concave cubes allowed them to generate an intense color signal by catalyzing 
chromogenic substrates. Using colorimetric enzyme-linked immunosorbent assay (ELISA) as a 
model IVD platform, antibody conjugated Pt concave nanocubes as labels were able to detect 
prostate-specific antigen (PSA, a biomarker of prostate cancer) with a broad linear range (20-2000 
pg/mL) and a detection limit of 0.8 pg/mL, which is much lower than that of a commercial ELISA 
kit. 
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Figure 1.13 (a) Catalase-like activity of Pd octahedrons and nanocubes. The plots (left column) 
show the steady-state kinetic assay of Pd nanostructures with H2O2. Vmax and Km in the inset 
indicate the maximal reaction velocity and the Michaelis-Menten constant, respectively. The right 
column shows high-resolution TEM images of individual Pd octahedra (top) and nanocubes 
(bottom). The models show simulated atomic structures on metal surfaces after the reaction of 
H2O2 + HO2 → O2 + OH + H2O. Adapted with permission from ref 146. Copyright 2016 American 
Chemical Society. (b) ELISA of prostate specific antigen (PSA) using Pt concave nanocubes as 
the labels, which act as peroxidase mimics to generate a color signal by catalyzing chromogenic 
substrates. Left column shows the schematic illustration of the assay. Right column shows the 
calibration curve of the assay for PSA standards. The inset shows a TEM image of an individual 
Pt concave nanocube. Adapted with permission from ref 149. Copyright 2017 Royal Society of 
Chemistry. 
Besides those above-mentioned examples, the shape of a noble-metal nanostructure also 
affects the generation of other types of detection signals in IVDs. For instance, in metal-enhanced 
fluorescence (MEF), the enhancement of the fluorescence signal has a strong dependence on the 
plasmonic properties that are largely determined by the shape of a nanostructure.150-151 The color 
of a Au or Ag nanostructure suspension can be tuned by changing the particle shape, which allows 
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for multiplexed detection of the biomarker/virus with colorimetric assays.152 The electrochemical 
signal of a noble-metal nanostructure can also be enhanced by carefully controlling the shape.153-
154 
1.3.3 Impact of Elemental Composition 
It should be emphasized that certain properties of NMNSs within a category could be 
distinctively different because the inherent nature of metal is unique with each other.19, 155 For 
example, the plasmonic sensitivity of Ag nanorods is up to 2 times higher than that of Au nanorods 
with similar resonance wavelengths.156 Apparently, elemental composition of a noble-metal 
nanostructure plays an important role in determining its properties and performance in IVDs. In 
the following discussion, instead of a monometallic system, a bimetallic system will be used to 
demonstrate that the performance of a noble-metal nanostructure in IVDs can be substantially 
improved by incorporating a second metal. In many cases, a subtle change in elemental 
composition makes a dramatic difference. The ideas and strategies discussed below can be 
extended to multimetallic systems. 
First, a second metal can enhance the detection signal generated from a nanostructure. For 
example, our research group has developed a novel type of peroxidase mimic—Pd@Ir1-2L 
core@shell nanocubes (Figure 1.14a)—that was prepared by coating ∼18 nm Pd nanocubes with 
a few atomic layers of Ir.66 The Pd@Ir1-2L cubes displayed a record-high catalytic efficiency with 
a Kcat at the level of 106 s-1, which is approximately 2 and 3 orders of magnitude higher than those 
of the initial Pd nanocubes and HRP, respectively (Figure 1.14b). Obviously, the enhanced 
efficiency of Pd@Ir1-2L cubes relative to the Pd nanocubes as the seeds can be attributed to the coat 
of Ir shells. To understand the impact of Ir shells on the catalytic efficiency, a set of Pd@Ir cubes 
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with different molar ratios of Ir to Pd were prepared, and their Kcat values were determined. 
Interestingly, it was found that the Kcat values showed a volcano-shaped dependence on the Ir 
contents, with a maximum point corresponding to approximately a monolayer of Ir on a Pd surface. 
Density functional theory (DFT) based theoretical calculations were conducted to gain more 
insights into the experimental observations, where Pd(100), Ir(100), Ir1L/Pd(100), and Ir3L/Pd(100) 
were compared. The simulation results indicated that Ir1L/Pd(100) among the four surfaces was the 
most reactive since the adsorption energies of key species in the catalytic reaction on this surface 
were most exothermic, which agreed well with the experimental results. Using ELISA as a model 
IVD platform and PSA as a disease biomarker, the Pd@Ir1-2L cube-based ELISA achieved a 
detection limit of 0.67 pg/mL, which is ∼110-fold lower than that of the conventional HRP-based 
ELISA (Figure 1.14c, d). This substantial improvement in detection sensitivity can be ascribed to 
the enhanced catalytic efficiency of Pd@Ir1-2L cubes relative to HRP because all the antibodies and 
materials used in the two ELISAs were kept the same. Enhancing the detection signal by 
incorporating a second metal is also evident in electrochemical biosensors.157-158 
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Figure 1.14 Pd@Ir1-2L core@shell cubes and their use in ELISA. (a) HAADF-STEM image of an 
individual Pd@Ir1-2L cube. (b) A chart comparing the peroxidase-like efficiencies (in terms of Kcat) 
of HRP, Pd cubes, and Pd@Ir1-2L cubes. (c) Schematics showing the principles of Pd@Ir1-2L cube- 
and HRP-based ELISAs. (d) Calibration curves of the two ELISAs for PSA standards. Inset shows 
the linear range region of the Pd@Ir1-2L cube-based ELISA. Adapted with permission from ref 66. 
Copyright 2015 American Chemical Society. 
Second, a second metal can enhance the stability of a nanostructure, ensuring reliable IVDs. 
Nanostructures of Ag are known to possess the strongest plasmonic activities among noble metals 
owing to their appropriate electronic structure and thus dielectric function.126, 159-161 Nevertheless, 
the excellent plasmonic properties of Ag nanostructures have not been fully utilized in IVDs and 
many other applications due to the relatively poor chemical and structural stabilities of Ag under 
unfavorable environments.162-164 Therefore, development of approaches that can stabilize Ag 
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nanostructures without compromising their plasmonic properties is critical to the practical 
applications of Ag nanostructures. An effective approach is to incorporate Ag nanostructures with 
Au, which is much more stable and has almost the same lattice constant as Ag. For example, Yang 
et al. reported a robust synthesis of Ag@Au core@shell nanocubes by depositing Au atoms onto 
Ag nanocubes.165 The key to the successful synthesis relied on the inhibition of the galvanic 
replacement between Ag and Au3+ by introducing a strong reducing agent to rapidly consume Au3+ 
ions. The conformal and ultrathin Au shells (sub-10 atomic layers, see a representative sample in 
Figure 1.15a) were able to protect the Ag nanocubes in oxidative environments. The Ag@Au 
nanocubes displayed surface plasmonic properties essentially identical to those of the initial Ag 
nanocubes. Significantly, because of the stronger adsorption of Raman probe molecules on the Au 
surface relative to Ag, the Ag@Au nanocubes exhibited an outstanding and stable SERS activity 
with an enhancement factor (EF) ∼5-fold greater than that of Ag nanocubes (Figure 1.15b). In 
another study by Gao et al., instead of core@shell structure, Au was mixed with Ag to form a 
Ag/Au alloyed structure (Figure 1.15c).166 Unlike conventional methods based on co-reduction of 
Au and Ag precursors, the Ag/Au alloy was formed through the annealing process at elevated 
temperatures (∼1000 °C). The high-temperature annealing promoted the complete mixing of Ag 
and Au at the atomic scale. The alloyed nanostructure obtained from this method is featured by 
homogeneous distribution of Ag and Au, minimal crystallographic defects, and the absence of 
structural and compositional interfaces. These features ensured outstanding plasmonic properties 
(e.g., large extinction cross-sections and narrow bandwidths) and enhanced stabilities for the 
resultant Ag/Au alloyed nanostructures (see Figure 1.15d). Collectively, these approaches 
preserved the superior plasmonic properties of Ag while adopting the excellent stabilities of Au, 
making the Au-incorporated Ag nanostructures particularly suitable for IVDs (e.g., SPR and SERS 
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biosensing). 
 
Figure 1.15 (a) HAADF-STEM image of an individual Ag@Au core@shell nanocube. Inset is a 
magnified image highlighting the three atomic layers of Au on the Ag core. (b) SERS spectra taken 
from aqueous suspensions of 1,4-benzenedithiol functionalized Ag@Au nanocubes (sample in a) 
and Ag nanocubes. Adapted with permission from ref 165. Copyright 2014 American Chemical 
Society. (c) STEM and EDX mapping images of Ag/Au alloyed NPs (Ag/Au = 5). (d) UV-vis 
spectra recorded from pure Ag NPs and Ag/Au alloyed NPs that were suspended in a mixed solvent 
of H2O2 and ammonia. Adapted with permission from ref 166. Copyright 2014 American Chemical 
Society. 
1.3.4 Impact of Internal Structure  
The internal structure of NMNSs in this section refers to the hollowness. Hollow NMNSs 
have received great interest in recent years because of the unique and useful properties that cannot 
be offered by their solid counterparts.167 For example, hollow nanostructures of Au or Ag are 
known to have better plasmonic properties compared to their solid counterparts thanks to the 
interaction of plasmon fields in the inner and outer layers, in compliance with the plasmon 
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hybridization mechanism.168 The hybridizations of the plasmons leads to the enhanced plasmon 
fields together with homogeneous distribution and a red-shift of plasmon resonances.169-171 In a 
recent work, Genç et al. systematically investigated the plasmon resonances of Au/Ag cubic 
nanostructures with different extents of hollowness (including solid nanocubes, nanocubes with 
pinholes, nanoboxes with completely hollow interior, and nanoframes with an open structure) on 
the nanoscale.172 Electron energy loss spectroscopy (EELS) was employed to obtain the spatially 
resolved mapping of plasmon resonances. Among those nanostructures, nanoboxes exhibited 
homogeneous distribution of plasmon resonances. As shown by the selected area EEL spectra 
obtained from different sites of a single nanobox (Figure 1.16a), the plasmon peaks were located 
in a relatively narrow range of ∼2-2.5 eV and had similar energies to one another. The abundance 
maps clearly show the homogeneous distribution of plasmon resonance all around the nanobox. 
These experimental observations were accurately correlated with the simulation results based on 
the BEM.33 In contrast, other nanostructures showed much fewer homogeneous distributions. This 
work revealed that the homogeneous distribution of plasmon resonances is the key feature for the 
enhanced plasmonic properties of hollow nanostructures. As a proof-of-concept demonstration, 
the nanoboxes were applied to label free SPR detection of bovine serum albumin (BSA) and anti-
BSA antibodies, of which performance was benchmarked against solid Au nanoparticles (see 
Figure 1.16b). The adsorption of biomolecules on the plasmonic nanostructures induces refractive 
index changes that can be measured by a UV-vis spectrometer. Compared with solid Au 
nanoparticles, ∼4-times stronger shifts in extinction wavelength were observed for the Au/Ag 
nanoboxes. This enhanced detection sensitivity could be ascribed to the enhancement of the 
localized electromagnetic field around the hollow nanoboxes that allowed for sensitive responses 
to binding events in their vicinity. 
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The hollow feature of a nanostructure also benefits its SERS enhancement and thus SERS 
biosensing. For example, in a work by Lim et al., Au nanobridged nanogap particles (Au-NNPs, 
see Figure 1.16c) with ∼1 nm gap between the core and shell were synthesized using dyed DNA-
functionalized Au nanoparticles as the seeds.173 Owing to the drastically enhanced electromagnetic 
field localized in the interior-gap region of the Au-NNP, the Raman signal from dyes trapped in 
the nanogap can be significantly amplified. Compared with solid Au nanoparticles, the Raman 
signal from the Au-NNPs was approximately 2 orders of magnitude stronger. Atomic force 
microscope (AFM)-correlated nano-Raman measurement was performed to determine the EF of 
the Au-NNPs. Random mapping of 200 individual Au-NNPs showed that their EF values were 
narrowly and uniformly distributed within the range of 1.0×108 to 5.0×109, making the Au-NNPs 
capable of single-molecule detection. Such a SERS enhancement by interior nanogap was also 
observed in Au/Ag double-walled nanoboxes. Notably, the size of the nanogap was found to play 
an important role in determining the SERS EF. Overall, the EF continuously decreased as the gap 
size increased from ∼1 to ∼16 nm. 
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Figure 1.16 (a) Plasmonic properties of Au/Ag nanoboxes (NBs). HAADF-STEM image of a 
single Au/Ag NB (top left), selected area EEL spectra of the areas marked in the HAADF-STEM 
image (bottom), and abundance map obtained by vertex component analysis (VCA) processing 
(top right). (b) The shifts of major LSPR peaks (Δλmax) for Au/Ag NB and AuNP suspensions after 
they had been conjugated with BSA and then anti-BSA antibody (BSA-Ab). Adapted with 
permission from ref 172. Copyright 2016 American Chemical Society. 
https://pubs.acs.org/doi/10.1021/acsphotonics.5b00667 (c) Au nanobridged nanogap particles 
(Au-NNPs) that were prepared using dye-DNA modified AuNPs as the seeds. TEM image of a 
single Au-NNP (top left), calculated near-field electromagnetic field distribution of a Au-NNP (top 
right), and a chart comparing the Raman intensities of Cy3 dye modified AuNPs and AuNNPs in 
solution. Adapted with permission from ref 173. Copyright 2011 Nature Publishing Group. 
It is worth noting that most of above-mentioned enhanced performance relies on the 
superior plasmonic properties of hollow nanostructures. Nevertheless, hollow nanostructures have 
several other distinctive advantages over their solid counterparts that may be taken into 
consideration in future IVD development. For example, the outer and inner surfaces of a hollow 
nanostructure offer more flexibilities for biomolecule conjugation. The cavity in a hollow 
nanostructure affects its density/weight and thus transport properties (e.g., diffusion and 
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sedimentation), which may influence its performance in IVD tests. The enlarged surface area and 
active surface atoms of a hollow nanostructure can boost its catalytic activities, providing 
enhanced detection signal. 
1.4 Objective and Overview of This Thesis 
Since the NMNSs serve as the signal transducers of IVDs, they are mainly responsible for 
the detection performance in relevance. Engineering NMNSs provides an efficient way to improve 
their physicochemical properties, thereby the signal generation in the IVDs. To date, many of the 
reported studies focused on the engineered Ag, Au, Pd, and Pt nanostructures,  few attentions have 
been paid to the rest. Also, improvement of peroxidase-like efficiency of NMNSs-based enzyme 
mimics has met with limited success.  
Facing with those challenges, we set up two objectives upon completion of the dissertation 
research: engineering NMNSs with superior peroxidase-like activity and developing ultrasensitive 
colorimetric IVD platforms for practical cancer detection. Inspired by our pioneer work of Pd-Ir 
nanocubes with record-high peroxidase-like efficient,66 several projects were carried out. Briefly, 
introduction of each chapters is organized as follow: 
Chapter 2 introduces the synthesis of Ru nanoframes (RuNFs) with face-centered cubic 
(fcc) crystal phase and enhanced catalytic activities. A two-step method was developed involving 
preferentially deposition of Ru on Pd cuboctahedra as seeds and selectively removal of Pd content, 
leading to the formation of RuNFs. The seed-mediated growth was believed to be responsible for 
the formation of fcc crystal phase of RuNFs.  
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Chapter 3 introduces a work that for the first time reports the Ru nanostructures with 
inherent peroxidase-like activity, of which the Kcat was approximately three times more active than 
natural peroxidases.  
Chapter 4 introduces an enzyme-free signal amplification technique for ultrasensitive 
colorimetric assay of disease biomarkers. In this study, sub-10 nm Pd-Ir nanooctahedra 
encapsulated gold vesicles were employed as labels to replace the enzymes in conventional 
ELISA, achieving substantially enhanced detection sensitivity. 
Chapter 5 introduces the facile synthesis of polyvinylpyrrolidone (PVP)-capped Pt 
nanocubes. The method we developed features several advantages over conventional preparation 
of Pt nanocubes. Also, the PVP-capped Pt nanocubes showed a superior peroxidase‐like efficiency.  
Chapter 6 introduces a novel strategy for colorimetric Ag(I) ions detection with high 
sensitivity. In this study, we found that the Ag(I) ions could significantly inhibit the peroxidase-
like activity of Pt nanocubes as-prepared in Chapter 5. On the basis of this discovery, we developed 
a colorimetric method for Ag+ ions detection. Also, the inhibition mechanism was investigated.  
Chapter 7 introduces a non-enzyme cascade-amplification (NECA) strategy for 
colorimetric assay of disease biomarkers. The amplification principle was again based on the 
inhibition effect of Ag(I)  ions to the peroxidase-like activity of Pt nanocubes. Coupling with silver 
enhancement, the NECA strategy could achieve a more sensitive detection of cancer biomarker 
than conventional ELISA.  
Chapter 8 introduces a dual-mode colorimetric IVD platform based on Au@Pt core-shell 
nanostructures as the signal transducers. Specifically, the Au@Pt core-shell nanostructures possess 
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the plasmonic property of the Au cores and high peroxidase-like activity of the Pt skins, allowing 
them to provide “on/off-demand” detection modes: one produced by the red color of interior 
AuNPs as the low-sensitivity mode and the other generated by the blue color from the Pt-catalyzed 
oxidation of peroxidase substrate as the high-sensitivity mode. 
1.5 Reference 
1. Faraday, M. Philos. Trans. R. Soc. London, 1857, 147, 145-181. 
2. Feynman, R. P. Caltech. Eng. Sci. 1960, 23, 22-36. 
3. Binnig, G. Helv. Phys. Acta 1982, 55, 726. 
4. Binnig, G. Phys. Rev. Lett. 1986, 56, 930. 
5. Drexler, K. E. Molecular machinery, manufacturing and computation. 1992. 
6. Hutchings, G. J.; Brust, M.; Schmidbaur, H. Chem. Soc. Rev. 2008, 37, 1759-1765. 
7. Fahlman, B. D. Semiconducting materials. In Materials Chemistry, Springer: 2007, 153-219. 
8. Roco, M. C. The long view of nanotechnology development: the National Nanotechnology 
Initiative at 10 years. Springer: 2011. 
9. Somorjai, G. A. Chem. Rev. 1996, 96, 1223-1236. 
10. Davey, N.; Seymour, R. Platin. Met. Rev. 1985, 29, 2-11. 
11. Maier, S. A.; Brongersma, M. L.; Kik, P. G.; Meltzer, S.; Requicha, A. A.; Atwater, H. A. Adv. 
Mater. 2001, 13, 1501-1505. 
12. Mulvaney, P. MRS Bull. 2001, 26, 1009-1014. 
13. Obuchi, A.; Ohi, A.; Nakamura, M.; Ogata, A.; Mizuno, K.; Ohuchi, H. Appl. Catal. B: 
Environ. 1993, 2, 71-80. 
14. Wang, H.; Brandl, D. W.; Nordlander, P.; Halas, N. J. Acc. Chem. Res. 2007, 40, 53-62. 
15. Yang, X.; Skrabalak, S. E.; Li, Z.-Y.; Xia, Y.; Wang, L. V. Nano Lett. 2007, 7, 3798-3802. 
16. Dreaden, E. C.; Alkilany, A. M.; Huang, X.; Murphy, C. J.; El-Sayed, M. A. Chem. Soc. Rev. 
2012, 41, 2740-2779. 
17. Ratner, M. A.; Ratner, D. Nanotechnology: A gentle introduction to the next big idea. Prentice 
Hall Professional: 2003. 
18. Xia, Y.; Xiong, Y.; Lim, B.; Skrabalak, S. E. Angew. Chem., Int. Ed. 2009, 48, 60-103. 
44 
 
19. Chen, M.; Wu, B.; Yang, J.; Zheng, N. Adv. Mater. 2012, 24, 862-879. 
20. Smith, I. C.; Carson, B. L.; Ferguson, T. L. Environ. Health Perspect. 1974, 8, 201. 
21. Kelly, K. L.; Coronado, E.; Zhao, L. L.; Schatz, G. C. J. Phys. Chem. B 2003, 107, 668-677. 
22. Hatef, A.; Meunier, M. Opt. Express 2015, 23, 1967-1980. 
23. Lal, S.; Link, S.; Halas, N. J. Nat. Photonics 2007, 1, 641. 
24. Jain, P. K.; El-Sayed, I. H.; El-Sayed, M. A. Nano today 2007, 2, 18-29. 
25. Mayer, K. M.; Hafner, J. H. Chem. Rev. 2011, 111, 3828-3857. 
26. Mie, G. Ann. Phys 1908, 25, 377-445. 
27. Gans, R. Ann. Phys.(Lepzig) 1912, 37, 881. 
28. Wriedt, T. Mie theory: a review. In The Mie Theory, Springer: 2012; 53-71. 
29. Purcell, E. M.; Pennypacker, C. R. Astrophys. J. 1973, 186, 705-714. 
30. Draine, B. T.; Flatau, P. J. J. Opt. Soc. Am. A 1994, 11, 1491-1499. 
31. Schatz, G. C. J. Mol. Struct. 2001, 573, 73-80. 
32. Wiley, B. J.; Im, S. H.; Li, Z.-Y.; McLellan, J.; Siekkinen, A.; Xia, Y. J. Phys. Chem. 
B, 2006, 110, 15666-15675. 
33. Myroshnychenko, V.; Rodríguez-Fernández, J.; Pastoriza-Santos, I.; Funston, A. M.; Novo, 
C.; Mulvaney, P.; Liz-Marzan, L. M.; de Abajo, F. J. G. Chem. Soc. Rev. 2008, 37, 1792-1805. 
34. Jain, P. K.; Huang, X.; El-Sayed, I. H.; El-Sayed, M. A. Acc. Chem. Res. 2008, 41, 1578-1586. 
35. Sinfelt, J. H.; Yates, D. J. J. Catal. 1967, 8, 82-90. 
36. Lee, I.; Morales, R.; Albiter, M. A.; Zaera, F. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 15241-
15246. 
37. Sinfelt, J. Adv. Catal. 1973, 23, 91-119. 
38. Rao, C. R.; Trivedi, D. Coord. Chem. Rev. 2005, 249, 613-631. 
39. An, K.; Somorjai, G. A. ChemCatChem 2012, 4, 1512-1524. 
40. Kuhn, J. N.; Huang, W.; Tsung, C.-K.; Zhang, Y.; Somorjai, G. A. J. Am. Chem. Soc. 2008, 
130, 14026-14027. 
41. Bratlie, K. M.; Lee, H.; Komvopoulos, K.; Yang, P.; Somorjai, G. A. Nano Lett. 2007, 7, 3097-
3101. 
42. Xiong, Y.; Wiley, B. J.; Xia, Y. Angew. Chem., Int. Ed. 2007, 46, 7157-7159. 
45 
 
43. Xie, S.; Choi, S.-I.; Lu, N.; Roling, L. T.; Herron, J. A.; Zhang, L.; Park, J.; Wang, J.; Kim, M. 
J.; Xie, Z. Nano Lett. 2014, 14, 3570-3576. 
44. Zhang, L.; Roling, L. T.; Wang, X.; Vara, M.; Chi, M.; Liu, J.; Choi, S.-I.; Park, J.; Herron, J. 
A.; Xie, Z. Science 2015, 349, 412-416. 
45. Wei, H.; Wang, E. Chem. Soc. Rev. 2013, 42, 6060-6093. 
46. Wu, J.; Wang, X.; Wang, Q.; Lou, Z.; Li, S.; Zhu, Y.; Qin, L.; Wei, H. Chem. Soc. Rev. 2019. 
47. Nelson, D. L.; Lehninger, A. L.; Cox, M. M. Lehninger principles of biochemistry. Macmillan: 
2008. 
48. Wang, X.; Guo, W.; Hu, Y.; Wu, J.; Wei, H. Nanozymes: next wave of artificial enzymes. 
Springer: 2016. 
49. Passardi, F.; Theiler, G.; Zamocky, M.; Cosio, C.; Rouhier, N.; Teixera, F.; Margis-Pinheiro, 
M.; Ioannidis, V.; Penel, C.; Falquet, L. Phytochemistry 2007, 68, 1605-1611. 
50. Pandey, V.; Awasthi, M.; Singh, S.; Tiwari, S.; Dwivedi, U. Biochem. Anal. Biochem. 2017, 
6. 
51. Hiraga, S.; Sasaki, K.; Ito, H.; Ohashi, Y.; Matsui, H. Plant Cell Physiol. 2001, 42, 462-468. 
52. Gaetani, G. F.; Galiano, S.; Canepa, L.; Ferraris, A. M.; Kirkman, H. N. Blood 1989, 73, 334-
339. 
53. Veitch, N. C. Phytochemistry 2004, 65, 249-259. 
54. Price, C. P.; Newman, D. J. Principles and practice of immunoassay. Springer: 1991. 
55. Klibanov, A. M.; Tu, T.-M.; Scott, K. P. Science 1983, 221, 259-261. 
56. Chattopadhyay, K.; Mazumdar, S. Biochemistry 2000, 39, 263-270. 
57. Gao, L.; Zhuang, J.; Nie, L.; Zhang, J.; Zhang, Y.; Gu, N.; Wang, T.; Feng, J.; Yang, D.; 
Perrett, S. Nat. Nanotechnol. 2007, 2, 577. 
58. Song, Y.; Qu, K.; Zhao, C.; Ren, J.; Qu, X. Adv. Mater. 2010, 22, 2206-2210. 
59. Sun, H.; Zhou, Y.; Ren, J.; Qu, X. Angew. Chem., Int. Ed. 2018. 
60. Fan, J.; Yin, J.-J.; Ning, B.; Wu, X.; Hu, Y.; Ferrari, M.; Anderson, G. J.; Wei, J.; Zhao, Y.; 
Nie, G. Biomaterials 2011, 32, 1611-1618. 
61. André, R.; Natálio, F.; Humanes, M.; Leppin, J.; Heinze, K.; Wever, R.; Schröder, H. C.; 
Müller, W. E.; Tremel, W. Adv. Funct. Mater. 2011, 21, 501-509. 
46 
 
62. Zhao, H.; Dong, Y.; Jiang, P.; Wang, G.; Zhang, J. ACS Appl. Mater. Interfaces 2015, 7, 6451-
6461. 
63. Liu, S.; Lu, F.; Xing, R.; Zhu, J. Chem. Eur. J. 2011, 17, 620-625. 
64. Sun, X.; Guo, S.; Chung, C. S.; Zhu, W.; Sun, S. Adv. Mater. 2013, 25, 132-136. 
65. Zhang, X.; Wu, G.; Cai, Z.; Chen, X. Talanta 2015, 134, 132-135. 
66. Xia, X.; Zhang, J.; Lu, N.; Kim, M. J.; Ghale, K.; Xu, Y.; McKenzie, E.; Liu, J.; Ye, H. ACS 
nano 2015, 9, 9994-10004. 
67. Kang, Y.; Pyo, J. B.; Ye, X.; Diaz, R. E.; Gordon, T. R.; Stach, E. A.; Murray, C. B. ACS nano 
2012, 7, 645-653. 
68. Xia, Y.; Xia, X.; Peng, H.-C. J. Am. Chem. Soc. 2015, 137, 7947-7966. 
69. Banholzer, M. J.; Millstone, J. E.; Qin, L.; Mirkin, C. A. Chem. Soc. Rev. 2008, 37, 885-897. 
70. Dieringer, J. A.; Lettan, R. B.; Scheidt, K. A.; Van Duyne, R. P. J. Am. Chem. Soc. 2007, 129, 
16249-16256. 
71. Turner, A. P.; Chen, B.; Piletsky, S. A. Clin. Chem. 1999, 45, 1596-1601. 
72. Michalet, X.; Pinaud, F.; Bentolila, L.; Tsay, J.; Doose, S.; Li, J.; Sundaresan, G.; Wu, A.; 
Gambhir, S.; Weiss, S. Science 2005, 307, 538-544. 
73. Khlebtsov, N.; Dykman, L. Chem. Soc. Rev. 2011, 40, 1647-1671. 
74. Jin, Z.; Hildebrandt, N. Trends Biotechnol. 2012, 30, 394-403. 
75. Rohr, U.-P.; Binder, C.; Dieterle, T.; Giusti, F.; Messina, C. G. M.; Toerien, E.; Moch, H.; 
Schäfer, H. H. PLoS One 2016, 11, e0149856. 
76. Zhou, W.; Gao, X.; Liu, D.; Chen, X. Chem. Rev. 2015, 115, 10575-10636. 
77. Scott, M. G.; Bruns, D. E.; Boyd, J. C.; Sacks, D. B. Clin. Chem. 2009, 55, 18-20. 
78. Peter, J. G.; Theron, G.; Dheda, K. PloS one 2013, 8, e54875. 
79. Gottlieb, S.; Woodcock, J. Nat. Biotechnol. 2006, 24, 927. 
80. Giljohann, D. A.; Mirkin, C. A. Nature 2009, 462, 461. 
81. Ambrosi, A.; Airo, F.; Merkoçi, A. Anal. Chem. 2009, 82, 1151-1156. 
82. Beqa, L.; Fan, Z.; Singh, A. K.; Senapati, D.; Ray, P. C. ACS Appl. Mater. Interfaces 2011, 3, 
3316-3324. 
83. Rundle, A.; Neugut, A. I. Prostate 2008, 68, 373-380. 
47 
 
84. Thaxton, C. S.; Elghanian, R.; Thomas, A. D.; Stoeva, S. I.; Lee, J.-S.; Smith, N. D.; Schaeffer, 
A. J.; Klocker, H.; Horninger, W.; Bartsch, G. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 18437. 
85. Rissin, D. M.; Kan, C. W.; Campbell, T. G.; Howes, S. C.; Fournier, D. R.; Song, L.; Piech, 
T.; Patel, P. P.; Chang, L.; Rivnak, A. J. Nat. Biotechnol. 2010, 28, 595. 
86. Asiago, V. M.; Alvarado, L. Z.; Shanaiah, N.; Gowda, G. N.; Owusu-Sarfo, K.; Ballas, R. A.; 
Raftery, D. Cancer Res. 2010, 0008-5472. CAN-10-1319. 
87. Turner, A. P. Chem. Soc. Rev. 2013, 42, 3184-3196. 
88. Vashist, S. K.; Schneider, E. M.; Luong, J. H. Biosens. Bioelectron. 2015, 67, 73-78. 
89. Jain, K. K. Clin. Chim. Acta 2005, 358, 37-54. 
90. Chi, X.; Huang, D.; Zhao, Z.; Zhou, Z.; Yin, Z.; Gao, J. Biomaterials 2012, 33, 189-206. 
91. Butler, S. A.; Khanlian, S. A.; Cole, L. A. Clin. Chem. 2001, 47, 2131-2136. 
92. Van Amerongen, A.; Wichers, J.; Berendsen, L.; Timmermans, A.; Keizer, G.; Van Doorn, A.; 
Bantjes, A.; Van Gelder, W. J. Biotechnol. 1993, 30, 185-195. 
93. Leuvering, J. H.; Thal, P.; Waart, M. v. d.; Schuurs, A. J. Immunoassay. Immunochem. 1980, 
1, 77-91. 
94. Kimling, J.; Maier, M.; Okenve, B.; Kotaidis, V.; Ballot, H.; Plech, A. J. Phys. Chem. B 2006, 
110, 15700-15707. 
95. Turkevich, J. Gold Bull. 1985, 18, 125-131. 
96. Enustun, B.; Turkevich, J. J. Am. Chem. Soc. 1963, 85, 3317-3328. 
97. Nightingale, A. M.; Bannock, J. H.; Krishnadasan, S. H.; O'Mahony, F. T.; Haque, S. A.; Sloan, 
J.; Drury, C.; McIntyre, R. J. Mater. Chem. A 2013, 1, 4067-4076. 
98. Lohse, S. E.; Eller, J. R.; Sivapalan, S. T.; Plews, M. R.; Murphy, C. J. ACS nano 2013, 7, 
4135-4150. 
99. Niu, G.; Zhang, L.; Ruditskiy, A.; Wang, L.; Xia, Y. Nano Lett. 2018, 18, 3879-3884. 
100. Sepúlveda, B.; Angelomé, P. C.; Lechuga, L. M.; Liz-Marzán, L. M. nano today 2009, 4, 
244-251. 
101. Huang, X.; Liu, Y.; Yung, B.; Xiong, Y.; Chen, X. ACS nano 2017, 11, 5238-5292. 
102. Howes, P. D.; Rana, S.; Stevens, M. M. Chem. Soc. Rev. 2014, 43, 3835-3853. 
103. Perfezou, M.; Turner, A.; Merkoçi, A. Chem. Soc. Rev. 2012, 41, 2606-2622. 
48 
 
104. Wu, X.; Xu, L.; Ma, W.; Liu, L.; Kuang, H.; Kotov, N. A.; Xu, C. Adv. Mater. 2016, 28, 
5907-5915. 
105. Rodríguez-Lorenzo, L.; De La Rica, R.; Álvarez-Puebla, R. A.; Liz-Marzán, L. M.; Stevens, 
M. M. Nat. Mater. 2012, 11, 604. 
106. Zhu, H.; Sigdel, A.; Zhang, S.; Su, D.; Xi, Z.; Li, Q.; Sun, S. Angew. Chem., Int. Ed. 2014, 
53, 12508-12512. 
107. Hu, Y.; Cheng, H.; Zhao, X.; Wu, J.; Muhammad, F.; Lin, S.; He, J.; Zhou, L.; Zhang, C.; 
Deng, Y. ACS nano 2017, 11, 5558-5566. 
108. Xie, J.; Zhang, Q.; Lee, J. Y.; Wang, D. I. ACS nano 2008, 2, 2473-2480. 
109. Gao, L.; Liu, M.; Ma, G.; Wang, Y.; Zhao, L.; Yuan, Q.; Gao, F.; Liu, R.; Zhai, J.; Chai, Z. 
ACS nano 2015, 9, 10979-10990. 
110. Liu, D.; Huang, X.; Wang, Z.; Jin, A.; Sun, X.; Zhu, L.; Wang, F.; Ma, Y.; Niu, G.; Hight 
Walker, A. R. ACS nano 2013, 7, 5568-5576. 
111. Bui, M.-P. N.; Ahmed, S.; Abbas, A. Nano Lett. 2015, 15, 6239-6246. 
112. Hong, R.; Fischer, N. O.; Emrick, T.; Rotello, V. M. Chem. Mater. 2005, 17, 4617-4621. 
113. Latham, A. H.; Williams, M. E. Langmuir 2006, 22, 4319-4326. 
114. Pale-Grosdemange, C.; Simon, E. S.; Prime, K. L.; Whitesides, G. M. J. Am. Chem. Soc. 
1991, 113, 12-20. 
115. Xia, X.; Yang, M.; Wang, Y.; Zheng, Y.; Li, Q.; Chen, J.; Xia, Y. ACS nano 2011, 6, 512-
522. 
116. Yan, Y.; Wang, T.; Li, X.; Pang, H.; Xue, H. Inorg. Chem. Front. 2017, 4, 33-51. 
117. Zhang, X.; Si, S.; Zhang, X.; Wu, W.; Xiao, X.; Jiang, C. ACS Appl. Mater. Interfaces 2017, 
9, 40726-40733. 
118. Xia, X.; Xia, Y. Front. Phys. 2014, 9, 378-384. 
119. Kim, M. S.; Kweon, S. H.; Cho, S.; An, S. S. A.; Kim, M. I.; Doh, J.; Lee, J. ACS Appl. Mater. 
Interfaces 2017, 9, 35133-35140. 
120. Zhu, Z.; Guan, Z.; Jia, S.; Lei, Z.; Lin, S.; Zhang, H.; Ma, Y.; Tian, Z. Q.; Yang, C. J. Angew. 
Chem., Int. Ed. 2014, 53, 12503-12507. 
121. Lee, Y. W.; Kim, M.; Kang, S. W.; Han, S. W. Angew. Chem., Int. Ed. 2011, 50, 3466-3470. 
49 
 
122. Sankar, M.; Dimitratos, N.; Miedziak, P. J.; Wells, P. P.; Kiely, C. J.; Hutchings, G. J. Chem. 
Soc. Rev. 2012, 41, 8099-8139. 
123. Chen, C.; Kang, Y.; Huo, Z.; Zhu, Z.; Huang, W.; Xin, H. L.; Snyder, J. D.; Li, D.; Herron, 
J. A.; Mavrikakis, M. Science 2014, 343, 1339-1343. 
124. Hong, J. W.; Kang, S. W.; Choi, B.-S.; Kim, D.; Lee, S. B.; Han, S. W. ACS nano 2012, 6, 
2410-2419. 
125. Park, J.; Joo, J.; Kwon, S. G.; Jang, Y.; Hyeon, T. Angew. Chem., Int. Ed. 2007, 46, 4630-
4660. 
126. Rycenga, M.; Cobley, C. M.; Zeng, J.; Li, W.; Moran, C. H.; Zhang, Q.; Qin, D.; Xia, Y. 
Chem. Rev. 2011, 111, 3669-3712. 
127. Murphy, C. J.; Sau, T. K.; Gole, A. M.; Orendorff, C. J.; Gao, J.; Gou, L.; Hunyadi, S. E.; Li, 
T. J. Phys. Chem. B, 2005, 109, 13857-13870. 
128. Daniel, M.-C.; Astruc, D. Chem. Rev. 2004, 104, 293-346. 
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CHAPTER 2 RU NANOFRAMES WITH AN FCC STRUCTURE AND 
ENHANCED CATALYTIC PROPERTIESa 
2.1 Introduction 
Nanoframes (NFs) made of noble metals have received great attention in recent years due 
to their remarkable performance in many applications including catalysis, plasmonics, and 
biomedicine.1-3 The highly open structure of NFs is mainly responsible for their enhanced 
properties and superior performance. In catalysis, for example, nanocatalysts with frame 
morphologies ensure increased surface area to volume ratio and reduced coordination number for 
atoms on the surface, thereby maximizing the catalytic activity.4-6 In plasmonics, the localized 
surface plasmon resonance peaks of noble-metal (e.g., Au and Ag) nanostructures could be tuned 
to the near-infrared region when they are engineered to be frames, making them particularly 
suitable for in vivo medical applications.7-9 
Over the past two decades, a variety of noble-metal NFs have been actively developed, 
including those made of Au, Ag, Pt, Pd, Rh, and a combination of them.4-26 Notable examples 
include Au-Ag cubic,7, 13, 14 triangular,8 octahedral,9 and decahedral10 NFs by the Xia, Mirkin, Li, 
and Kitaev groups, respectively, Pt concave cubic NFs by Lou and co-workers,11 Pd cubic NFs by 
Matsui and co-workers,12 Rh cubic NFs by Xia and co-workers,15 and Pt-Ni rhombic dodecahedral 
NFs by Yang and co-workers.4 However, to the best of our knowledge, Ru NFs have never been 
reported before. It should be noted that Ru nanostructures have found widespread use in many 
industrially important catalytic reactions such as hydrogenation, ammonia synthesis, and CO 
                                                          
aReprinted with permission from Nano Lett. 2016, 16, 2812-2817.  
Copyright © 2016, American Chemical Society 
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oxidation,27-29 which motivated us to explore NFs of Ru and investigate their catalytic properties. 
Moreover, unlike the cases of other noble metals, shape-controlled synthesis of Ru nanostructures 
has received very limited success.30, 31 Herein, we report a robust approach, based on seeded 
growth and chemical etching, to the synthesis of Ru NFs with an octahedral shape, edge length of 
sub-10 nm, and thickness of only ∼2 nm. Notably, the Ru NFs exhibited a face-centered cubic 
(fcc) structure that is unusual for Ru nanocrystals. Using the reduction of p-nitrophenol by sodium 
borohydride (NaBH4) and the dehydrogenation of ammonia borane as model reactions, we 
demonstrated that the fcc Ru NFs showed enhanced catalytic activities compared to Ru nanowires 
with a hexagonal close-packed (hcp) structure and a similar thickness. 
Figure 2.1 illustrates the two-step synthetic approach for the Ru NFs. In the first step, Ru 
was directed to selectively grow on the corners and edges of Pd truncated octahedra as the seeds, 
resulting in the formation of Pd-Ru core-frame octahedra. Here, the site-selective growth of Ru 
was achieved by manipulating the reaction kinetics (which will be discussed in detail later). In the 
second step, Ru NFs were obtained by removing Pd from the Pd-Ru core-frame octahedra using 
an oxidative etchant, of which strength is sufficiently strong to etch Pd while too weak to react 
with Ru. 
 
Figure 2.1 Schematic illustration showing the two steps involved in the synthesis of Ru NFs: (1) 
selective nucleation and growth of Ru on the corners and edges of Pd truncated octahedra, yielding 
Pd-Ru core-frame octahedra, and (2) formation of Ru octahedral NFs by etching away the Pd cores. 
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2.2 Results and Discussion 
We started with the growth of Ru on Pd-truncated octahedral seeds. In a standard synthesis, 
a solution of RuCl3·xH2O (precursor to Ru) in ethylene glycol was injected at a rate of 2.0 mL/h 
using a syringe pump into a mixture containing Pd-truncated octahedra with an average size of 5.6 
nm as the seeds (Figure S2.1 in Appendix B), L-ascorbic acid as a reductant, and 
poly(vinylpyrrolidone) (PVP) as a colloidal stabilizer, which had been preheated to 200 °C under 
magnetic stirring. The reasons why we chose Pd-truncated octahedra as the seeds are (i) they can 
be easily prepared with high purity and large quantity because they represent the most 
thermodynamically stable product (i.e., the Wulff polyhedron)30 and (ii) they expose a set of well-
defined, low-index facets on the surface, {100} at corners, {110} at edges, and {111} at side faces 
(see the model in Figure 2.1 and corresponding high-resolution transmission electron microscopy, 
HRTEM, Figure S2.1 in Appendix B),32 making it convenient to achieve the site-selective growth 
of Ru. Figure 2.2a shows a typical TEM image of the products obtained from a standard synthesis. 
It can be seen that the products took an octahedral shape with sharp corners and straight edges of 
∼6.1 nm, implying the successful deposition of Ru on the corners and edges of Pd seeds and thus 
the formation of Pd-Ru core-frame octahedra. The composition and structure of the Pd-Ru 
bimetallic octahedra were characterized by energy dispersive X-ray (EDX) analyses and HAADF-
STEM. The line profiles of EDX analysis recorded from an individual Pd-Ru octahedron along 
two different directions (Figure 2.2b) clearly show that the corners and edges exhibited high Ru 
content while the core was essentially made of pure Pd, confirming that the products were Pd-Ru 
core-frame octahedra. The high-resolution HAADF-STEM (Figure 2.2c) and HRTEM (Figure 
S2.2 in Appendix B) images taken from individual Pd-Ru core-frame octahedron clearly indicate 
that Ru was epitaxially grown on Pd seeds and replicated the fcc structure of Pd as indicated by 
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the continuous lattice from the Pd core to the Ru frame. The lattice fringe spacing of 1.9 and 2.2 
Å marked on the corner and edge regions (see Figure 2.2c) can be indexed to the {200} and {111} 
reflections, respectively, of fcc Ru.33 Note that Ru and Pd have similar atomic masses, and the 
lattice mismatch between fcc Ru and Pd is only 1.8% (3.82 vs. 3.89 Å), so it is impossible to 
resolve the elemental composition from the STEM image. Because the reduction potential of 
Pd2+/Pd (0.95 V vs. SHE) is more positive than that of Ru3+/Ru (0.60 V vs. SHE),34 galvanic 
replacement between Pd seeds and RuCl3 should not occur during the synthesis.
35 This argument 
was validated by the experimental observation that no characteristic pits or cavities caused by 
galvanic replacement reaction35 were observed in the Pd-Ru core-frame octahedra (Figure 2.2a, 
c). 
 
Figure 2.2 Structural and compositional analyses of the Pd-Ru core-frame octahedra that were 
obtained by growing Ru on the corners and edges of Pd truncated octahedra as the seeds. (a) 
Typical TEM image showing the octahedral shape and good uniformity of the sample. Inset shows 
corresponding atomic model. (b) Line-scan EDX spectra of elemental Pd and Ru that were 
acquired from an individual octahedron (inset) along a corner-to-corner and an edge-to-edge 
directions as indicated by the white arrows. (c) High-resolution HAADF-STEM image of an 
individual octahedron orientated along ⟨110⟩ direction. 
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It is worth pointing out that in most cases Ru tends to take an hcp structure during the 
synthesis of Ru nanocrystals.36-38 Despite fcc Ru nanocrystals being occasionally observed,33, 39 
the mechanism of fcc structure formation is still unclear. In a sense, the epitaxial overgrowth of 
Ru on an fcc Pd seed reported here provides a simple and effective method to synthesize fcc Ru 
nanocrystals. To further demonstrate this method, we also used Pd nanocubes (Figure 2.3a) that 
were mainly covered by {100} facets as the seeds for the overgrowth of Ru. Because all the side 
faces of these Pd cubes were blocked by Br ions,40 the overgrowth of Ru was forced to occur on 
the corner sites, leading to the formation of Pd-Ru octapods (Figure 2.3b). In this case, the growth 
direction of Ru was along the ⟨111⟩ directions that is completely different from the previous case 
of Pd truncated octahedral seeds (e.g., ⟨100⟩ and ⟨110⟩ directions). Nevertheless, as indicated by 
the HRTEM image in Figure 2.3c, d, Ru at the out-extending corners of a Pd-Ru octapod still took 
the fcc structure regardless of the growth direction. In the absence of Pd seeds and under the similar 
reaction conditions, however, Ru wavy nanowires (NWs) of ∼2 nm in thickness (Figure 2.4a) 
were obtained as the products. Interestingly, these Ru NWs took an hcp structure that was 
confirmed by the HRTEM image in Figure 2.4b and the X-ray diffraction (XRD) data in Figure 
2.4c. These results demonstrated the versatility of this seeded-growth method to the synthesis of 
fcc Ru nanocrystals. 
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Figure 2.3 Overgrowth of Ru on the corners of 18 nm Pd nanocubes as the seeds. (a) TEM image 
of the 18 nm Pd cubic seeds; (b) TEM image of the Pd-Ru octapods that were grown from the 18 
nm Pd cubic seeds; (c) HRTEM of an individual Pd-Ru octapod orientated along the <100> 
direction; (d) magnified HRTEM image of the region marked by a white box in (c), showing the 
fcc structure of Ru at the corners. Insets in (a, b) show corresponding atomic models of the samples. 
 
Figure 2.4 (a) Typical TEM image of Ru wavy NWs that were prepared in the absence of Pd 
seeds. (b) HRTEM image recorded from part of an individual Ru NW, showing the hcp structure. 
(c) XRD pattern recorded from the Ru NWs shown in (a). (d) XRD pattern recorded from the Ru 
58 
 
NFs shown in Figure 2.6. Insets in (c, d) show corresponding models of the crystal structures. 
Blue bars in (c): JCPDS no. 06-0663 (hcp Ru). Red bars in (d): JCPDS no. 88-2333 (fcc Ru). 
The key to the successful synthesis of Pd-Ru core-frame octahedra is to induce preferential 
overgrowth of Ru at the corners and edges of a Pd truncated octahedral seed by controlling the 
reaction kinetics. On the basis of our recent mechanistic understanding on kinetic control,41, 42 we 
assume that the growth pathway for the current system could be summarized in Figure 2.5a: the 
newly generated Ru atoms from the reduction of RuCl3·xH2O were initially deposited on the 
corners of a Pd truncated octahedral seed due to their higher reactivity relative to the edges and 
side faces.43 Upon deposition, the Ru adatoms could migrate to the edges and side faces through 
surface diffusion. The growth pathway of the seed was determined by the ratio between the rates 
for atom deposition and surface diffusion (Vdeposition/Vdiffusion). When Vdeposition/Vdiffusion >> 1, surface 
diffusion can be ignored and thereby the growth will be largely confined to the corner sites of 
seeds, resulting in the formation of Pd-Ru hexapods. On the contrary, when Vdeposition/Vdiffusion << 1 
the growth will be dominated by surface diffusion, facilitating the conformal coating of Ru and 
thus the formation of Pd-Ru truncated octahedra as the final product. When Vdeposition and Vdiffusion 
are comparable, a portion of the Ru adatoms at the corners will migrate to the edges (which are 
relatively active than the side faces)43 of seeds, leading to the formation of Pd-Ru core-frame 
octahedra. To validate this assumption, we adjusted Vdeposition by controlling the injection rate for 
RuCl3·xH2O solution using a syringe pump, while kept Vdiffusion unchanged by fixing the reaction 
temperature at 200 °C.42 In this way, Vdeposition/Vdiffusion should increase as the injection rate for 
RuCl3·xH2O solution increases. If the proposed mechanism is reasonable, Pd-Ru hexapods and 
truncated octahedra should be obtained when the injection rate in the standard synthesis (e.g., 2.0 
mL/h) is increased and decreased, respectively. As expected, the final product took a hexapod-like 
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morphology (Figure 2.5b) when the injection rate was increased to 10 mL/h; truncated octahedra 
(Figure 2.5c) with a slightly enlarged size compared to the initial seeds were obtained when the 
injection rate was decreased to 0.5 mL/h. 
 
Figure 2.5 (a) Schematic illustrations summarizing the different pathways and the corresponding 
morphologies expected for the overgrowth of Ru on a Pd truncated octahedral seed under three 
different conditions; (b) TEM image of Pd-Ru hexapods corresponding to the case i) in (a), which 
were obtained by increasing the injection rate for RuCl3·xH2O in a standard synthesis of Pd-Ru 
core-frame octahedra from 2.0 mL/h to 10 mL/h; (c) TEM image of Pd-Ru truncated octahedra 
corresponding to the case iii) in (a), which were obtained by decreasing the injection rate for 
RuCl3·xH2O in a standard synthesis of Pd-Ru core-frame octahedra from 2.0 mL/h to 0.5 mL/h. 
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Note that the TEM images of Pd-Ru core-frame octahedra corresponding to the case ii) in (a) are 
shown in Figure 2.2. 
In order to obtain Ru NFs from the Pd-Ru core-frame octahedra shown in Figure 2.2, Pd 
cores need to be selectively removed. It is known that the chemical stabilities of Ru and Pd are 
quite different.44 Specifically, Ru is highly resistant to oxidative corrosion and can hardly be 
dissolved by aqua regia.45 In contrast, Pd is much more vulnerable to chemical oxidation. On the 
basis of this difference in chemical stability, we chose chemical etching to selectively remove the 
Pd cores from the Pd-Ru core-frame octahedra. The etching was conducted in an aqueous solution 
at 90 °C using an etchant based on the Fe3+/Br– pair, where Pd was etched through reaction: Pd + 
2 Fe3+ + 4 Br–→ PdBr42– + 2Fe2+.15 As shown by the TEM and HAADF-STEM images in Figure 
2.6a-c, most of the Pd cores were successfully removed, leaving only Ru NFs with an overall 
octahedral shape. This result further confirms that Ru was preferentially grown on the corners and 
edges on a Pd-truncated octahedral seed. It should be pointed out that most of the products had an 
imperfect octahedral shape with some edges and/or corners undeveloped (HAADF-STEM images 
of representative samples are shown in Figure S2.3 of Appendix B). For simplicity, we refer to 
the products as “octahedral NFs” in this study. The undeveloped edges/corners of Ru octahedral 
NFs might be ascribed to the incomplete diffusion of Ru adatoms across the edges of Pd seeds. 
This assumption was supported by the observation that Ru octahedral NFs with more missing 
edges/corners (Figure S2.4 in Appendix B) were obtained as the final products when Ru precursor 
was halved during the overgrowth of Ru on Pd seeds. The additional low-magnification TEM 
image in Figure S2.5 (Appendix B) demonstrated that the Ru NFs could be obtained with a high 
purity and good uniformity. From the magnified TEM image in Figure 2.6b, the average edge 
length and thickness of the Ru NFs were measured to be 6.1 and 1.8 nm, respectively. This edge 
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length of Ru NFs was essentially the same as that of the initial Pd-Ru core-frame octahedra, 
indicating that Ru was intact during the etching. We also analyzed the chemical composition of 
the NFs by inductively coupled plasma-optical emission spectrometry (ICP-OES) in which the 
molar ratio of Ru to Pd was determined to be ∼4.5:1. According to previous studies,46, 47 the small 
portion of Pd in Ru NFs likely exists in the form of Ru/Pd alloy due to the interdiffusion between 
Ru and Pd. Significantly, the fcc structure and lattice spacing of Ru were maintained during the 
etching as indicated by the HRTEM image in the inset of Figure 2.6d. The fcc structure of the Ru 
NFs was also confirmed by the XRD data in Figure 2.4d. 
 
Figure 2.6 Characterization of the Ru NFs that were obtained by etching away Pd cores from the 
Pd-Ru core-frame octahedra shown in Figure 2.2. (a) Low-magnification TEM image showing 
the good uniformity. (b) TEM image at a higher magnification showing the overall octahedral 
shape. Inset shows an ideal atomic model of the sample. (c) HAADF-STEM image. Inset shows a 
high-resolution HAADF-STEM image of an individual Ru NF (scale bar = 1 nm). (d) HRTEM 
image of an individual Ru NF orientated along ⟨110⟩ direction. 
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Finally, the fcc Ru NFs were evaluated as catalysts for model catalytic reactions. We started 
with the reduction of p-nitrophenol by NaBH4. We chose this reaction because it has been widely 
used for evaluating the catalytic properties of noble-metal catalysts and its reaction kinetics can be 
conveniently determined with a UV-vis spectrophotometer.48-51 Because the hcp Ru NWs (Figure 
2.4a) have a similar thickness with the fcc Ru NFs, we benchmarked the catalytic activity of the 
fcc Ru NFs against the hcp Ru NWs. For all experiments, the initial concentrations of p-nitrophenol 
and NaBH4 were kept at 0.15 mM and 10 mM, respectively. The concentrations of both Ru-based 
catalysts were 2.2 μM in Ru element. The p-nitrophenol solution exhibited a major absorption 
peak at 317 nm under neutral or acidic condition. Upon the addition of NaBH4, the absorption peak 
shifted to 400 nm due to the increase of alkalinity of the solution and the dominance of p-
nitrophenolate ions.52, 53 After Ru-based catalyst was added, the absorption peak at 400 nm 
gradually dropped in intensity as the reduction reaction proceeded (Figure 2.7a, b). The reaction 
kinetics was monitored by measuring the concentration of p-nitrophenolate ions based on the 
absorbance at 400 nm. Figure 2.7c shows the plots of extinction intensity at 400 nm (Iext) as a 
function of time (t) for both Ru NFs and Ru NWs. It is clear that Ru NFs catalyzed reaction was 
much faster than Ru NWs catalyzed one. In our reaction system, the concentration of NaBH4 was 
far more in excess than that of p-nitrophenol, so its concentration can be considered as a constant 
during the reaction. As such, the pseudo-first-order kinetics with respect to p-nitrophenol could be 
applied to the reaction.53 This assumption was supported by the approximately linear shape of the 
plot of -ln Iext versus time as shown in Figure 2.7d. On the basis of this linear relationship, the 
average reaction rate constant (k) from three independent experiments for the Ru NFs and Ru NWs 
were calculated to be 0.022 ± 0.001 and 0.005 ± 0.0002 min–1, respectively, indicating a higher 
catalytic activity for Ru NFs relative to Ru NWs. 
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Figure 2.7 Comparison of the catalytic activities of fcc Ru NFs (red) and hcp Ru NWs (blue) 
toward the reduction of p-nitrophenol by NaBH4. (a, b) The extinction spectra of reaction solutions 
at different times, indicating the decrease of peak intensity at 400 nm for p-nitrophenol due to the 
reduction of -NO2 group into -NH2 group (see the inset in panel a). (c) Normalized extinction 
(against the initial point) at the 400 nm peak for p-nitrophenol as a function of time. (d) Plots of -
ln Iext against time that were generated from (c), where Iext denotes the normalized extinction at the 
400 nm peak. 
We also evaluated the catalytic performance of Ru NFs in dehydrogenation of ammonia 
borane (H3N-BH3, which will be referred to as “AB” in the following discussion for simplicity). 
AB is an attractive hydrogen storage material because of its high hydrogen content (19.6 wt %) 
and good stability in solid form at room temperature.54-56 Hydrogen can be conveniently generated 
from AB through dehydrogenation in the presence of a suitable catalyst. Ru nanoparticles have 
been proven to be an effective type of catalysts for this reaction.57-59 In our tests, the catalytic 
reaction was initiated by adding an aqueous suspension of Ru NFs (Figure 2.6) or Ru NWs 
(Figure 2.4a) to an aqueous solution of AB held in a flask. The amount of generated H2 was 
measured by a gas buret. As indicated by the plots of H2 production against time (Figure 2.8), Ru 
NFs showed higher catalytic activity in terms of turnover frequency58 compared with Ru NWs 
(19.7 vs. 13.2 mol H2 sec
-1 (mol Ru)-1). The enhanced catalytic activities for Ru NFs toward these 
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reactions might be ascribed to their unique fcc crystal structure (note that other factors such as the 
small portion of Pd-Ru alloy in Ru NFs have not yet been ruled out). Further studies including 
theoretical calculations are needed to understand the catalytic mechanism for the fcc Ru NFs. 
 
Figure 2.8 Plots of hydrogen evolution versus time during AB dehydrogenation catalyzed by fcc 
Ru NFs (red), hcp Ru NWs (blue), and deionized water (black, referred to as “blank”) at room 
temperature (∼22 °C) and under 1 atm of pressure. The final concentrations of AB and Ru catalysts 
in the reaction solution were 49 and 0.0075 mM (in Ru element), respectively. Volume of reaction 
solution = 10 mL. 
2.3 Conclusion 
In summary, we have demonstrated a two-step method based on seeded growth and 
chemical etching for the synthesis of Ru NFs. The key was to direct the overgrowth of Ru to 
selectively occur on the corner and edge sites of Pd truncated octahedral seeds in the first step by 
kinetic control. In this way, Ru NFs could be easily obtained in the second step by removing Pd 
cores from the resultant Pd-Ru core-frame octahedra through chemical etching. Significantly, the 
fcc structure of Pd seeds was replicated by Ru that usually takes an hcp structure. This work not 
only represents the first successful attempt for the synthesis of Ru NFs but also provides a general 
route to fcc Ru nanocrystals. We believe the synthetic strategy reported here can also be extended 
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to the synthesis of nanoframes of other metals and the development of nanostructures with unusual 
crystal structures. 
2.4 Materials and Experiment 
2.4.1 Chemicals and Materials 
Ruthenium (III) chloride hydrate (RuCl3·xH2O, MW=207.4), sodium 
tetrachloropalladate(II) (Na2PdCl4, 98%), potassium bromide (KBr, ≥99%), L-ascorbic acid (AA, 
≥99%), poly(vinyl pyrrolidone) (PVP, MW≈55,000), hydrochloric acid (HCl, 37%), iron(III) 
chloride (FeCl3, 97%), p-nitrophenol, borane-ammonia complex (H3N-BH3, 90%), and sodium 
borohydride (NaBH4, ≥99%) were all obtained from Sigma-Aldrich. Ethylene glycol (EG) was 
obtained from J. T. Baker. All aqueous solutions were prepared using deionized (DI) water with a 
resistivity of 18.0 MΩ·cm. 
2.4.2 Preparation of Pd Nanocrystals to be Used as Seeds 
1) 5.6 nm Pd truncated octahedra. In a typical synthesis, 2 mL of an EG solution containing 
40 mg of PVP was hosted in a vial and preheated to 160 oC in an oil bath under magnetic stirring 
for 10 min. 1 mL of an EG solution containing 16 mg of Na2PdCl4 was then quickly injected into 
the reaction solution using a pipette. The reaction was allowed to continue at 160 oC for 3 h. After 
being washed with acetone once and ethanol twice via centrifugation, the final product was re-
dispersed in 1 mL of EG for future use. 
2) 18 nm Pd nanocubes. 8.0 mL of an aqueous solution containing 105 mg of PVP, 60 mg 
of AA, and 600 mg of KBr was hosted in a vial and pre-heated to 80 oC in an oil bath under 
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magnetic stirring. Subsequently, 3.0 mL of an aqueous solution containing 57 mg of Na2PdCl4 was 
added with a pipette. The reaction was allowed to continue at 80 oC for 3 h. After being washed 
with DI water twice via centrifugation, the final product was re-dispersed in 2 mL of EG for future 
use. 
2.4.3 Standard Procedure for the Overgrowth of Ru on Pd Truncated Octahedral Seeds 
In a standard procedure, 8 mL of an EG solution containing 100 mg of PVP and 50 mg of 
AA was hosted in a 50-mL three-neck flask and preheated to 200 oC in an oil bath under magnetic 
stirring for 5 min. Then, 0.5 mL of the 5.6 nm truncated octahedral Pd seeds was added to the flask 
using a pipette. After 5 min, 8.0 mL of RuCl3·xH2O solution (0.5 mg/mL, in EG) was injected to 
the flask at a rate of 2.0 mL/h using a syringe pump. The reaction was allowed to proceed for an 
additional 10 min after the RuCl3·xH2O precursor had been completed injected. The products (e.g., 
Pd-Ru core-frame octahedra) were collected by centrifugation, washed once with acetone, two 
times with water, and finally redispersed in 0.5 mL of DI water. The procedure for the overgrowth 
of Ru on 18 nm Pd cubic seeds was the same as the procedure above except for the substitution of 
0.5 mL truncated octahedral seeds with 0.5 mL cubic seeds. 
2.4.4 Removal of Pd Cores from Pd-Ru Core-frame Octahedra by Chemical Etching 
KBr (150 mg), PVP (25 mg), FeCl3 (25 mg), HCl (0.15 mL, 37%), DI water (2.85 mL), 
and an aqueous suspension of the as-prepared Pd-Ru core-frame octahedra (0.5 mL) were mixed 
together in a 20-mL glass vial under magnetic stirring at room temperature for 10 min. Then, the 
solution was heated to 80 oC in an oil bath under magnetic stirring. After 3 h, the solution was 
cooled down with a water bath to room temperature and the product was collected by 
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centrifugation, washed once with ethanol, twice with water, and finally re-dispersed in 0.5 mL of 
DI water for future use. 
2.4.5 Synthesis of Ru Nanowires 
The Ru nanowires shown in Figure 2.4 were synthesized through a one-pot method. In a 
typical synthesis, 8 mL EG containing 100 mg of PVP was hosted in a 20-mL glass vial and 
preheated to 200 oC in an oil bath under magnetic stirring for 10 min. Then, 3 mL of an EG solution 
containing 45 mg of RuCl3·xH2O was quickly added to the reaction solution using a pipette. The 
reaction was allowed to continue at 200 oC for 3 h. After being washed with acetone once and 
ethanol twice via centrifugation, the final product was re-dispersed in 5 mL of DI water for future 
use.  
2.4.6 Evaluation of Catalytic Activities 
1) Reduction of p-nitrophenol by NaBH4. The reaction was conducted in aqueous 
suspension and under room temperature. In a typical process, both aqueous suspensions of Ru 
nanocatalysts (e.g., Ru nanoframes and Ru nanowires) were first diluted to 0.218 mM in terms of 
Ru element (based on the result of inductively coupled plasma-optical emission spectroscopy, ICP-
OES). Meanwhile, aqueous solutions of p-nitrophenol (0.5 mM) and NaBH4 (2 M) were freshly 
prepared. Then, 0.690 mL of DI water was mixed with 0.295 mL p-nitrophenol solution in a 
cuvette. The color of the solution changed from colorless to yellow immediately after the addition 
of 0.005 mL of the NaBH4 solution. Finally, 0.010 mL Ru nanocatalysts was injected into the 
system and quickly mixed well using a pipette. The reaction time (t) was recorded immediately 
thereafter and the intensity of the absorption at 400 nm for the reaction solution was monitored 
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from t = 20 s to t = 60 min. The final concentrations of p-nitrophenol, NaBH4, and Ru catalysts in 
the reaction solution were about 0.15 mM, 10 mM, and 2.2 μM (in Ru element), respectively. 
2) Dehydrogenation of ammonia borane. The reaction was conducted in aqueous 
suspension, at room temperature, and under one atmosphere of pressure. In a typical process, 9.8 
mL of ammonia borane aqueous solution (50 mM) and 0.2 mL of an aqueous suspension of Ru 
catalyst (nanoframes or nanowires, 0.375 mM in Ru element) or deionized water (blank) were 
sequentially added into a 50 mL three-neck flask kept at room temperature (~ 22 oC) under 
magnetic stirring, with one of the openings connected to a gas burette. The volume of hydrogen 
produced from the flask at different reaction time was recorded using the gas burette. The number 
of moles of hydrogen (n) could be calculated from the volume of hydrogen (V) according to the 
ideal gas law PV = nRT (P: absolute pressure of gas; R: ideal gas constant; T: absolute temperature). 
n will then be used to calculate the turnover frequency (mol H2 sec
-1 (mol Ru)-1). 
2.5 Characterizations 
The TEM images were taken using a JEOL JEM-2010 microscope operated at 200 kV. 
HAADF-STEM and the energy dispersive X-ray (EDX) analyses were performed using a JEOL 
ARM200F with STEM Cs corrector operated at 200 kV. The UV-vis spectra of the catalytic 
reaction solution were recorded using an Agilent Cary 60 UV-vis spectrophotometer. XRD 
patterns were taken using a Scintag XDS2000 powder diffractometer. The concentrations of Pd 
and Ru ions were determined using an inductively coupled plasma-optical emission spectroscopy 
(ICP-OES, Perkin Elmer Optima 7000DV). 
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CHAPTER 3 PEROXIDASE-LIKE PROPERTIES OF RUTHENIUM 
NANOFRAMESa 
3.1 Introduction 
Peroxidase mimics of inorganic nanomaterials hold great potential for replacing natural 
peroxidases in diagnostic, sensing, and imaging applications, providing enhanced performance.1-8 
Since the first demonstration of ferromagnetic nanoparticles as peroxidase mimics,9 a vast variety 
of inorganic nanomaterials have been reported to show peroxidase-like properties, including 
nanostructures made of metal oxides,10-14 noble metals,15-21 carbon materials,22-24 and a 
combination of them.25, 26 Among them, noble-metal mimics are particularly intriguing because: 
(i) they are ultra-stable owing to their chemical inertness, enabling them to survive harsh 
environments; and (ii) their surfaces can be conveniently functionalized with biomolecules by 
means of physical adsorption or metal-thiolate bonding,27 facilitating biomedical applications. 
While peroxidase-like properties have been demonstrated for NMNSs of Au, Pt, Pd, Ir and their 
alloys,15-21 to the best of our knowledge, there is no literature report on Ru nanostructure-based 
peroxidase mimics. Ru is quite unique compared to other noble metals. For example, Ru is 
chemically super stable and is even invulnerable to aqua regia;28 Ru is the only noble metal that 
normally takes the hexagonal close-packed (hcp) crystal structure.29 These unique features of Ru 
inspired us to explore Ru nanostructure-based peroxidase mimics.  
In this work, we demonstrate the peroxidase-like properties of Ru nanoframes (RuNFs) 
with an octahedral shape and size <10 nm. Specifically, uniform RuNFs were first synthesized 
                                                          
aReprint with permission from Sci. Bull. 2016, 61, 1739-1745 
Copyright © Science China Press and Springer-Verlag Berlin Heidelberg 2016 
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using a method as reported as Chapter 2.29 The peroxidase-like activity of the frames was then 
demonstrated by the catalytic reactions between hydrogen peroxide and different peroxidase 
substrates. Using 3,3’,5,5’-tetramethylbenzidine (TMB)30 as a model substrate, we have quantified 
the catalytic efficiency of the RuNFs. Finally, superior stabilities of the RuNFs as peroxidase 
mimics were demonstrated. This work represents the first attempt to explore Ru-based peroxidase 
mimics and, in a sense, offers a promising prospect for the application of Ru nanomaterials in 
biomedicine. 
3.2 Results and Discussion 
Figure 3.1 shows the TEM images of the RuNFs produced from a standard synthesis. As 
indicated by the low magnification TEM image (Figure 3.1a), the RuNFs were obtained with a 
high purity (>95 %) and good uniformity. The magnified TEM image in Figure 3.1b clearly 
reveals the frame structure with an octahedral shape for the products. By randomly analyzing 200 
individual particles, the average edge length and thickness of the RuNFs equaled 6.2 and 1.8 nm, 
respectively. The high-resolution TEM (HRTEM) and high-angle annular dark-field scanning 
TEM (HAADF-STEM) images shown in Figure 3.1c, d clearly reveal the face-centered cubic 
(fcc) crystal structure and octahedral frame morphology for the RuNFs. The lattice spacing of 
RuNFs in Figure 3.1c was determined to be 0.22 nm, which could be indexed to the {111} plane 
of fcc Ru crystal structure. Since the RuNFs were grown from the ~5.6 nm Pd seeds with a well-
defined truncated octahedral shape,29 the total amount of the frames produced from a standard 
synthesis should be equal to that of the initial Pd seeds, which was estimated to be 4.7×1015 
particles/mL based on the inductively coupled plasma-optical emission spectrometry (ICP-OES) 
analysis. Therefore, the particle concentration for the RuNFs suspension obtained from a standard 
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synthesis was estimated to be 4.7×1015 particles/mL or 3.9×10-6 M. This data is essential to 
quantitative understanding of the peroxidase-like activity of the RuNFs (see more discussions 
below).  
 
Figure 3.1 Typical TEM images of RuNFs obtained in a standard synthesis. (a) Low magnification 
TEM image showing the high yield and good uniformity of the sample. (b) TEM image at a higher 
magnification showing the frame structure with hollow interiors. (c) HRTEM image of an 
individual Ru frame orientated along <110> direction. The inset shows a 3D model of the sample. 
(d) HAADF-STEM image showing the 3D octahedral frame morphology of the sample. 
The peroxidase-like property of the RuNFs was demonstrated by catalyzing the oxidation 
of peroxidase substrates with hydrogen peroxide (H2O2). As shown in Figure 3.2, RuNFs 
efficiently catalyze the oxidation of TMB (a typical peroxidase substrate)34 by H2O2, generating 
blue-colored oxidized TMB with characteristic absorption peaks at 371, 653, and 892 nm (Figure 
3.2b).34 The reaction rate was directly proportional to the particle concentration of RuNFs in the 
reaction solution (Figure 3.2c). In addition to TMB, the RuNFs could also rapidly catalyze the 
oxidation of other peroxidase substrates such as 3,3’-diaminobenzidine (DAB) and o-
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phenylenediamine (OPD),9, 35 yielding brown- and light orange-colored products, respectively 
(Figure 3.2a). These observations clearly demonstrate the peroxidase-like activity of the RuNFs.  
 
Figure 3.2 Peroxidase-like activity of RuNFs. (a) A digital photograph taken at the reaction time 
t = 5 min, demonstrating the capability of RuNFs as peroxidase mimics in catalyzing the oxidation 
of different substrates (e.g., TMB, DAB, and OPD) by H2O2. (b) UV-Vis spectrum of the TMB-
H2O2 reaction system catalyzed by RuNFs (1.0×10
-11 M). (c) Time- and particle concentration-
dependent absorbance at 653 nm measured from the reaction solutions containing TMB (0.8 mM), 
H2O2 (2.0 M), and RuNFs with different concentrations in 0.2 M HOAc/NaOAc buffer (pH 4.0) 
at room temperature. 
We also evaluated the effects of various reaction conditions on the catalytic activity of the 
RuNFs using the oxidation of TMB by H2O2 as a model reaction. We chose to focus on this 
reaction because its mechanism has been well understood in previous studies and TMB is less 
toxic compared to other substrates.34 As shown in Figure 3.3, the catalytic efficiency of the RuNFs 
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(1.0×10-11 M in particle concentration) had a strong dependent on pH, temperature, and 
concentrations of TMB and H2O2. Taken all the factors together, the optimal conditions for 
maximized reaction rate were found to be roughly pH 4.0, 40 oC, 0.8 mM TMB, and 6.0 M H2O2. 
Since no significant change of catalytic efficiency for temperatures at 20-40 oC (Figure 3.3b) and 
H2O2 concentrations at 2.0-8.0 M (Figure 3.3d), for simplicity, we adopted pH 4.0, room 
temperature (~22 oC), 0.8 mM TMB, 2.0 M H2O2, and 1.0×10
-11 M RuNFs as the standard 
conditions for subsequent experiments.  
 
Figure 3.3 The effects of (a) pH, (b) temperature, (c) TMB concentration, and (d) H2O2 
concentration on the catalytic activity of RuNFs. The experiments were carried out in aqueous 
solution in the presence of 1.0×10-11 M RuNFs as the catalysts. Other reaction conditions were 0.2 
M HOAc/NaOAc buffer (pH 4.0), 2.0 M H2O2, 0.8 mM TMB, and room temperature, unless 
otherwise stated. The maximum absorbance at 653 nm of reaction solutions at t = 5 min in each 
plot (a-d) was set as 100%. 
To quantitatively understand the catalytic activity of the RuNFs, we determined the 
apparent steady-state kinetic parameters for the catalytic reaction between TMB and H2O2.
34 
Basically, the initial reaction velocity was determined by quantifying the concentration of colored 
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product (e.g., oxidized TMB with a maximum absorbance at 653 nm)34, 36 as a function of time 
with the aid of a spectrophotometer (experimental details were provided in Section 3.4.3). As 
shown in Figure 3.4, typical Michaelis-Menten curves were observed for both TMB (Figure 3.4a) 
and H2O2 (Figure 3.4c) when the initial reaction velocities were plotted against the concentrations 
of H2O2 and TMB, respectively. The curves could then be fitted to the double-reciprocal or 
Lineweaver-Burk plots33 (Figure 3.4b, d). From the double-reciprocal plots, the kinetic 
parameters for RuNFs were determined and summarized in Table 3.1. For comparison, we also 
determined the kinetic parameters of initial 5.6 nm Pd octahedral seeds and listed those of HRP 
from Ref. 9 in Table 3.1. It can be seen that the catalytic efficiencies (in terms of catalytic constant, 
Kcat, which is defined as the maximum number of chemical conversions of substrate molecules per 
second per catalyst)37 of the RuNFs toward TMB and H2O2 were approximately three and two 
times higher than those of HRP, respectively. Note that the catalytic efficiencies of RuNFs were 
also several times higher than initial Pd octahedral seeds (Table 3.1). Since colored products are 
originated from TMB, it can be concluded that the RuNFs are about three times more efficient in 
generating a detectable color signal. The Michaelis constant Km (which measures the substrate 
concentration at which the reaction velocity is half of the maximum velocity, Vmax)
37 toward TMB 
for RuNFs was seven times lower than that for HRP, implying that RuNFs had a higher affinity 
for TMB than HRP. In contrast, the Km toward H2O2 for RuNFs was eighty-six times higher than 
that for HRP, suggesting a lower affinity for RuNFs in binding to H2O2 as compared to HRP.  
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Figure 3.4 Kinetic assays of RuNFs as catalysts for the oxidation of TMB by H2O2. The initial 
reaction velocity (v) was measured under standard conditions. Error bars indicate the standard 
deviations of three independent measurements. (a) Plot of v against TMB concentration, in which 
H2O2 concentration was fixed at 2.0 M; (b) double-reciprocal plot generated from (a); (c) plot of v 
against H2O2 concentration, in which TMB concentration was fixed at 0.8 mM; (d) double-
reciprocal plot generated from (c). 
Table 3.1 Comparison of kinetic parameters of RuNFs and HRP toward the oxidation of TMB by 
H2O2. 
Catalyst E (M) Substrate Km (M) Vmax (M‧s-1) Kcat (s-1) 
RuNFs 
1.06×10-11 TMB 6.03×10-5 1.34×10-7 1.26×104 
1.06×10-11 H2O2 3.18×10
-1 7.41×10-8 6.98×103 
Pd seeds 
1.06×10-11 TMB 4.7×10-5 3.8×10-7 3.6×103 
1.06×10-11 H2O2 7.3×10
-1 1.4×10-7 1.3×103 
HRP9 
2.50×10-11 TMB 4.3×10-4 1.0×10-7 4.0×103 
2.50×10-11 H2O2 3.7×10
-3 8.7×10-8 3.5×103 
E represents the catalyst concentration, Km is the Michaelis constant, Vmax is the maximal reaction 
velocity, and Kcat is the catalytic constant that equals Vmax/E 
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To examine possible changes of crystal structure for the RuNFs during the catalytic 
reaction, we analyzed individual frames before and after the catalysis by HRTEM. As indicated 
by the HRTEM images and corresponding Fourier transform patterns shown in Figure 3.5, the fcc 
crystal structure for RuNFs was well retained after the catalytic reaction. Finally, we evaluated the 
stability for the RuNFs as peroxidase mimics. It should be noted that stability is a key parameter 
for a peroxidase mimic because it largely determines the durability and reproducibility of the 
mimic in certain applications.  
 
Figure 3.5 Representative HRTEM images of individual RuNFs a before and b after they had been 
used as catalysts for the oxidation of TMB by H2O2. Insets are corresponding Fourier transform 
patterns. 
To test the chemical stability, we incubated RuNFs in solutions of different pH ranging 
from 0 to 12 for a period of 2h prior to the measurement of their catalytic activities. As shown in 
Figure 3.6a, the catalytic activity of the RuNFs was fairly stable even though they had been treated 
with strong acid or base, indicating their outstanding chemical stabilities. We also evaluated the 
thermal stability of RuNFs by heating them at different temperatures. As shown in Figure 3.6b, 
their catalytic activity essentially kept unchanged after they had been heated for 2h at temperatures 
up to 200 oC. The observed stable catalytic performance of the RuNFs might be attributed to their 
inherent inertness (e.g., ultrahigh resistance to oxidative etching) and the excellent thermal stability 
of elemental Ru (e.g., with an ultrahigh melting point of >2,000 oC).28,38 
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Figure 3.6 (a) Chemical and (b) thermal stability tests for the RuNFs in catalyzing the oxidation 
of TMB by H2O2. In a, RuNFs (3.9×10
-8 M, in deionized water) were first incubated in solutions 
with pH of 0 to 12 for 2h. Their relative catalytic activities (e.g., absorbance at 653 nm of reaction 
solutions at t = 5 min, standard conditions) were then measured, in which the activity at pH 4.0 
was set as 100 %; In (b), RuNFs (3.9×10-8 M, in ethylene glycol) were heated at temperatures of 
40 to 200 oC for 2 h. Their relative catalytic activities were then measured under standard 
conditions, in which the activity at room temperature (~22 oC) was set as 100%. 
3.3 Conclusion 
In conclusion, we have demonstrated a new kind of peroxidase mimic— RuNFs of sub-10 
nm in size. The RuNFs could be produced in a high purity and good uniformity. The catalytic 
efficiency of the RuNFs was found to be higher than that of natural peroxidase. In addition, the 
frames displayed excellent chemical and thermal stabilities. This work represents the first 
demonstration of Ru nanostructure-based peroxidase mimics, and thus opens a new avenue for 
exploring the bioapplications of Ru nanomaterials. 
3.4 Materials and Experiment 
3.4.1 Chemicals and Materials 
Ruthenium (III) chloride hydrate (RuCl3·xH2O, MW=207.4), sodium 
tetrachloropalladate(II) (Na2PdCl4, 98%), potassium bromide (KBr, ≥99%), L-ascorbic acid (AA, 
≥99%), poly(vinyl pyrrolidone) (PVP, MW≈55,000), hydrochloric acid (HCl, 37%), iron(III) 
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chloride (FeCl3, 97%), 3,3’,5,5’-tetramethylbenzidine (TMB, >99 %), 3,3’-diaminobenzidine 
(DAB, >99 %), o-phenylenediamine (OPD, > 98 %), hydrogen peroxide solution (30 wt. % in 
H2O), sodium chloride (NaCl, 99.5 %), sodium phosphate dibasic (Na2HPO4, 99 %), potassium 
phosphate monobasic (KH2PO4, 99 %), tris base (99.9 %), citric acid (99 %), acetic acid (HOAc, 
99.7 %), and sodium acetate (NaOAc, 99 %) were all obtained from Sigma-Aldrich. Ethylene 
glycol (EG) was obtained from J. T. Baker. All aqueous solutions were prepared using deionized 
(DI) water with a resistivity of 18.0 M Ω·cm. 
3.4.2 Preparation of RuNFs 
The standard preparation of Ru nanoframes could be found in Section 2.4.3 and 2.4.4 in 
Chapter 2. 
3.4.3 Evaluation of the Peroxidase-like Activities of RuNFs 
The experiments were performed at room temperature in 1.5 mL tubes. The catalytic 
reactions were carried out in different buffer solutions (e.g., 1.0 mL 0.2 M NaOAc/HOAc buffer 
solution pH 4.0 for TMB, 1.0 mL 0.2 M Na2HPO4 + 0.1 M citric acid buffer solution pH 7.8 for 
DAB, and 1.0 mL Tris-HCl + 0.15 M NaCl buffer solution pH 7.8 for OPD). Each contained ~1 × 
10-11 M RuNFs, 2 M H2O2, and 0.8 mM TMB, DAB, or OPD. Control experiments were conducted 
under the same conditions except for the absence of RuNFs.  
3.4.4 Kinetic Assays 
The steady-state kinetic assays9, 20 were performed at room temperature (~22 oC) in 1.0 mL 
0.2 M NaOAc/HOAc solution (pH 4.0). Upon the addition of substrates (TMB and H2O2) in the 
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buffer system containing RuNFs (1.06×10-11 M), the absorbance at 653 nm of the reaction solution 
as a function of time were recorded using a spectrophotometer for 2 min (interval of 6 s). The 
initial reaction velocity (v) was derived through v = SlopeInitial/ (ɛTMB-653 nm×l), where SlopeInitial 
was obtained from the first derivation of each ‘‘absorbance vs. time’’ plots, ɛTMB-653 nm was the 
molar extinction coefficient of TMB at 653 nm that equals 3.9 × 104 M-1‧cm-1,[32] and l is the length 
of cuvettes that equals 1.0 cm. The “v vs. substrate concentrations” plots were then fitted with the 
Michaelis-Menten equation v = Vmax×[S]/(Km + [S]), where Vmax represents the maximal reaction 
velocity, [S] is the substrate concentration, and Km is the Michaelis constant. Kinetic parameters 
Km and Vmax were determined from the double reciprocal plot (or Lineweaver-Burk plot
[33]).  
3.5 Characterizations 
TEM images were taken using a JEOL JEM-2010 microscope. HRTEM and HAADF-
STEM images were performed using a JEOL ARM200F with STEM Cs corrector operated at 200 
kV. The UV-Vis spectra of the catalytic reaction solutions were recorded using an Agilent Cary 
60 UV-Vis spectrophotometer. The concentrations of Ru ions were determined using an 
inductively coupled plasma-optical emission spectroscopy (ICP-OES, Perkin Elmer Optima 
7000DV), which could be converted to the particle concentration of Pd once the particle shape and 
size had been resolved through TEM imaging. pH values of solutions were measured using an 
Oakton pH 700 Benchtop Meter. Photographs of samples in tubes were taken using a Canon EOS 
Rebel T5 digital camera.  
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CHAPTER 4 AN ENZYME-FREE SIGNAL AMPLIFICATION 
TECHNIQUE FOR ULTRASENSITIVE COLORIMETRIC ASSAY OF 
DISEASE BIOMARKERSa 
4.1 Introduction 
Simple and affordable technologies for detection of disease biomarkers are essential to the 
improvement of standard of living, especially for resource-constrained areas or countries. Enzyme-
based colorimetric assays (e.g., enzyme-linked immunosorbent assay (ELISA), 
immunohistochemistry, and Western blot) are broadly recognized as such kind of technology 
because they can be performed by less-trained personnel with an inexpensive spectrophotometer, 
ordinary light microscope, or even naked eyes.1-5 Nevertheless, the major drawback for these 
colorimetric assays is the relatively low detection sensitivity compared to other technologies such 
as those based on fluorescence and plasmonics.6-9  
In conventional colorimetric assays, the detectable color signal is generated from enzymes 
(in many cases, HRP), which are conjugated to antibodies and specifically convert substrates to 
colored molecules.1-5 Therefore, their detection sensitivity is largely determined by the 
performance of enzymes. Accordingly, a general strategy for enhancing the sensitivity is to 
amplify color signal by assembling as many enzyme molecules as possible on certain carriers (e.g., 
avidin, polymers, and nanoparticles).10-16 For example, Merkoçi et al. conjugated HRPs to gold 
nanoparticles (GNPs) as carriers and applied these conjugates as labels to ELISA of breast cancer 
biomarker, of which detection sensitivity was several times higher than conventional ELISA using 
                                                          
aReprinted with permission from ACS Nano 2017, 11, 2052-2059. 
Copyright © 2017, American Chemical Society 
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HRP as label.14 Qian et al. further increased HRP loading amount by employing a combination of 
GNPs and graphene oxide sheets as carriers, achieving a 64-fold improvement of 
sensitivity.15 Despite these demonstrations, the detection sensitivity is ultimately limited by the 
catalytic efficiency of enzymes and the loading amount of enzymes on a carrier. 
Herein, we report an enzyme-free signal amplification technique to break the intrinsic 
limitations of enzymes, achieving substantially enhanced detection sensitivity. In this technique, 
sub-10 nm Pd-Ir nanoparticles (NPs) encapsulated gold vesicles (referred to as “Pd-Ir NPs@GVs”) 
are employed as alternatives to enzymes. In this study, we used ELISA as a model platform to 
demonstrate the enzyme-free technique, because ELISA has been the gold standard for detection 
and quantification of protein biomarkers for decades.2 As shown in Figure 4.1, at elevated 
temperature, gold vesicles (GVs) captured by analytes liberate thousands of individual Pd-Ir NPs 
because of the heat-induced breakup of the GV membrane.17-19 The released Pd-Ir NPs act as 
peroxidase mimics and generate intense color signal by catalyzing the oxidation of TMB by 
H2O2.
20 It should be pointed out that we have recently demonstrated the peroxidase-like property 
of Pd-Ir NPs and controlled release of GVs.17-20 However, to date, there has been no report yet on 
the development of a signal amplification platform based on the combination of these two systems. 
The ultralow detection limit of this enzyme-free ELISA arises from the following distinctive 
features of the amplification technique: (i) Pd-Ir NPs as enzyme mimics possess much higher 
catalytic efficiency than natural enzymes, providing enhanced color signal; (ii) the loading 
capacity of enzyme mimics is maximized by taking advantage of the large interior 3D space of the 
GVs as carriers.21, 22 in contrast, the loading of enzymes on carriers in current designs of ELISA is 
limited by the surface area that allows for the conjugation of enzymes; (iii) the loading of label-
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free enzyme mimics of Pd-Ir NPs in the pocket of GVs avoids the loss of catalytic efficiency 
caused by chemical conjugation; and (iv) Pd-Ir NPs could disperse in catalytic reaction solution 
upon release, making them more active than immobilized catalysts on solid surfaces, which is the 
case for conventional ELISAs. 
 
Figure 4.1 Schematic illustration of utilizing Pd-Ir NPs@GVs based ELISA for detection of 
disease biomarkers. The Pd-Ir NPs released from captured GVs act as effective peroxidase mimics 
to catalyze chromogenic substrates. 
In addition to the high detection sensitivity, our enzyme-free ELISA is featured by good 
stability and simplicity. The Pd-Ir NPs@GVs are mainly made of inert noble metals with excellent 
stabilities, enabling them to survive harsh environments. In particular, we have demonstrated in 
our recent work that the peroxidase-like activity of Pd-Ir NPs was well retained at high temperature 
(up to 200 °C) and in strong acidic/basic conditions.20 In this regard, our platform is more suitable 
for detection at some extreme conditions compared to natural enzyme-based amplification 
techniques even though their detection sensitivities may be comparable.23 As shown in Figure 4.1, 
the principle of our enzyme-free ELISA is essentially the same as the conventional HRP-based 
colorimetric ELISA except for the substitution of HRP with Pd-Ir NPs@GVs. The adoption of 
existing ELISA platform ensures the simplicity of the assay without the involvement of additional 
materials and equipment other than the Pd-Ir NPs@GVs. In contrast, other enzyme-free signal 
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amplification systems (e.g., those based on quantum dots24, 25) may require special materials and/or 
equipment. 
4.2 Results and Discussion 
4.2.1 Synthesis and Characterization of Pd-Ir NPs 
We started with the synthesis of Pd-Ir NPs by coating an ultrathin layer of Ir on preformed 
sub-10 nm Pd seeds. In a standard synthesis, a solution of Na3IrCl6 was injected slowly into a 
mixture containing Pd truncated octahedra with an average size of 5.6 nm as the seeds (Figure 
S4.1 in Appendix C), L-ascorbic acid as a reductant, and poly(vinylpyrrolidone) as a colloidal 
stabilizer. Figure 4.2a, b show typical TEM images of the produced Pd-Ir NPs. The Pd-Ir NPs 
exhibit a high purity (>95%) and good uniformity (Figure 4.2a and S4.2 in Appendix C). A close 
inspection of the NPs shows that the Pd seeds retained their truncated octahedral shape after the 
deposition of Ir, indicating a conformal coating of Ir (Figure 4.2b). The average size of the Pd-Ir 
NPs was measured to be 6.1 nm, which was 0.5 nm greater than that of the initial Pd seeds. 
Therefore, the average thickness of the deposited Ir shells was about 0.25 nm, indicating an 
approximate monolayer coating of Ir on Pd(111) surfaces.26, 27 The molar ratio of Ir to Pd for these 
Pd-Ir NPs was measured to be 0.28:1 by inductively coupled plasma-optical emission spectrometry 
(ICP-OES). On the basis of this data, the morphology of Pd seeds, and the unit cell parameters of 
Ir,22 the average number of Ir atomic layers was estimated to be 1 for the Pd-Ir NPs, further 
confirming the overall monolayer coating of Ir. We also characterized the structure and 
composition of the Pd-Ir NPs by XRD, HRTEM, HAADF-STEM, energy-dispersive X-ray (EDX) 
mapping/scanning, and X-ray photoelectron spectroscopy (XPS). The XRD patterns of initial Pd 
seeds and Pd-Ir NPs were shown in Figure S4.3 (Appendix C). It can be seen that the peaks for 
90 
 
Pd-Ir NPs were broadened and slightly shifted to the standard face-centered cubic (fcc) Ir peak 
positions as compared to the peaks for fcc Pd seeds, suggesting the successful deposition of Ir on 
Pd seeds and the retention of fcc crystal structure for the final Pd-Ir NPs. The typical HRTEM 
image of an individual Pd-Ir NP reveals the continuous lattice fringes from Pd core to Ir shell, 
indicating an epitaxial relationship between these two metals (Figure 4.2c).28 The color difference 
between the core (green = Pd) and the shell (red = Ir) of an individual Pd-Ir NP in the EDX maps 
(Figure 4.2d) confirmed the Pd-Ir core-shell structures of the final products. The line-scan EDX 
profile shown in along a corner-to-edge direction of an individual Pd-Ir NP (see Figure S4.4 in 
Appendix C) verified that the corners and edges were dominated by Ir, whereas the core was made 
of pure Pd. In addition, XPS was used to identify the oxidation state of the Ir layers. The XPS 
survey spectrum of the Pd-Ir NPs clearly showed the appearance of Ir 4f peaks (Figure S4.5a in 
Appendix C) as compared to the initial Pd seeds, confirming the existence of Ir layers on the Pd 
cores. The high-resolution spectra of the Ir 4f peaks (Figure S4.5b in Appendix C) revealed two 
chemical states for Ir species: (i) Ir04f7/2 and 4f5/2 peaks at 60.24 and 63.23 eV, and (ii) Irx+ 4f7/2 
and 4f5/2 at 61.25 and 64.46 eV, where the Ir0 was dominant. This data suggests that the shell of 
the Pd-Ir NPs is mainly composed of Ir(0). 
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Figure 4.2 Structural and compositional analyses of Pd-Ir NPs prepared by depositing Ir atoms on 
5.6 nm Pd truncated octahedral seeds. (a,b) low (a) and high (b) magnification TEM image of Pd-
Ir NPs. The inset is a 2D schematic model. (c) HRTEM image of an individual Pd-Ir NP; (d) 
HAADF-STEM image and EDX mapping of an individual Pd-Ir NP (red = Ir, green = Pd). 
4.2.2 Peroxidase-like Activity of Pd-Ir NPs 
We quantitatively evaluated the peroxidase-like activity of as-synthesized Pd-Ir NPs by 
apparent steady-state kinetic assay as shown in Figure 4.3.20, 29 Oxidation of TMB by H2O2 was 
chosen as a model catalytic reaction. The catalytic efficiency, in terms of catalytic constant (Kcat, 
which measures the maximum number of colored products generated per enzyme/mimic per 
second), for the Pd-Ir NPs was measured to be 1.1×105 s-1 (Table 4.1). In comparison, the values 
of Kcat for initial Pd seeds and HRP
29 were 4.8×103 and 4.0×103 s-1, respectively. This data 
suggests that (i) The Pd-Ir NPs are ~28 times more efficient than HRP in generating color products 
(e.g., oxidized TMB with maximum absorbance at 653 nm30, 31); and (ii) the enhanced catalytic 
efficiency for Pd-Ir NPs was ascribed to the coating of Ir monolayer on Pd seeds. 
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Figure 4.3 Kinetic assays of using Pd-Ir NPs as peroxidase mimics for the oxidation of TMB by 
H2O2. The reactions were conducted in 0.2 M HOAc/NaOAc buffer, pH 4.0 containing Pd-Ir NPs 
(1.5×10-12 M), 2 M H2O2 and TMB that was held in cuvettes at room temperature. (a) Plot of initial 
reaction velocity (ν) as a function of TMB concentration. (b) Double-reciprocal plot generated 
from (a), from which the kinetics parameters in Table 4.1 were derived. Error bars in the plots 
indicate standard deviations of three independent measurements. 
Table 4.1 Comparison of the kinetic parameters of Pd seeds (Figure S4.1 in Appendix C), Pd-Ir 
NPs (Figure 4.2), and HRP as catalysts towards the oxidation of TMB by H2O2. 
Catalyst [E] (M) Substrate Km (M) Vmax (M‧s-1) Kcat (s-1) 
Pd-Ir NPs 1.5×10-12 TMB 2.0×10-4 1.7×10-7 1.1×105 
Pd seeds 3.0×10-11 TMB 8.8×10-5 1.4×10-7 4.8×103 
HRP 2.5×10-11 TMB 4.3×10-4 1.0×10-7 4.0×103 
4.2.3 Encapsulation of Pd-Ir NPs to GVs 
We then encapsulated the Pd-Ir NPs into GVs that were achieved by assembling block 
copolymers (BCPs)-tethered GNPs in an aqueous suspension of Pd-Ir NPs. GNPs with a diameter 
of 33.0±4.7 nm were first modified with thiol-terminated BCPs of poly(ethylene oxide)-b-
polystyrene (PEO45-b-PS260-SH, Figure 4.4a) and poly(acrylic acid)-b-polystyrene (PAA23-b-
PS250-SH, Figure 4.4b) at a molar ratio of 20:1.
32 It should be mentioned that we chose these GNPs 
of ∼33 nm for the assemble of vesicles mainly because (i) the ease in the functionalization of 
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GNPs with polymers via Au-S bond, in order to trigger the formation of GVs and to conjugate 
biological moieties for sensing; (ii) the good stability of resultant GVs and their capability in 
retaining molecules (or nanoparticles) without noticeable leakage for a long time; our previous 
studies showed that GVs remain stable for months and minimal leakage of small organic molecules 
(or drugs) was observed from GVs after weeks, presumably owing to the jamming of particles in 
the vesicular membranes;19, 33 in contrast, small molecules tend to leak out from liposomes or 
polymersomes within a few hours, which makes them less attractive for the present 
application;34 (iii) these GNPs are relatively uniform and monodisperse;17 (iv) the GNP size of 33 
nm is greatly larger than that of Pd-Ir NPs (e.g., 6.1 nm), making it convenient to distinguish Pd-
Ir NPs from GNPs under electron microscope that is critical for monitoring the heat-induced NP 
release process. 
 
Figure 4.4 1H NMR spectra of (a) PEO45-b-PS260-SH and (b) PAA23-b-PS250-SH. 
A film rehydration method, which is widely used for scalable fabrication of liposomes in 
pharmaceutic industry, was used to fabricate the GVs.17 Specifically, pristine GVs were prepared 
by rehydrating a film of BCP-tethered GNPs in water under sonication, according to our previously 
94 
 
published procedures.17-19 To encapsulate Pd-Ir NPs into GVs, an aqueous suspension of Pd-Ir NPs 
at a high concentration (∼4.5 × 1016 particles/mL) was used for the rehydration. As indicated by 
the TEM and SEM images shown in Figure 4.5a, b, the Pd-Ir NPs@GVs showed an overall 
spherical shape. The low-magnification SEM image (Figure 4.5c) demonstrated that the Pd-Ir 
NPs@GVs could be obtained with a high purity and a good uniformity. Our analyses on 100 
random particles indicated that the products had an average diameter of ∼400 nm with a standard 
deviation of 48 nm. As shown by Figure 4.5d, the vesicular membranes of the GVs were 
composed of a monolayer of densely packed GNPs, which is consistent with our previous 
studies.17, 32, 35 On the basis of the packing density and size of GV, the average number of GNPs 
in an individual GV was roughly estimated to be 339 (Figure S4.6a in Appendix C). The loading 
amount of Pd-Ir NPs in individual GVs was estimated to be 1232 by quantifying elemental Pd and 
Au in GVs using ICP-OES (see Figure S4.6b in Appendix C for detailed estimation). 
 
Figure 4.5 (a, b) magnified TEM and SEM images, respectively, showing the overall spherical 
shape of the products. (c) low-magnification SETM image showing the yield and size distribution 
of the products. (d) SEM image of an individual particle with a cavity on the GV surface, showing 
that the GVs were composed of a monolayer of GNPs. 
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4.2.4 Heat-triggered Release of Pd-Ir NPs 
To demonstrate the heat-triggered release of Pd-Ir NPs from GVs, we incubated aqueous 
suspensions of Pd-Ir NPs@GVs (∼0.5 mg/mL in terms of Au element) at different temperatures 
for 1h. The morphological change of samples caused by heat treatment was monitored by TEM 
and SEM. We found that the assembled GVs gradually collapsed as the temperature increased 
(Figure 4.6). Compared to the initial Pd-Ir NPs@GVs (Figure 4.6a, e), small holes started to 
appear in the membranes of GVs when the temperature was set to 70 °C (Figure 4.6b, f). At 80 
°C, the holes in GVs became more evident and fragments began to fall off of the vesicles 
(Figure 4.6c, g). Finally, most of the GVs completely collapsed after 90 °C treatment 
(Figure 4.6d, h). We presume that the dissociation of GNPs is attributed to the breakup of Au-S 
bonds due to the thermal instability of the bonds at a temperature above 70 °C.36, 37 The 
disassembly of GVs is associated with the release of encapsulated Pd-Ir NPs (Figure 4.6b-d). A 
number of Pd-Ir NPs can be observed outside the GVs. The heat-triggered release of Pd-Ir NPs is 
further confirmed by dynamic light scattering (DLS) analysis. Pristine GVs and Pd-Ir NPs were 
used as control groups. As shown in Figure 4.7a, after heating at 90 °C for 1 h, the major size 
distribution peak of Pd-Ir NPs@GVs suspension shifted from 380 nm (solid, blue) to 260 nm 
(dashed, blue). In addition, two shoulder peaks at ∼8.5 nm and ∼32 nm were observed. The 8.5 
nm peak matched well with the peak of pristine Pd-Ir NPs (solid, red), indicating the successful 
release of Pd-Ir NPs from GVs. The 32 nm peak could be assigned to the dissociated GNPs from 
GVs since this peak was also observed for pristine GVs after they had been heated (dashed, black). 
Thermal treatment at 90 °C for 1 h was adopted for subsequent ELISA experiments. We are aware 
that heating for 1 h may limit the practical application of the platform for assays. The operation 
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time of assays can be drastically reduced by speeding up the release of payload from GVs via the 
irradiation of near-infrared light or the use of thermoresponsive polymer tethers.19, 33 
 
Figure 4.6 Heat-triggered release of Pd-Ir NPs from GVs. Representative (a-d) TEM and (e-h) 
SEM images of the Pd-Ir NPs@GVs treated at different temperatures (marked in each image) for 
1 h. In (b-d), insets show magnified TEM images of corresponding regions marked by red boxes. 
Some of the released Pd-Ir NPs are indicated by black arrows. 
4.2.5 Demonstration of Signal Amplification 
We also designed a set of experiments to demonstrate the color signal amplification 
mechanism shown in Figure 4.1. Briefly, aliquots were taken from an aqueous suspension of Pd-
Ir NPs@GVs before and after it had been heated at 90 °C for 1 h and were employed as catalysts 
for the oxidation of TMB by H2O2. Colored products were quantified by measuring the absorbance 
at 653 nm (A653nm), t = 2 min. For comparison, aqueous suspensions of pristine GVs and Pd-Ir NPs 
with the same amounts of GVs and Pd-Ir NPs (determined by ICP-OES), respectively, as those in 
Pd-Ir NPs@GVs were also tested. As shown in Figure 4.7b, before heat treatment, the reaction 
solution with the presence of Pd-Ir NPs@GVs was nearly colorless with A653nm ≈ 0.04. After heat 
treatment, the catalytic activity of Pd-Ir NPs@GVs was dramatically enhanced, generating an 
intense blue color (A653nm = 1.6, see the inset of Figure 4.7b). Since almost no absorbance at 653 
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nm was observed for GVs catalyzed reaction solutions, the enhanced catalytic activity for heat 
treated Pd-Ir NPs@GVs could be ascribed to the free Pd-Ir NPs released from GVs. It should be 
mentioned that, before heat treatment, the absorbance of Pd-Ir NPs@GVs catalyzed reaction 
solution was similar to that of GVs catalyzed reaction solution. This observation demonstrated that 
the GVs could effectively prevent the leakage of encapsulated Pd-Ir NPs when there is no heating. 
On the basis of the values of A653nm, heat treated Pd-Ir NPs@GVs was as active as pristine Pd-Ir 
NPs, indicating that most of the Pd-Ir NPs had been released from GVs and their catalytic 
efficiency was well retained. Taken together, these results clearly demonstrated the signal 
amplification mechanism described in Figure 4.1.  
 
Figure 4.7 Comparison of the properties of Pd-Ir NPs@GVs before and after heat treatment (90 
oC, 1 h). (a) DLS analysis of different samples: GVs (black), Pd-Ir NPs@GVs (blue), and Pd-Ir 
NPs (red); (b) Absorbance at 653 nm measured from catalytic reaction solutions containing 
different particles (marked under the bars) at t = 2 min. Concentrations of GVs were kept the same 
for suspensions of GVs and Pd-Ir NPs@GVs, while the concentrations of Pd-Ir NPs were kept the 
same for suspensions of Pd-Ir NPs@GVs and Pd-Ir NPs. Inset shows photographs of reaction 
solutions corresponding to Pd-Ir NPs@GVs. All tests in (a) and (b) were conducted at room 
temperature (~22 oC). 
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4.2.6 Immunoassay of Disease Biomarker 
Finally, we applied the Pd-Ir NPs@GVs to ELISA of human prostate surface antigen 
(PSA), according to the principle shown in Figure 4.1. PSA was chosen because it has been 
recognized as the key biomarker responsible for prostate cancer recurrence in patients who have 
undergone radical prostatectomy.38 It is vital to detect minute concentrations of PSA at the earliest 
stage possible to improve the survival rates of those patients.39, 40 Herein, antibodies were 
conjugated to Pd-Ir NPs@GVs through the EDC/NHS-mediated coupling reaction between the -
COOH groups of PAA23-b-PS250-S- on GVs and the -NH2 groups on antibodies (Figure 4.8).
41, 42 
PSA standards with a series of concentrations in dilution buffer were monitored in a 96-well 
microtiter plate (Figure 4.9a) and quantified using a PerkinElmer Victor 3 1420 multilabel plate 
reader. The yellow color of the wells arose from the two-electron oxidation products of TMB (e.g., 
diimine with λmax ≈ 450 nm) that were formed when the catalytic reaction was quenched by 
H2SO4.
30, 43 As shown in Figure 4.9b, a sigmoid curve regression between the logarithms of 
absorbance and PSA concentration was obtained. The linear range of detection was found to be 
0.2-200 pg/mL with a linear regression value of r2 = 0.997. The coefficient of variations (n = 8) 
across the entire concentration range were 2.15-12.24%, indicating a good reproducibility of the 
assay. The limit of detection (defined as the PSA concentration corresponding to a signal that is 3 
times the standard deviation above zero calibrator44, 45) was calculated to be 31 fg/mL. To evaluate 
the nonspecific binding between antibodies conjugated Pd-Ir NPs@GVs and the 96-well microtiter 
plate/capture antibodies, we have performed a control experiment by excluding antibodies 
conjugated Pd-Ir NPs@GVs from the blank well (e.g., 0 pg/mL PSA) while keeping all other 
conditions unchanged. The absorbance at 450 nm for the control group was measured to be 0.024, 
whereas the absorbance for the blank was 0.036 (both values of absorbance represent the averages 
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from 8 independent measurements). Therefore, on average, the absorbance at 450 nm of each well 
caused by nonspecific binding of antibodies conjugated Pd-Ir NPs@GVs was approximately 
0.012. This value is relatively low compared to the absorbance measured from the wells of PSA 
standards (Figure 4.9b), suggesting a good specificity of the antibodies conjugated Pd-Ir 
NPs@GVs. 
 
Figure 4.8 Schematic illustration showing the procedure for conjugation of antibodies (e.g., goat 
anti-mouse IgG) onto Pd-Ir NPs@GVs. 
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Figure 4.9 Pd-Ir NPs@GVs based ELISA of PSA. (a) Representative photographs taken from the 
ELISA of PSA standards; (b) Corresponding calibration curve (■) and imprecision profile (□) of 
the detection results shown in (a). Note that absorbance of the blank (e.g., 0 pg/mL PSA) was 
subtracted from those of PSA standards. Inset shows the linear range region of the calibration 
curve. 
We benchmarked the Pd-Ir NPs@GVs based ELISA against the conventional HRP based 
ELISA by using the same set of antibodies and procedures except for the exclusion of heat 
treatment. On the basis of the calibration curve shown in Figure 4.10, the linear detection range 
and overall coefficient of variations for the HRP based ELISA were found to be 0.2-100 ng/mL 
and 4.21-14.31%, respectively. The limit of detection was determined to be 48 pg/mL, which was 
∼1500-fold higher than our enzyme-free ELISA. This significantly enhanced detection sensitivity 
for the enzyme-free ELISA could be attributed to the signal amplification by Pd-Ir NPs@GVs, 
because other conditions of both ELISAs were kept identical. We also evaluated the correlation 
between the enzyme-free ELISA with conventional HRP based ELISA by quantifying the same 
12 PSA standards of concentrations in 0.5-50 ng/mL using the two ELISAs. For the quantification 
with enzyme-free ELISA, the standards were diluted with dilution buffer to ensure that the 
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concentrations of PSA were located in the linear range. The final quantitative data was obtained 
based on the detected PSA concentrations and the dilution factors. As shown in Figure 4.11, a 
good correlation between the two ELISAs was found with a correlation coefficient r = 0.998 (n = 
12). Taken together, these results demonstrate that our enzyme-free ELISA is three-orders-of-
magnitude more sensitive than conventional ELISA, while its reliability and quantitativity are as 
good as those of conventional ELISA. 
 
Figure 4.10 Calibration curve (■) and imprecision profile (□) of conventional HRP based 
colorimetric ELISA of PSA, in which PSA standards and antibodies were kept the same as what 
had been used for the Pd-Ir NPs@GVs based ELISA (Figure 4.9). Inset shows the detection 
principle. 
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Figure 4.11 Correlation analysis between the Pd-Ir NPs@GVs based ELISA (e.g., enzyme-free 
ELISA) and HRP based ELISA in quantification of PSA from 12 standards. Each data point in the 
plot represents the average from three independent measurements. 
To demonstrate the potential application of the Pd-Ir NPs@GVs based ELISA in clinical 
scenarios, we spiked human plasma samples (from a healthy female donor, provided by the UP-
Health System-Portage, Houghton, Michigan, United States) with PSA standard at different 
concentrations in range of 0.4-50 pg/mL and detected the concentrations of PSA. As summarized 
in Table 4.2, the analytical recoveries (defined as measured amount of PSA divided by the amount 
of PSA in original spiked samples)46 for the four PSA spiked human plasma samples were 
determined to be in the range of 93.25-105.85%. The coefficient of variation (n = 8) for all samples 
was below 10.14%. This data implies that the performance of Pd-Ir NPs@GVs based ELISA was 
not compromised by the complex components in plasma, suggesting the feasibility of this 
technique in detecting clinical samples. 
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Table 4.2 Analytical recoveries of Pd-Ir NPs@GVs based ELISA in detecting PSA spiked human 
plasma samples. 
PSA amount spiked 
(pg/mL) 
PSA amount measured 
(pg/mL) 
Coefficient of 
variations 
(%, n = 8) 
Recovery (%) 
0.40 0.37 10.14 93.25 
2.00 2.12 7.71 105.85 
10.00 9.87 3.92 98.72 
50.00 51.71 6.85 103.41 
4.3 Conclusion 
In summary, we have demonstrated an enzyme-free signal amplification technique based 
on Pd-Ir NPs@GVs for colorimetric assay with substantially enhanced detection sensitivity. To 
the best of our knowledge, such an enzyme-free signal amplification strategy using enzyme-like 
NPs encapsulated responsive GVs has never been demonstrated elsewhere. The enzyme-free 
technique we developed can be potentially extended to a variety of other enzymes-based diagnostic 
technologies beyond ELISA such as immunohistochemistry, Western blot, and point-of-care tests. 
Importantly, this technique is compatible with equipment and procedures of existing sensing 
technologies, making it practically useful for clinical diagnostics. Further optimization of the Pd-
Ir NPs@GVs system (e.g., size of GV, loading amount of Pd-Ir NPs, particle release time, and 
catalytic efficiency) and detection of clinical samples are the subjects of our future research. 
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4.4 Materials and Experiment 
4.4.1 Chemicals and Materials 
Sodium hexachloroiridate(III) hydrate (Na3IrCl6·xH2O, MW=473.9), sodium 
tetrachloropalladate(II) (Na2PdCl4, 98%), gold(III) chloride trihydrate (HAuCl4·3H2O, ≥99.9%), 
potassium bromide (KBr, ≥99%), L-ascorbic acid (AA, ≥99%), poly(vinylpyrrolidone) (PVP, 
MW≈55,000), 3,3',5,5'-tetramethylbenzidine (TMB, >99%), hydrogen peroxide solution (30 wt. 
% in H2O), acetic acid (HOAc, ≥99.7%), sodium acetate (NaOAc, ≥99%), human prostate surface 
antigen (PSA, ≥99%), Tween 20, bovine serum albumin (BSA, ≥98%), sodium chloride (NaCl, 
≥99.5%), potassium chloride (KCl, ≥99%), N-hydroxysulfosuccinimide sodium salt (NHS, 
≥98%), N-Ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC, ≥99%), sodium 
phosphate dibasic (Na2HPO4, ≥99%), potassium phosphate monobasic (KH2PO4, ≥99%), tris base 
(≥99.9%), sodium citrate, dimethylformamideand (DMF), tetrahydrofuran (THF), sodium azide 
(NaN3, ≥99.5%), and sulfuric acid (H2SO4, 95-98%) were all obtained from Sigma-Aldrich. 
Ethylene glycol (EG) was obtained from J. T. Baker. Mouse anti-PSA monoclonal antibody 
(mouse anti-PSA mAb) and rabbit anti-PSA polyclonal antibody (rabbit anti-PSA pAb) were 
obtained from Abcam plc. Goat anti-mouse IgG and HRP-goat anti-mouse IgG conjugate were 
obtained from Thermo Fisher Scientific, Inc.. 96-well microtiter plates (polystyrene, clear, flat 
bottom) was obtained from Corning Inc.. All aqueous solutions were prepared using deionized 
(DI) water with a resistivity of 18.0 M·cm. 
4.4.2 Preparation of 5.6 nm Pd Truncated Octahedra to be Used as Seeds 
In a typical synthesis, 30 mL of an EG solution containing 600 mg of PVP was hosted in a 
glass vial and preheated to 160 oC in an oil bath under magnetic stirring for 10 min. Then, 15 mL 
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of an EG solution containing 240 mg of Na2PdCl4 was quickly injected into the reaction solution 
using a pipette. The reaction was allowed to continue for 3 h. After being washed with acetone 
once and ethanol twice via centrifugation, the final product was redispersed in 10 mL of EG for 
future use. The concentration of Pd element in the final product was determined to be 7.5 mg/mL 
by ICP-OES, which could be converted to a particle concentration of ~5×1015 particles/mL 
(assuming that the particles were perfect octahedra). 
4.4.3 Preparation of Pd-Ir Core-shell Nanoparticles (Pd-Ir NPs) 
Pd-Ir NPs were prepared by coating a monolayer of Ir on Pd seeds according to our 
previously published procedure with some modifications.20 In a standard procedure, 100 mg of 
PVP and 60 mg of AA were mixed with the 10 mL Pd seeds in EG and were hosted in a 50-mL 
three-neck flask. The mixture was preheated to 200 oC in an oil bath under magnetic stirring for 
10 min. Then, 8.0 mL of Na3IrCl6·xH2O solution (7.0 mg/mL, in EG) was injected to the flask at 
a rate of 1.5 mL/h using a syringe pump. The reaction was allowed to proceed for an additional 10 
min after the Na3IrCl6·xH2O precursor had been completed injected. The products (e.g., Pd-Ir NPs) 
were collected by centrifugation, washed once with acetone, two times with water, and finally 
redispersed in 1 mL of DI water for future use. Particle concentration for the suspension of Pd-Ir 
NPs was estimated to be 4.5×1016 by ICP-OES. 
4.4.4 Evaluation of the Peroxidase-like Activities 
Peroxidase-like activity was measured by the steady-state kinetic assays.20, 24 All assays 
were carried out at room temperature in 1.0-ml cuvettes (path length, l = 1.0 cm), with 0.2 M 
NaOAc/HOAc solution, pH 4.0 being used as the reaction buffer. The rest procedure for collection 
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of Vmax and Km can be found in Chapter 3, Section 3.4.4. 
4.4.5 Synthesis of Amphiphilic Block Copolymers (BCPs) and Gold Nanoparticles (GNPs) 
Amphiphilic BCPs of poly(ethylene oxide)-b-polystyrene and poly(acrylic acid)-b-
polystyrene terminated with a thiol group at polystyrene end (PEO-b-PS-SH and PAA-b-PS-SH) 
were synthesized following the reversible addition-fragmentation chain-transfer (RAFT) 
polymerization procedures reported previously.17 The BCPs samples were designed with similar 
polystyrene (PS) lengths (PEO45-b-PS260-SH and PAA23-b-PS250-SH) as verified by proton nuclear 
magnetic resonance (1H NMR) as shown in Figure 4.4. 
GNPs with diameters of 33.0±4.7 nm were prepared by sodium citrate reduction method.46 
Briefly, a 10 mg of HAuCl4 was dissolved in 500 mL H2O and heated to boiling under stirring. A 
3 mL of sodium citrate (1 wt. %) solution was then quickly injected. The reaction mixture was 
refluxed for 30 min and then used as seeds for the further growth of GNPs in the presence of 
sodium citrate at 80 oC. The resultant 33.0 nm GNPs were collected by centrifugation. 
4.4.6 Preparation of Gold Vesicles (GVs) and Pd-Ir NPs@GVs 
GVs and Pd-Ir NPs@GVs were prepared by assembling GNPs tethered with BCPs in the 
presence of DI water and aqueous suspension of Pd-Ir NPs, respectively, according to our 
previously reported procedure with minor modifications. 
The surface of GNPs was modified with BCPs using the ligand exchange method.32 A 5 
mg BCPs of PEO45-b-PS260-SH and PAA23-b-PS250-SH with a molar ratio of 20:1 were dissolved 
in 10 mL DMF. Then, a concentrated solution of GNPs (~2 mg/mL) was slowly added into the 
BCP solution under vigorous shaking. The mixture was subsequently sonicated for 1 h to avoid 
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the aggregation of GNPs and was then kept static without stirring overnight. The BCP-tethered 
GNPs were purified by removing free polymers through centrifugation (6-8 times) and were finally 
redispersed in THF at a concentration of ~0.05 mg/mL. 
Self-assembly of BCP-tethered GNPs was conducted by the film rehydration method as 
reported previously.19 Briefly, a solution of BCP-modified GNPs in THF was first dried under 
nitrogen flow to form a thin film on a glass substrate, followed by rehydration in DI water (for 
pristine GVs) or an aqueous suspension of Pd-Ir NPs at 4.5×1016 particles/mL (for Pd-Ir NPs@GVs) 
with sonication for 1 min. The resultant GVs and Pd-Ir NPs@GVs were collected by centrifugation 
(5000 rpm, 5 min), washed 8 times with DI water, and finally re-dispersed in water for future use. 
4.4.7 Preparation of Pd-Ir NPs@GVs-goat Anti-mouse IgG Conjugates 
Anti-mouse IgG was conjugated to Pd-Ir NPs@GVs using EDC and NHS as coupling 
agents (see Figure 4.8).20,39,40 In brief, 50 µL of Pd-Ir NPs@GVs (~0.5 mg/mL in terms of Au 
element, in DI water) was added to a 450 µL of 10 mM phosphate buffered saline (PBS, pH 7.4) 
buffer at room temperature under stirring. Then, 5 µL of EDC (25 mM, in DI water) and 5 µL of 
NHS (50 mM, in DI water) were added. After 15 min, the particles were washed with DI water 
twice and redispersed in 50 µL PBS. Subsequently, 50 µL of goat anti-mouse IgG (2 mg/mL, in 
PBS) was added to the particle suspension. After incubation at room temperature for 30 min, the 
reaction solution was put in a refrigerator overnight at 4 oC. Then, 100 µL of blocking solution (5% 
BSA in PBS) was added to the reaction solution. After 2 h, the final products were collected by 
centrifugation, washed twice with PBS, and redispersed in 50 µL of PBS containing 1% BSA and 
0.05% NaN3 for future use. 
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4.4.8 Pd-Ir NPs@GVs-based ELISA of PSA 
First, 96-well microtiter plates were coated with rabbit anti-PSA pAb (100 µL per well, 5 
µg/mL in carbonate/bicarbonate buffer, pH=9.6) at 4 oC overnight. After washing the plates three 
times with washing buffer (10 mM PBS pH 7.4 containing 0.5% tween 20, PBST), the plates were 
blocked with 200 µL blocking buffer (3% BSA in PBST) for 2 h at room temperature. The plates 
were then washed three times with washing buffer, followed by the addition of 100 µL PSA 
standards or human plasma sample in dilution buffer (1% BSA in PBST). Note that plasma was 
pre-diluted 2 folds by dilution buffer prior to spiking of PSA and detection. After shaking at room 
temperature for 2 h, the plates were washed three times with washing buffer, and 100 µL mouse 
anti-PSA mAb (2 µg/mL, in dilution buffer) was added. After 1 h shake at room temperature, the 
plates were washed three times, and 100 µL Pd-Ir NPs@GVs-goat anti-mouse IgG conjugates 
(1:2000, in dilution buffer) was added, followed by 30 min shake at room temperature. After 
washing four times, 60 µL DI water was added. After being sealed with a plastic film, the plate 
was put in an oven set to 90 oC for 1 h. After the plate had been cooled down to room temperature, 
50 µL freshly prepared substrate solution (1.6 mM TMB and 4.0 M H2O2 in 0.4 M HOAc/NaOAc 
buffer, pH 4.0) was added to each well. After 30 min incubation at room temperature, 50 µL of 2 
M H2SO4 as a stopping solution was added. The absorbance of each well at 450 nm was read using 
a microplate reader. 
The procedure of HRP based ELISA was the same as the Pd-Ir NPs@GVs-based ELISA 
except for the substitutions of Pd-Ir NPs@GVs-goat anti-mouse IgG conjugates with 100 µL HRP-
goat anti-mouse IgG conjugates (1 µg/mL, in dilution buffer), the difference in the components of 
substrate solution (0.8 mM TMB and 5 mM H2O2 in citric acid-Na2HPO4 buffer, pH 5.0), and the 
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exclusion of heat treatment step. 
4.5 Characterizations 
The UV-vis spectra were recorded using an Agilent Cary 60 UV-vis spectrophotometer. 
TEM images were taken using a JEOL JEM-2010 microscope operated at 200 kV. HRTEM 
images, HAADF-STEM images and energy dispersive X-ray (EDX) mapping were acquired using 
a double Cs-corrected JEOL ARM200F TEM at Brookhaven National Laboratory. The 
concentration of Pd, Ir, and Au ions were determined using an inductively coupled plasma-optical 
emission spectroscopy (ICP-OES, Perkin Elmer Optima 7000DV), which could be converted to 
the particle concentration of Pd seeds, Pd-Ir NPs, and Au NPs once the particle sizes and shapes 
had been resolved by TEM imaging. The X-ray photoelectron spectroscopy (XPS) measurements 
were performed on an SSX-100 system (Surface Science Laboratories, Inc.) equipped with a 
monochromated Al Kα X-ray source, a hemispherical sector analyzer (HSA) and a resistive anode 
detector. X-ray diffraction (XRD) pattern was taken using a Scintag XDS2000 powder 
diffractometer. Dynamic light scattering (DLS) analysis was conducted using a Photocor-FC light 
scattering instrument. 1H NMR spectra were recorded on a Bruker AV-400 MHz high-resolution 
NMR spectrometer in CDCl3. The absorbance of samples in microtiter plates was read using a 
Perkin Elmer Victor 3 1420 Multilabel Plate Reader. Microtiter plates were shaken using a Corning 
LSE Digital Microplate Shaker. pH values of buffer solutions were measured using an Oakton pH 
700 Benchtop Meter. Photographs of samples in tubes and microplates were taken using a Canon 
EOS Rebel T5 digital camera. 
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CHAPTER 5 POLYVINYLPYRROLIDONE (PVP)-CAPPED PT 
NANOCUBES WITH SUPERIOR PEROXIDASE-LIKE ACTIVITYa 
5.1 Introduction 
Peroxidases (in many cases, HRP) are the key components in various colorimetric 
diagnostic and imaging technologies such as ELISA, immunohistochemistry, and western blots.1-
4 Since peroxidases are the inherent driving force for the generation of detectable color signal, their 
essential issues such as the poor stability and low catalytic efficiency largely limit the development 
and evolution of corresponding analytical technologies. To break this confinement of peroxidases, 
peroxidase mimics made of nanoscale particles have been actively developed over the past decade 
as alternatives.5-7 Notable examples include inorganic nanomaterials made of metal oxides (e.g., 
Fe3O4, CeO2, MnO2, and V2O5),
8-11 noble metals (e.g., Au, Pt, Pd, and Ir),12-15 and carbon materials 
(e.g., carbon dots and graphene).16-18 In contrast to their natural counterparts, peroxidase mimics 
are invulnerable to denaturation and protease digestion and therefore are much more stable.5 
Despite the remarkably enhanced stability, improvement in catalytic efficiency for peroxidase 
mimics has been met with very limited success. 
The catalytic efficiencies, in terms of catalytic constant (Kcat, defined as the maximum 
number of colored molecules produced per second per catalyst8) of most previously reported 
peroxidase mimics is limited to the regime of 104 s-1, which is only up to one order of magnitude 
more efficient than HRP as a model natural peroxidase (Kcat = 10
3 s-1).5, 8, 19 It is worth pointing out 
that, in general, the dimensions of peroxidase mimics (typically tens to hundreds nanometers in 
                                                          
aReprinted with permission from ChemNanoMat 2017, 3, 33-38. 
Copyright © 2017 Wiley‐VCH Verlag GmbH & Co. KGaA, Weinheim 
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size) are greater than those of HRP (several nanometers in diameter20). In a sense, the specific 
catalytic efficiency (Kcat‐specific, defined as the normalized Kcat to the total surface area of an 
individual catalyst) of peroxidase mimics is even lower than that of natural peroxidases. Taken 
together, substantially improving the catalytic efficiency of peroxidase mimics remains a grand 
challenge and deserves further investigation. 
In this work, we report a type of highly efficient peroxidase mimic—polyvinylpyrrolidone 
(PVP)‐capped Pt nanocubes of sub‐10 nm in size. These Pt cubes show a superior peroxidase‐like 
efficiency with Kcat and Kcat‐specific at the regimes of 10
5 s-1 and 103 s-1‧nm-2, respectively. To the 
best of our knowledge, this Kcat‐specific represents the record‐high specific efficiency among all the 
existing peroxidase mimics (see Table S5.2 in the Appendix D and the discussion below). Owing 
to the usage of inert Pt element, the cubes also showed excellent catalytic stabilities. The Pt cubes 
could be conveniently synthesized in good uniformity, controllable sizes, and large quantity. 
Mechanisms of nanocrystal formation and the surface properties were carefully investigated. 
5.2 Results and Discussion 
In a standard synthesis of the Pt cubes, a solution of Na2PtCl6⋅6 H2O in ethylene glycol was 
rapidly injected (with a pipet) into a mixture containing PVP55 (MW ≈ 55 000) and KBr that had 
been preheated to 180 °C under magnetic stirring. After the addition of Na2PtCl6⋅6 H2O for 20 min, 
the reaction was immediately quenched with an ice/water batch (see Section 5.4.2 for details). 
Figure 5.1a shows typical TEM image of the Pt nanocrystals prepared with the standard 
procedure. It can be seen that the products were pretty uniform and showed an overall cubic shape 
with an average edge length of 7.35 nm. A close examination of the sample (Figure 5.1b) revealed 
that some of the nanocrystals were imperfect cubes with anisotropic truncations at the corners (the 
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growth mechanism will be discussed later). Figure 5.1c shows HRTEM image of an individual Pt 
cube, from which periodic lattice fringes could be clearly resolved. The lattice spacing of each 
group of parallel fringes was about 1.94 Å, which corresponded to the {200} planes, indicating the 
exposure of six {100} facets on the cube surface.21 Figure 5.1d shows an X‐ray diffraction (XRD) 
pattern of the sample. All the diffraction peaks could be indexed to the face‐centered cubic (fcc) 
Pt (JCPDS no. 04‐0802), confirming the elemental Pt and fcc crystal structure.  
 
Figure 5.1 Structural analyses of PVP55‐capped Pt cubes prepared in a standard synthesis. (a, b) 
TEM images, (c) HRTEM image, and (d) XRD pattern. Inset in (c) shows the corresponding 
Fourier transform pattern. Black bars in (d): JCPDS no. 04‐0802 (Pt). 
It should be emphasized that, in previous studies, Pt cubes were typically synthesized in 
the presence of cetyltrimethylammonium bromide (CTAB) or tetradecyltrimethylammonium 
bromide (TTAB) as both the stabilizer and Pt{100} facet specific capping agent.22-24 In this work, 
we used PVP55 as the stabilizer and ionic Br
- (from KBr) as the capping agent for Pt{100}. 
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Therefore, the surface property of our Pt cubes should be different from that of conventional 
CTAB/TTAB‐capped Pt cubes. To examine chemical ligands on the surface, we conducted X‐ray 
photoelectron spectroscopy (XPS) analysis for the Pt cubes shown in Figure 5.1. Figure 5.2a 
shows the XPS survey spectra of the sample deposited on silicon wafer. The observation of peaks 
for O 1s, N 1s, Pt 4d, C 1s and Pt 4f indicated the adsorption of PVP molecules on the surface.25 In 
addition, the Br 3p peak (inset of Figure 5.2a) could also be seen, suggesting the presence of 
Br- ions on the surfaces. Figure 5.2b shows high‐resolution XPS spectra of the Pt 4f region, from 
which weak peaks of Pt2+ were resolved. The existence of PtII species on the surface can be 
ascribed to the chemisorption of Br- ions.26 To further confirm the adsorption of PVP on the 
surface of the Pt cubes, we also carried out Fourier transform infrared spectroscopy (FTIR) 
analysis for both the Pt cubes and pure PVP powder. As shown by Figure S5.1 in the Appendix 
D, FTIR spectrum taken from the Pt cubes matched well with that of pure PVP powder. In 
particular, peaks for C=O and C-N stretch at 1660 cm-1, C-H deformation of cyclic C-H group at 
1400 cm-1, and C-N stretch at 1280 cm-1could be clearly observed, indicating the presence of 
pyrrolidone species on the Pt surface.25, 27 In addition, the O-H stretch at 3500 cm-1 could be 
ascribed to the hydroxyl group at the terminal end of the commercially PVP.28 Taken together, 
these observations demonstrate the adsorption of PVP on the Pt cube surfaces. To be more specific, 
we refer to these Pt cubes as the “PVP55‐capped Pt cubes” in the following discussion. 
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Figure 5.2 XPS analysis of the PVP55‐capped Pt cubes. (a) XPS survey spectra, and (b) high 
resolution XPS spectra of the Pt 4f region. Inset in (a) highlights the Br 3p region. 
To understand the formation mechanism of the PVP55‐capped Pt cubes, aliquots of the 
reaction solution were taken from a standard synthesis at different stages and examined by TEM. 
In the initial stage of the reaction (t = 1.5 min, Figure 5.3b), nanoparticles with sizes of several 
nanometers were formed. HRTEM analysis (inset of Figure 5.3b) indicated that these 
nanoparticles were single‐crystal Pt particles with an overall spherical shape. At t = 2.5 min 
(Figure 5.3c), the size of the nanoparticles had increased to 4-5 nm. Meanwhile, a nearly truncated 
octahedral or cuboctahedral shape was observed for the sample. As the reaction had proceeded to t 
= 5 min (Figure 5.3d), anisotropically truncated cubes with sizes of 5-6 nm were formed. 
Eventually, cubes and a small portion of anisotropically truncated cubes of ≈7 nm as the final 
products were obtained at t = 20 min (Figure 5.3e). Further extension of reaction time did not 
result in any obvious changes in both the size and shape. Figure 5.3a summarized the shape 
evolution during synthesis in an ideal situation: Pt atoms from the reduction of precursor first 
nucleated and grew into truncated octahedra or cuboctahedra enclosed by both {100} and {111} 
facets. The selective binding of Br− ions to the {100} facets made these facets thermodynamically 
more stable than {111} facets.29 As a result, the addition of consequent Pt atoms preferentially 
occurred on {111} facets, resulting in the shrinkage of {111} facets and eventually the formation 
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of Pt cubes mainly covered by {100} facets. The {100}‐specific binding of Br− ions was 
demonstrated by the result that the final product became cuboctahedra with an overall spherical 
shape in the absence of Br− ions (Figure S5.2 in Appendix D). The anisotropically truncated cubes 
as the byproducts might be ascribed to the relatively low rate of surface diffusion relative to atom 
deposition.30-32 Since the reduction of Pt precursor and thus the deposition of Pt atoms on growing 
seeds was very fast in this case,33 the Pt adatoms had no sufficient time to migrate to all the {111} 
facets of a seed. Those {111} facets that received fewer Pt atoms would eventually form the 
truncations at the corners of a cube.  
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Figure 5.3 (a) Schematics illustrating the formation of PVP55‐capped Pt cubes. (b-e) TEM images 
of Pt nanocrystals obtained at different stages of a standard synthesis for the PVP55‐capped Pt 
cubes: (b) 1.5, (c) 2.5, (d) 5, and (e) 20 min. Inset in (b) is the HRTEM image of an individual Pt 
particle. Insets in (c) and (d) are TEM images of the same samples at higher magnification. 
It is worth noting that our PVP55‐capped Pt cubes have several distinctive advantages over 
conventional CTAB/TTAB‐capped Pt cubes, making them extremely suitable for industrial use: i) 
they can be synthesized in a short period. The reaction time of the PVP55‐capped Pt cubes is much 
shorter than that of CTAB/TTAB‐capped Pt cubes (20 min vs. 6-7 hours22-24); ii) they can be 
produced in large quantities. As quantified by inductively coupled plasma‐optical emission 
spectroscopy (ICP‐OES), ≈ 6.7 mg of Pt cubes could be obtained in a standard synthesis. We have 
also demonstrated that the synthesis can be easily scaled up by ten times to reach a production of 
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≈67 mg per batch. As shown by the TEM images in Figure 5.4, sample quality was not 
compromised by the scale‐up. In contrast, conventional CTAB/TTAB cubes could be only 
produced at the scale of a few milligram or less per batch;22-24 iii) their size can be tuned by simply 
varying the amount of PVP55 added in the standard synthesis. For example, the sizes of PVP55‐
capped Pt cubes could be changed to 8.16 and 6.45 nm, respectively, when 8 and 200 mg 
PVP55 (instead of 40 mg PVP55) were added to the reaction solution (see Figure 5.5). We believe 
the size control is related to the reducibility of PVP molecule at high temperature.28, 34 The 
reduction rate of Pt precursor and thus the number of Pt seeds formed in the initial stage will be 
increased by adding more PVP. Accordingly, when the amount of Pt precursor is kept the same, 
the size of final product will be smaller (vice versa). 
 
Figure 5.4 10-fold scale up synthesis of the PVP55-capped Pt cubes. (a) low-magnification TEM 
image showing the yield and uniformity of the sample; (b) TEM image at a higher magnification 
showing detailed morphology of the sample. 
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Figure 5.5 TEM images of Pt nanocrystals that were prepared using the standard procedure for 
PVP55-capped Pt cubes shown in Figure 5.1, except for the variation in amount of PVP55: (a) 8 
and (b) 200 mg. 
Peroxidase‐like activity of the PVP55‐capped Pt cubes was determined by the apparent 
steady‐state kinetic assay,8, 19 in which the oxidation of TMB35 by H2O2 was employed as a model 
catalytic reaction. All the kinetic assays were carried out at room temperature in cuvettes with path 
length of 1.0 cm. A UV/Vis spectrophotometer was used for determining the concentration of 
colored products (e.g., oxidized TMB with λmax=653 nm8) and thereby the initial reaction 
velocities. By plotting the initial reaction velocities against TMB concentration, a typical 
Michealis-Menten curve was observed (Figure 5.4a). This curve was then fitted to the double‐
reciprocal plot36 (Figure 5.4b), from which the kinetic parameters listed in Table 5.1 were 
derived. For comparison, we also synthesized and determined the kinetic parameters of CTAB‐
capped Pt cubes with an average edge length of 8.62 nm (see Figure S5.3 in Appendix D for TEM 
image and FTIR analysis of these cubes). As summarized in Table 5.1, the Kcat value of the PVP55‐
capped Pt cubes is as high as 8.16×105 s-1, which is approximately 2 and 200‐fold higher than those 
of CTAB‐capped Pt cubes and HRP, respectively. Significantly, these PVP55‐capped Pt cubes 
exhibited a record‐high specific efficiency of Kcat‐specific=2.52×103 s-1‧nm-2 among all the existing 
peroxidase mimics with sizes of 1-100 nm (see Table S5.1 in Appendix D for detailed 
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comparison). The Michaelis constant (Km) of the PVP55‐capped cubes toward TMB was close to 
that of HRP, suggesting that these cubes had similar binding affinity to TMB compared to HRP. 
It should be mentioned that the Pt cuboctahedra or spheres shown in Figure S5.2 (Appendix D) 
showed a similar Kcat‐specific compared to that of the PVP55‐capped Pt cubes, implying that Pt(111) 
surface is as active as Pt(100) surface toward this catalytic reaction. In addition to the ultrahigh 
catalytic efficiency, we have also demonstrated the excellent chemical and thermal stabilities for 
the PVP55‐capped Pt cubes as peroxidase mimics by treating them with strong acid/base and heat 
up to 200 °C (Figure 5.7). Moreover, the catalytic activity only decreased by 6.8 % when these 
PVP55‐capped cubes had been stored in aqueous solution at room temperature for 45 days, 
suggesting a good storage stability of the cubes. 
 
Figure 5.6 Kinetic assays of the PVP55‐capped Pt cubes as catalysts for the oxidation of TMB by 
H2O2. The initial reaction velocity (ν) was measured in 0.2 m HOAc/NaOAc buffer, pH 4.0, 
containing 2.0 m H2O2, 4.1×10-13 m cubes, and TMB of different concentrations at room 
temperature. (a) Plot of ν against TMB concentration; (b) the double‐reciprocal plot generated 
from (A). Error bars indicate the standard deviations of three independent measurements.  
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Figure 5.7 Stability test for the PVP55-capped Pt cubes shown in Figure 5.1 in catalyzing the 
oxidation of TMB by H2O2. (a) Pt cubes (4.1×10
-13 M, in DI water) were first incubated at a range 
of values of pH from 0 to 12 for 2 h and then their relative catalytic activities (e.g., absorbance at 
653 nm of reaction solutions at t = 5min, standard conditions) were measured, in which the activity 
at pH 4.0 was set as 100%; (b) Pt cubes (3.1×10-13 M, in ethylene glycol) were first heated at a 
range of temperatures for 2 h and then their relative catalytic activities were measured under 
standard conditions, in which the activity at 22 oC was set as 100%. 
Table 5.1 Comparison of kinetic parameters of various catalysts toward the oxidation of TMB by 
H2O2. 
Catalyst 
Size 
(nm) 
[E] 
(M) 
Km 
(M) 
Vmax 
(M‧s-1) 
Kcat 
(s-1) 
Kcat-specific 
(s-1‧nm-2) 
PVP55-Pt 
cubes 
7.35 4.1×10-13 7.3×10-4 3.3×10-7 8.2×105 2.5×103 
CTAB-Pt 
cubes 
8.62 2.4×10-13 4.2×10-4 1.1×10-7 4.6×105 1.0×103 
PVP10-Pt 
cubes 
6.69 5.4×10-13 5.2×10-4 2.4×10-7 4.4×105 1.6×103 
PVP360-Pt 
cubes 
8.24 2.6×10-13 8.1×10-4 3.0×10-7 1.2×106 2.8×103 
HRP8 - 2.5×10-11 4.3×10-4 1.0×10-7 4.0×103 - 
 
Even though the explicit mechanism behind the superior peroxidase‐like activity of the 
PVP55‐capped Pt cubes is unclear, we believe surface capping plays an important role. It has been 
demonstrated that CTAB tends to form a compact bilayer on the surface of Pt cubes.37 As such, 
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the capping of CTAB may make the Pt surface less accessible to TMB, a large aromatic compound. 
In contrast, PVP is more loosely packed on Pt surface,38 resulting in the exposure of a more active 
surface and thus enhanced catalytic efficiency. In this vein, we also investigated the effect of PVP 
chain length on the catalytic efficiency. Specifically, we evaluated both PVP10‐ and PVP360‐capped 
Pt cubes (Figure 5.8) that were prepared using the standard protocol except for the substitution of 
PVP55 with PVP10 (MW≈10 000) and PVP360(MW≈360 000) with the same concentration in terms 
of PVP repeating unit. As shown in Table 5.1, the values of Kcat‐specific for different PVP‐capped 
cubes increased in the order of: PVP10‐capped Pt cubes<PVP55‐capped Pt cubes<PVP360‐capped 
Pt cubes. This trend of Kcat‐specific might be related to the packing density of PVP
39,40 on Pt cube 
surfaces. Specifically, the packing densities of PVP10, PVP55, and PVP360 were estimated to be 
1.30, 1.19, and 0.87 nm−2, respectively (Figure 5.9 and Table 5.2), according to TGA 
analysis.41 As PVP packing density increases, the accessibility of TMB molecules to Pt surface is 
expected to decrease, leading to the decrease of catalytic efficiency. Interestingly, we found that 
PVP packing density could barely be changed by varying the amount of certain PVP added to the 
reaction solution. For example, PVP packing densities of the 8.16, 7.35, and 6.45 nm PVP55‐Pt 
cubes, which were synthesized in the presence of 8, 40, and 200 mg PVP55, were almost the same 
(Table 5.2). The specific catalytic activities (Kcat‐specific) for these three types of PVP55‐Pt cubes 
were close to each other (Table S5.1 in Appendix D). Taken together, these results implied that 
PVP packing density has a direct impact on the peroxidase‐like catalytic efficiency of the PVP‐
capped cubes, while the effect of particle size in range of ≈6-8 nm on catalytic efficiency could be 
ignored. Given that the effect of surface capping on peroxidase‐like activity is rarely investigated, 
these initial findings may serve as a foundation for inspiring future work in the field.  
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Figure 5.8 TEM images of Pt nanocrystals that were prepared using the standard procedure for 
PVP55-capped Pt cubes shown in Figure 5.1, except for substitution of PVP55 with: (a) PVP10 and 
(b) PVP360. The concentrations of different PVP in terms of repeating unit were kept the same. 
 
Figure 5.9 Normalized TGA curves of different (A) PVP amount and (B) PVP species capped Pt 
cubes. To calculate the packing density, the weight percentages (w%) at the temperature of 350, 
550, and 600 oC were used.  
Using the PVP55-Pt cubes as an example, the w%(600 
oC) = 9.50%, the w%(550 oC) = 11.30%, 
and w%(350 oC) =50.54%. Therefore, the mass percentage of Pt cubes is 9.50% and PVP55 is 
39.24%. The PVP packing density (nm-2) could be expressed in following equation: 
 
where the MPVP is the molecular weight (55,000 g/mol), NA is the Avogadro's number (6.02×10
23 
mol-1), 𝜌 is the density of Pt (21.45 g/cm3), and ɑ is the average length of the cubes (7.35 nm). 
Substituting each parameter, we get the packing density for PVP55-Pt cubes is 1.19 nm
-2. 
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Table 5.2 List of the TGA parameters of PVP species and Pt for different PVP-capped Pt cubes. 
Sample 
Size 
(nm) 
w% 
(350 oC) 
w% 
(550 oC) 
Δw%  
(550 oC-
350 oC) 
w% 
(600 oC) 
Packing 
density 
(nm-2) 
8 mg PVP55-Pt 
cubes 
8.16 46.24% 11.39% 34.85% 9.62% 1.16 
40 mg PVP55-Pt 
cubes 
7.35 50.54% 11.30% 39.24% 9.50% 1.19 
200 mg PVP55-
Pt cubes 
6.45 38.75% 8.97% 29.78% 6.44% 1.17 
40 mg PVP10-Pt 
cubes 
6.69 50.23% 6.34% 43.89% 4.87% 1.30 
40 mg PVP360-
Pt cubes 
8.24 48.20% 3.63% 44.57% 2.42% 0.91 
 
5.3 Conclusion 
In summary, we have demonstrated a type of highly efficient peroxidase mimic—PVP‐
capped Pt cubes of sub‐10 nm sizes. Distinctive features of this new mimic include record‐high 
specific catalytic efficiency, excellent stability, good uniformity, controllable size, and facile and 
large quantity production. We believe that the PVP‐capped Pt cubes presented here may be 
promising candidate of enzyme mimic for a range of applications including sensing, imaging, and 
detection. 
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5.4 Materials and Experiment 
5.4.1 Chemicals and Materials 
Sodium hexachloroplatinate(IV) hexahydrate (Na2PtCl6·6H2O, 98%), potassium 
tetrachloroplatinate(II) (K2PtCl4, 99%), potassium bromide (KBr, 99%), sodium borohydride 
(NaBH4, ≥99%), polyvinylpyrrolidone (PVP, MW≈10,000, 55,000, and 360,000), 
cetyltrimethylammonium bromide (CTAB), 3,3',5,5'-tetramethylbenzidine (TMB, >99%), 
hydrogen peroxide solution (wt=30% in H2O), acetic acid (HOAc, ≥99.7%), and sodium acetate 
(NaOAc, ≥99%) were all obtained from Sigma-Aldrich. Ethylene glycol (EG) was obtained from 
J. T. Baker. All aqueous solutions were prepared using deionized (DI) water with a resistivity of 
18.0 MΩ·cm. 
5.4.2 Preparation of PVP55-capped Pt Cubes 
In a standard procedure, 3 mL of an EG solution containing 40 mg of PVP55 and 20 mg of 
KBr was hosted in a 20-mL vial and preheated to 180 oC in an oil bath under magnetic stirring for 
10 min. Then, 1.0 mL of Na2PtCl6·6H2O solution (20 mg/mL, in EG) was pipetted into the vial. 
The reaction was allowed to proceed for 20 min and cooled down immediately with an ice/water 
bath. The products were collected by centrifugation, washed once with acetone, twice with water, 
and finally redispersed in 3.2 mL of DI water for future use. The concentration of Pt element in 
the final product was measured to be 2.1 mg/mL by inductively coupled plasma-optical emission 
spectroscopy (ICP-OES). 
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5.4.3 Scaled-up Synthesis of the PVP55-capped Pt Cubes 
The 10-fold scaled up synthesis was conducted in 30 mL EG solution with 400 mg of PVP 
and 200 mg of KBr that was hosted in a 100-mL flask and preheated to 180 oC in an oil bath under 
magnetic stirring for 10 min. Then, 10 mL of Na2PtCl6·6H2O solution (20 mg/mL, in EG) was 
pipetted into the vial. The reaction was allowed to proceed for 20 min and cooled down 
immediately with an ice/water bath. The products were collected by centrifugation, washed once 
with acetone, twice with water, and finally redispersed in 10 mL of DI water. The concentration of 
Pt element in the final product was measured to be 6.7 mg/mL by ICP-OES. 
5.4.4 Preparation of CTAB-capped Pt Cubes 
CTAB-capped Pt cubes were prepared using a previously reported method with slight 
modifications.24 In brief, 4 mL of aqueous solution containing 10 mg K2PtCl4 and 0.73 g CTAB 
was hosted in a 20-ml vial and preheated to 50 oC in an oil bath for 5 min (the solution became 
clear). Then, 0.5 mL ice-cold aqueous solution of 1.35 M NaBH4 was added to the vial, and the 
reaction was allowed to proceed for 7 h. The products were collected by centrifugation, washed 
twice with water, and finally redispersed in 4.0 mL of DI water. 
5.4.5 Steady-state Kinetic Assays8, 19 
All the kinetic assays were carried out at room temperature (~22 oC) in 1.0 mL cuvettes 
with path length (L) of 1.0 cm. A 0.2 M NaOAc/HOAc solution (pH 4.0) was used as the reaction 
buffer. Final concentrations of all the PVP-capped cubes and the CTAB-capped cubes were listed 
in the Tables 5.1 and S5.1. The rest procedure for collection of Vmax and Km can be found in 
Chapter 3, Section 3.4.4. 
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5.5 Characterizations 
The TEM images were taken using a JEOL JEM-2010 microscope operated at 200 kV. The 
UV-vis spectra of the catalytic reaction solution were recorded using an Agilent Cary 60 UV-vis 
spectrophotometer. The X-ray photoelectron spectroscopy (XPS) measurements were performed 
on an SSX-100 system (Surface Science Laboratories, Inc.) equipped with a monochromated Al 
Kα X-ray source, a hemispherical sector analyzer (HSA) and a resistive anode detector. Fourier 
transform infrared spectroscopy (FTIR) spectra were measured with a Perkin Elmer, Spectrum 
One spectrophotometer. X-ray diffraction (XRD) pattern was taken using a Scintag XDS2000 
powder diffractometer. The concentrations of Pt element from the Pt cubes were determined using 
an inductively coupled plasma-optical emission spectroscopy (ICP-OES, Perkin Elmer Optima 
7000DV), in which Pt cubes were dissolved to Pt ions with aqua regia. Thermal Gravimetric 
Analysis (TGA) was carried out by using Shimadzu’s TGA-50 series thermogravimetric analyzers. 
The thermal decomposition experiment was carried out from room temperature to 600°C at a 
heating rate of 10°C/min  and remain at 600 °C for 30 min under N2 flow at 20 mL/min. 
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CHAPTER 6 FACILE COLORIMETRIC DETECTION OF SILVER IONS 
WITH PICOMOLAR SENSITIVITYa 
6.1 Introduction 
With the extensive use of metallic silver (Ag) and its compounds in industries and in our 
daily life (e.g., antimicrobial agents, catalysis, electronics, photography, and jewelry), Ag-ion- 
(Ag+-) containing wastewaters have been continuously discharged into the environment over the 
past several decades, especially in developing countries.1-3 As one of the most hazardous heavy-
metal pollutants, Ag+ are extremely toxic to humans at high doses.1, 2, 4 In particular, Ag+ can 
inactivate enzymes by binding to thiol, amino, and carboxyl groups and/or displacing other 
essential metal ions in functional enzymes, thereby seriously disrupting biological systems.2-
4 According to the Secondary Drinking Water Standards of the U.S. Environmental Protection 
Agency (EPA), the maximum permissible level of Ag+ in drinking water systems is 0.1 mg‧L-1 (or 
0.93 μM). Consequently, the development of sensitive analytical methods for accurately detecting 
trace Ag+ is of paramount importance for water quality control, public health, and environmental 
monitoring. 
Typical sensitive techniques for Ag+ detection include atomic absorption spectrometry 
(AAS), inductively coupled plasma-mass spectrometry and -optical emission spectrometry (ICP-
MS and -OES, respectively), fluorescence spectroscopy, and voltammetry.1-5 Nevertheless, these 
                                                          
aReprinted with permission from Anal. Chem. 2017, 89, 3622-3629 
Copyright © 2017 American Chemical Society 
Haihang Ye contributed the conception and design of the related work, acquisition and 
interpretation of data, and preparation of the article. 
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techniques generally require sophisticated instruments, complicated protocols, and skilled 
operators. Such requirements greatly limit practical applications of these techniques, especially in 
resource-limited areas such as remote villages. In contrast, colorimetric methods are broadly 
recognized as a type of simple and cost-effective technique for Ag+ detection because they can be 
easily performed by less-trained personnel with an inexpensive spectrophotometer or even the 
naked eye.6-18 The most notable approach in the colorimetric detection of Ag+ is to utilize 
plasmonic Au or Ag nanoparticles because of their relatively high detection sensitivity.9, 12-14, 16, 18 
Owing to their large extinction coefficients (which are several orders of magnitude higher than 
those of conventional organic dyes),19, 20 Au and Ag nanoparticles can display distinct color 
changes through Ag+-triggered changes in interparticle distance or morphology and thereby 
achieve relatively sensitive detection of Ag+. For instance, Tseng and co-workers modified the 
surface of citrate-capped Au nanoparticles with Tween 20 as a stabilizer.9 The reduction of Ag+ 
by the citrate ions led to the deposition of Ag on the Au particle surfaces, displacing the Tween 
20. The displacement of Tween 20 triggered a red-to-blue color change of the Au nanoparticles 
because the particles tended to aggregate without the stabilization provided by Tween 20. This 
colorimetric method could detect Ag+ at concentrations as low as 100 nM. Using the same Tween 
20-stabilized Au nanoparticles, Chen and co-workers designed a reverse color change system (e.g., 
blue-to-red) for Ag+ detection by harnessing the ion-redox-modulated surface chemistry, 
achieving a detection limit of 10 nM.13 Similarly to Tween 20, Ag+-responsive cytosine- (C-) 
enriched single-stranded DNA was also used to stabilize Au nanoparticles.18 In the presence of 
Ag+ , double-stranded structures of C-Ag+-C base pairs formed that compromised the stability of 
the Au nanoparticles, leading to a red-to-blue color change. Despite these demonstrations, the 
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bottleneck for current colorimetric methods remains the low detection sensitivity (confined to the 
nanomolar level) relative to that of the aforementioned sophisticated instrument-based techniques. 
In this work, we demonstrate a novel strategy to break this restriction of low detection 
sensitivity for colorimetric Ag+ detection. In this strategy, instead of relying on the plasmonic 
properties of Au or Ag nanoparticles, we take advantage of the excellent peroxidase-like activity 
of a unique type of Pt nanoparticles (PVP-capped Pt cubes21) as reported in Chapter 5. 
Specifically, Ag+ were found to be able to specifically and strongly bind to the surfaces of such 
PVP-capped Pt cubes, leading to the inhibition of their peroxidase-like activity that could be easily 
monitored with a UV-vis spectrophotometer. This new strategy could push the detection limit of 
colorimetric methods into the picomolar (pM) range, which is even lower than those of fluorescent 
methods (see Table S6.1 in Appendix E). Significantly, the method reported herein is quite simple 
and rapid. The detection was conducted at room temperature in an aqueous system, and the entire 
procedure required only ∼6 min. These distinctive features make this approach extremely suitable 
for on-site Ag+ detection. 
6.2 Results and Discussion 
6.2.1 Detection Principle 
As shown in Figure 6.1a, the detection method relies on the high peroxidase-like catalytic 
activity of PVP-capped Pt cubes and the specific inhibition toward the catalytic activity by Ag+. 
As demonstrated, the PVP-capped Pt cubes exhibit excellent peroxidase-like activity with an area-
specific catalytic efficiency (in terms of Kcat-specific, which is defined as the maximum number of 
reaction products generated per second per unit surface area of catalyst23) as high as 2.5×103 s-
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1‧nm-2.21 These cubes can efficiently catalyze the oxidation of TMB24, 25 by H2O2, generating an 
intense blue-colored signal. In the presence of Ag+, the surfaces of the cubes are specifically and 
strongly passivated by Ag+ through adsorption, thereby inhibiting the generation of the colored 
signal. The more Ag+ in the system, the weaker the colored signal generated by the catalytic 
reaction. As such, the concentration of Ag+ can be conveniently determined by measuring the 
absorbance of the catalytic reaction solution using a UV-vis spectrometer. Alternatively, 
qualitative detection can be achieved with the naked eye. 
6.2.2 Characterization of PVP-Capped Pt Cubes 
Figure 6.1b shows a representative TEM image of the PVP-capped Pt cubes from a 
standard synthesis. Our analyses of 200 random particles indicated that ∼80% of particles 
displayed well-defined cubic shapes, and the average edge length of the cubes was measured to be 
7.3 nm with a narrow size distribution (0.6-nm standard deviation). The high-resolution TEM 
image of an individual cube (inset in Figure 6.1b) clearly shows the corresponding lattice fringes 
and {100}-covered side faces. The lattice fringe spacing of 1.9 Å can be indexed to the {200} 
reflections of face-centered-cubic (fcc) Pt.26 These TEM results demonstrate the successful 
preparation, with a relatively high yield and good uniformity, of PVP-capped Pt cubes, which 
formed the basis for the subsequent design and experiments. 
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Figure 6.1 PVP-capped Pt cubes for the colorimetric detection of Ag+. (a) Schematic of the 
detection principle. (b) TEM image of PVP-capped Pt cubes. Inset: HRTEM image of an 
individual Pt cube. (c) Photographs and corresponding UV-vis spectra of solutions in cuvettes 
containing a) PVP-capped Pt cubes (∼3.78 × 1010 particles/mL), b) TMB-H2O2, c) PVP-capped 
Pt cubes + TMB-H2O2, d) 50 nM AgNO3 + PVP-capped Pt cubes + TMB-H2O2, and e) 10 μM 
AgNO3 + PVP-capped Pt cubes + TMB-H2O2. 
6.2.3 Demonstration of Detection Feasibility 
We started with the feasibility demonstration of as-proposed colorimetric method for 
Ag+ detection by involving Ag+  into the PVP-capped Pt cubes catalyzed reaction (e.g., oxidation 
of TMB by H2O2). As shown in Figure 6.1c, neither the PVP-capped Pt cubes as catalysts at a low 
concentration (e.g., 3.78×1010 particles/mL, trace a) nor the TMB-H2O2 solution (trace b) 
exhibited a distinguishable color. Only a mixture of the PVP-capped Pt cubes with the TMB-H2O2 
solution yielded a blue-colored solution with a maximum absorbance at 653 nm (A653 nm ≈ 1.0, 
trace c), which is the characteristic peak of oxidized TMB.24, 25 These observations confirmed the 
high peroxidase-like activity of the PVP-capped Pt cubes. Interestingly, when PVP-capped Pt 
cubes were incubated with a colorless Ag+ solution of 50 nM for 40 s before being mixed with the 
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TMB-H2O2 solution, the intensity of the blue color of the final reaction solution decreased 
significantly (A653 nm ≈ 0.21, trace d). Increasing the Ag+ concentration further decreased the 
intensity of the blue color. At 10 μM Ag+, the reaction solution was almost colorless (A653 nm ≈ 
0.026, trace e). These results imply that Ag+ can effectively inhibit the peroxidase-like activity of 
PVP-capped Pt cubes. To single out the role of the Ag+, we conducted additional control 
experiments by replacing 50 nM AgNO3 in the trace c experiment with 50 nM NaNO3 and 
CF3COOAg. As shown in Figure 6.2, the peroxidase-like activity of the PVP-capped Pt cubes 
remained unchanged (A653 nm = 0.99) after they had been treated with NaNO3. In contrast, the 
activity of the PVP-capped Pt cubes decreased to a significant extent similar to what was observed 
for 50 nM AgNO3 (A653 nm = 0.19) after the cubes were mixed with CF3COOAg. These data 
verified that the inhibition of the catalytic activity of Pt cubes was specifically attributable to the 
Ag+. Taken together, this set of experiments demonstrated the feasibility of the proposed 
colorimetric method for Ag+ detection. 
 
Figure 6.2 UV-vis spectra taken from reaction solutions in cuvettes containing: (a) 50 nM NaNO3 
+ PVP-capped Pt cubes + (H2O2-TMB); and (b) 50 nM CF3COOAg + PVP-capped Pt cubes + 
(H2O2-TMB). Reaction conditions were kept the same as those in standard Ag
+ detection procedure 
except for the substitution of AgNO3 with NaNO3 or CF3COOAg. 
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6.2.4 Sensitivity and Reproducibility 
We then evaluated the detection sensitivity and reproducibility of the proposed colorimetric 
method. The detection was quite simple and straightforward. In a standard procedure, the PVP-
capped Pt cubes were incubated with Ag+ standard or sample in a buffer solution held in a cuvette 
for a short period of time before being mixed with TMB-H2O2 solution. After several minutes of 
reaction, the final reaction solution was subjected to examination with a UV-vis spectrometer, a 
camera, or the naked eye. Based on the systematic examination of various experimental parameters 
(Figure 6.3), the optimal conditions for Ag+ detection were found to be (i) room temperature (∼22 
°C) for the entire process, (ii) a pH value of 6.0 and an incubation time of 40 s for the incubation 
of Ag+ standards/samples with Pt cubes, (iii) 0.8 mM TMB plus 2.0 M H2O2 for the TMB-
H2O2 solution,
21, 23 and (iv) t  =  5 min for the catalytic reaction. Under these conditions, the 
detection was conducted at room temperature and in aqueous solution, and the entire procedure 
required only ∼6 min. 
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Figure 6.3 Optimization of experimental conditions for the detection of Ag+ ions with the 
proposed colorimetric method. Effects of: (a) buffer pH value for the solution system in which Ag+ 
and PVP-capped Pt cubes were mixed; (b) incubation time for Ag+ and PVP-capped Pt cubes, and 
(c) reaction time for the PVP-capped Pt cubes catalyzed reaction (e.g., oxidation of TMB by H2O2). 
In all experiments, 5 nM Ag+ standard was chosen as a model sample for optimization of the 
detection system. To make the proposed method more applicable for environmental scenarios, 
room temperature (~22 °C) was selected as the operational temperature for all measurements and 
incubations throughout the experiment. All other conditions were kept the same as those in the 
standard detection procedure. Error bars represent the standard deviations of six independent 
measurements (n = 6). Red arrows indicate the optimized parameters. 
Figure 6.4a shows photographs of cuvettes containing final reaction solutions with 
Ag+ standards ranging in concentration from 0 to 10000 nM. It can be seen that the solutions 
displayed a continuous color change from deep blue to light blue and eventually to nearly colorless. 
Qualitative analysis with the naked eye could achieve a detection limit of ∼5 nM Ag+. The 
detection results could be conveniently quantified with the aid of an ordinary UV-vis spectrometer. 
As shown in Figure 6.4b, c, a proportional decrease in the absorbance of the reaction solutions at 
653 nm as a function of the concentration of Ag+ was clearly seen. By plotting the decrease in 
absorbance (A0 – Ax, where A0 and Ax denote the absorbances at 653 nm of the blank solution and 
the Ag+ standard of x nM, respectively) against the Ag+ concentration, calibration curves for Ag+ 
were generated (see Figure 6.4d, e). As indicated by Figure 6.4d, the colored signal could be 
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differentiated for Ag+ in the range of 0.01-10000 nM (6 orders of magnitude), suggesting a wide 
response range of the colorimetric method toward Ag+. As shown in Figure 6.4e, a high-quality 
linear relationship (R2 = 0.998) in the range of 0.1-1 nM Ag+ was observed. The limit of detection 
(LOD, defined as the concentration corresponding to a signal that is 3 times the standard deviation 
above the zero-calibration point27) was calculated to be 80 pM. The coefficients of variation across 
the entire concentration range were between 0.13% and 7.64% (n = 6), indicating a good 
reproducibility of the method. 
 
Figure 6.4 (a) Photographs showing the final reaction solutions with different Ag+ standards in 
cuvettes. (b) Corresponding UV-vis spectra of the samples shown in panel a. (c) Magnified UV-
vis spectra of the region marked by a blue box in panel b. (d) Calibration curve generated by 
plotting the decrease of the absorbance at 653 nm relative to that of the blank for the reaction 
solutions (A0 – Ax) as a function of the Ag+ concentration. Inset: Same plot on a logarithmic scale. 
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(e) Linear region of the calibration curve shown in panel d. In panel d and e, the error bars represent 
the standard deviations of six independent  
We also investigated the effect of particle size on the detection performance. To this end, 
in addition to the 7.3-nm Pt cubes shown in Figure 6.1, we prepared PVP-capped Pt cubes of two 
other sizes (e.g., 6.2 and 9.5 nm; see Figure 6.5a, b) by simply varying the amount of PVP in the 
standard synthesis. As shown in Figure 6.5c, we found that particle size in range of ∼6.2-9.5 nm 
has no distinct impact on the detection performance. 
 
Figure 6.5 (a, b) TEM images of PVP-capped Pt cubes with average edge lengths of (a) 6.2 nm 
and (b) 9.5 nm. (c) Inhibition efficiencies of Ag+ toward the peroxidase-like activities of PVP-
capped Pt cubes of various edge lengths: 6.2 nm, 7.3 nm (sample in Figure 6.1), and 9.5 nm. In 
(c), A0 and Ax are the absorbances at 653 nm of reaction solutions catalyzed by certain Pt cubes 
before and after incubation with 5 nM Ag+, respectively. The concentrations of Pt cubes were set 
to certain values at which A0 for all the cubes was normalized to ~1.0. Error bar represents the 
standard deviation of three independent measurements (n = 3). 
To highlight the distinctive advantages of our method, we compared its analytical 
performance with those of previously reported methods for Ag+ detection. As summarized 
in Table 6.1, our method exhibited a record-high detection sensitivity (LOD = 80 pM) among all 
of the existing colorimetric methods. Significantly, it was even more sensitive than most 
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fluorescence methods reported in the literature (Table S6.1 in Appendix E). In addition, the entire 
detection time of our method was only ∼6 min, making it faster than most of the reported methods. 
Moreover, our method is cost-effective because of the use of a tiny amount of Pt cubes (∼3×10-
9 g of Pt per test) and ordinary reagents such as TMB and H2O2. The materials cost for each test 
was estimated to be less than US$0.1. 
The ultrahigh detection sensitivity of our colorimetric method can be ascribed to the 
outstanding catalytic activity of the Pt cubes and the efficient inhibition of Ag+ toward the catalysis 
(as discussed later), which together led to an amplified signal diminishment process. The 
magnitude of signal diminishment of the system could be quantified by comparing the amount of 
Ag+ in the system with the extent of the decrease of colored products relative to the amount in the 
blank sample (e.g., without Ag+). Taking the detection of 0.5 nM Ag+ (in a volume of 590 μL) as 
an example, the presence of 2.95×10-13 mol of Ag+ was found to correspond to a decrease of 
2.45×10-9 mol of oxidized TMB molecules (which was calculated based on their absorbance and 
molar absorption coefficient25), suggesting a signal amplification of approximately 4 orders of 
magnitude by the detection system. 
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Table 6.1 Comparison of analytical performances of various colorimetric methods for 
Ag+ detection 
Detection probes LOD (nM) Assay time (min) Ref 
BSA-stabilized Au clusters 204 10 8 
Tween 20-Au nanoparticles 100 5 9 
G-quadruplex-hemin DNAzyme 64 110 10 
3,3′,5,5′-tetramethylbenzidine 50 30 11 
Core-shell Au nanoparticles 10 15 12 
Tween 20-Au nanoparticles 10 33 13 
Au-Ag core-shell nanoparticles 8.76 4 14 
G-quadruplex-hemin DNAzyme 6.3 110 15 
N-1-(2-mercaptoethyl)adenine-Au 
nanoparticles 
3.3 20 16 
DNAzyme switch 2.5 4 17 
DNA-Au nanoparticles 0.59 32 18 
PVP-capped Pt cubes 0.08 6 
This 
work 
aLOD = limit of detection. 
6.2.5 Specificity Test 
We also evaluated the specificity of our method toward other ionic species. Common 
cations (NH4
+, Na+, K+, Li+, Ba2+, Ca2+, Cd2+, Co2+, Cu2+, Fe2+, Mg2+, Mn2+, Ni2+, Pb2+, Zn2+, Al3+, 
Cr3+, Fe3+, Cu+, Pd2+, and Hg2+) and anions (F–, Cl–, Br–, NO3
–, Ac–, SO3
2–, SO4
2–, CO3
2–, and PO4
3–
) as interfering ions were tested using the standard procedure. Note that Ag+ was not included 
among these interfering ions. DI water and 5 nM Ag+ solution as the blank and control, 
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respectively, were also tested. As shown in Figure 6.6, a significant decrease in absorbance at 653 
nm relative to the blank was observed with Ag+, whereas no distinct change in the absorbance was 
seen for any of the interfering ions except for Pd2+ and Hg2+. Nevertheless, the extents to which 
the absorbance was decreased for Pd2+ and Hg2+ were much lower than that for Ag+. These results 
indicate the relatively good specificity of the colorimetric method for detecting Ag+.  
 
Figure 6.6 Specificity test of the developed colorimetric method. Intensities of the absorbance at 
653 nm were recorded from reaction solutions containing various ionic species using the standard 
procedure for Ag+ detection. The numbers under each bar correspond to the ions indicated by the 
same numbers. Blank (sample 1) denotes DI water. The ionic concentrations for samples 2-28 and 
samples 29-32 were 50 and 5 nM, respectively. The error bars represent the standard deviations of 
three independent measurements (n = 3). 
6.2.6 Demonstration of Real Sample Detection 
To demonstrate the potential use of the proposed method in environmental scenarios, tap-
water samples (from the faucet in our laboratory) spiked with Ag+ were analyzed. It should be 
mentioned that the original tap water was free of Ag+, as confirmed by ICP-OES analysis. 
Specifically, 12 Ag+-spiked tap-water samples with Ag+ concentrations in the range of 0.4-100 nM 
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were analyzed using the standard procedure. The Ag+ in each sample were quantified based on the 
calibration curve shown in Figure 6.2e. Note that samples with high Ag+ concentrations were 
diluted to fall within the linear detection range (e.g., 0.1-1 nM). The detection results are 
summarized in Figure 6.7 and Table 6.2. A strong positive correlation between the spiked Ag+ 
concentrations and the found Ag+ concentrations was observed, with a slope of 0.9720 and an 
intercept of 0.0225, which are close to the ideal values of 1 and 0, respectively. The recoveries of 
all of the samples were between 93.7% and 108.6%. The coefficients of variation for the 
quantification were in the range of 5.8-12.6% (n = 3). These data demonstrate the capability of the 
proposed method to detect Ag+ in real-life samples. 
 
Figure 6.7 Correlation analysis between the Ag+ concentrations in 12 Ag+-spiked tap-water 
samples and the Ag+ concentrations found by the developed colorimetric method. The error bars 
represent the standard deviations of three independent measurements (n = 3). Quantitative data 
and the recovery of each sample are summarized in Table 6.2. 
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Table 6.2 Summary of the detection of Ag+ from spiked tap-water samples as shown in Figure 
6.7. 
Sample no. 
Spiked 
concentration 
(nM) 
Found concentration 
[mean ± SDa (n = 3)]  
(nM) 
CVb  
(%) 
Recoveryc  
(%) 
1 0.4 0.41 ± 0.04 9.8 104.1 
2 1 1.03 ± 0.13 12.6 103.4 
3 2 1.91 ± 0.12 6.3 95.5 
4 3 3.26 ± 0.32 9.8 108.6 
5 5 4.80 ± 0.39 8.1 95.9 
6 10 9.86 ± 0.71 7.2 98.6 
7 20 20.6 ± 1.5 7.3 102.8 
8 35 38.0 ± 4.0 10.5 108.4 
9 50 47.6 ± 4.3 9.0 95.2 
10 65 60.9 ± 4.3 7.1 93.7 
11 80 79.9 ± 4.6 5.8 99.9 
12 100 93.9 ± 6.0 6.4 93.9 
aSD = standard deviation.                                                                   bCV = coefficient of variation. 
cRecovery is defined as the amount of Ag+ found divided by the amount of Ag+ originally spiked 
in the sample. 
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6.2.7 Mechanistic Understanding 
Finally, we designed and conducted a set of experiments in an attempt to gain insight into 
the mechanism behind the detection. Because the peroxidase-like catalytic property of PVP-
capped Pt cubes was elaborated in our recent work,21 the focus in this case was on understanding 
how Ag+ inhibits the catalytic activity. We first performed XPS analysis to characterize the 
surfaces of the PVP-capped Pt cubes before and after they had been incubated with Ag+. It should 
be noted that, after incubation with an excess amount of Ag+, the Pt cubes were centrifuged and 
washed with DI water 10 times to remove free Ag+ in the solution. Figure 6.8a shows XPS survey 
spectra of the Pt cubes before and after Ag+ incubation. The peaks for Pt 4f, C 1s, Pt 4d, N 1s, and 
O 1s at specific positions can be seen in the spectrum of the initial Pt cubes, confirming the 
presence of PVP molecules on the Pt cube surface.28 For the cubes after incubation with Ag+, in 
addition to the characteristic peaks of PVP and Pt, peaks for Ag 3d were clearly 
observed,29 indicating the adsorption of Ag+ on the surface. Therefore, we assume that the binding 
of Ag+ prevented TMB and/or H2O2 from accessing the Pt surfaces and, thus, inhibited the 
catalytic activity of the Pt cubes. It should be pointed out that the peak positions and relative 
intensities of the peaks for PVP and Pt remained essentially unchanged after Ag+ adsorption, 
implying that the Ag+ did not extensively react with or replace PVP molecules on the cube 
surface. Figure 6.8b, c show high-resolution XPS spectra of the Pt 4f region for both Pt cube 
samples. No significant difference can be observed between the two spectra, indicating a very 
weak chemical interaction between the adsorbed Ag+ ions and Pt surface. Figure 6.8d shows a 
high-resolution XPS spectrum of the Ag 3d region for the cubes after Ag+ incubation, in which 
only Ag+ peaks can be resolved.29 This observation indicates the presence of only Ag(I) species 
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on the surface and further confirmed that almost no chemical reactions occurred between Ag+ and 
PVP/Pt during the adsorption of the Ag+. 
 
Figure 6.8 XPS analyses of the PVP-capped Pt cubes before and after incubation with Ag+. (a) 
XPS survey spectra of both samples. (b, c) Pt 4f XPS spectra of the Pt cubes (b) before and (c) 
after incubation with Ag+. (d) Ag 3d XPS spectrum of the Pt cubes after incubation with Ag+. 
To better understand the adsorption of Ag+ on the PVP-capped Pt cubes, we conducted a 
comparison study by testing the efficiencies of Ag+ ions in inhibiting the peroxidase-like activities 
of several other sub-10-nm nanostructures. These nanostructures included 6.5-nm PVP-capped Pt 
nanospheres (Figure 6.9a), 5.0-nm citrate-capped Pt nanospheres (Figure 6.9b),22 5.9-nm PVP-
capped Pd nanocubes (Figure 6.9c),23 and 4.5-nm PVP-capped Au nanospheres (Figure 6.9d). 
The nanostructures were first incubated with Ag+ and then utilized as catalysts for the oxidation 
of TMB by H2O2 using the standard procedure for PVP-capped Pt cubes, in which the ratio of Ag
+ 
to total surface area of each nanostructure was kept the same. The inhibition efficiency of 
Ag+ toward the catalytic activity was calculated as (A0 – Ax)/A0, where A0 and Ax are the 
absorbances at 653 nm of the reaction solutions catalyzed by the nanostructures before and after 
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incubation with Ag+, respectively. Herein, the concentrations of the nanostructures were set to 
certain values such that A0 for all of the nanostructures was normalized to ∼1.0. Figure 6.9e 
compares the inhibition efficiencies of Ag+ toward the various nanostructures. It can be seen that 
the inhibition efficiency of Ag+ toward the PVP-capped Pt spheres was almost the same as that 
toward the PVP-capped Pt cubes. This result indicates that the Pt{100} facet of the Pt cubes is not 
the determinative factor in the adsorption of Ag+ because the Pt spheres were encased by a 
combination of Pt{100} and Pt{111} facets.30, 31 In this regard, the performance of the PVP-capped 
Pt spheres is expected to be as good as that of the PVP-capped Pt cubes in practical detection. In 
the present study, we focused on Pt cubes for demonstration mainly because they are more uniform 
in terms of both shape and size than Pt spheres, which makes it convenient to gain a quantitative 
understanding of the detection mechanism. In contrast, the inhibition efficiency toward the citrate-
capped Pt spheres was much lower than that toward the PVP-capped Pt cubes or spheres 
(see Figure 6.9e), suggesting that PVP plays an important role in facilitating the adsorption of 
Ag+.32-35 Based on these results, we hypothesize that the strong adsorption of Ag+ on the PVP-
capped Pt cubes can be ascribed to the synergistic effect of the fcc crystal structure of Pt and PVP. 
In particular, a good match in geometry between Ag+ and the fcc structure of Pt might promote the 
Ag+ adsorption.36 This argument is supported by the facts that (i) a similar inhibition efficiency of 
Ag+ was observed for PVP-capped cubes made of Pd (Figure 6.9e), whose lattice constant is 
almost the same as that of Pt (<1% in lattice mismatch37, 38), and (ii) Ag+ did not inhibit the 
peroxidase-like activity of PVP-capped Au nanospheres (Figure 6.9e). Note that the lattice 
mismatch between Pt and Au is as large as 3.8%.39 In addition, this argument is, to some extent, 
also supported by the data shown in Figure 6.6. In particular, Hg2+ could also inhibit the 
peroxidase-like activity of PVP-capped Pt cubes even though its inhibition efficiency was lower 
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than that of Ag+. This observation might be due to the fact that the ionic radius of Hg2+ is similar 
to that of Ag+ (0.126 nm vs. 0.110 nm),40, 41 which ensures a relatively good match between Hg2+ 
and the Pt fcc structure. To further demonstrate this synergistic effect, we carried out another 
control experiment in which the same amount of Ag+ was preincubated with excess PVP and then 
used to inhibit the catalytic activity of PVP-capped Pt cubes (Figure 6.9f). Interestingly, the 
inhibition efficiency of Ag+ was almost the same as that of the case without the preincubation with 
free PVP. This result suggests that free PVP barely binds to Ag+ and that only the combination of 
PVP and the Pt surface can induce the strong adsorption of Ag+. 
 
Figure 6.9 Inhibition of Ag+ toward the peroxidase-like activities of various nanostructures. (a-d) 
TEM images of (a) 6.5-nm PVP-capped Pt spheres, (b) 5.0-nm citrate-capped Pt spheres, (c) 5.9-
nm PVP-capped Pd cubes, and (d) 4.5-nm PVP-capped Au spheres. (e) Inhibition efficiencies of 
Ag+ toward the peroxidase-like activities of different nanostructures. (f) Inhibition efficiencies of 
Ag+ toward the peroxidase-like activities of two PVP-capped Pt cube samples (from the same 
synthesis batch) that were preincubated with 0 or 5 mg/mL PVP aqueous solution. In panel e and 
f, A0 and Ax are the absorbances at 653 nm of reaction solutions catalyzed by certain nanostructures 
before and after incubation with Ag+, respectively. The concentrations of the nanostructures were 
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set to certain values at which A0 for all of the nanostructures was normalized to ∼1.0. The error 
bars represent the standard deviations of three independent measurements (n = 3). 
To achieve a quantitative analysis, we determined the coverage density of Ag+ on the PVP-
capped Pt cubes using ICP-OES. The cubes were first incubated with an excess amount of Ag+ and 
washed 10 times with DI water by centrifugation. The resultant Ag+-adsorbed Pt cubes were 
digested with aqua regia and then subjected to ICP-OES analysis. The molar ratio of Ag to Pt was 
quantified to be 0.074:1. Based on this result, the size of the Pt cubes, and the unit-cell parameters 
of Ag,42, 43  the average number of Ag atomic layers adsorbed on the Pt cubes was estimated to be 
0.972. This result suggests the nearly monolayer adsorption of Ag+ on the Pt cube surface and 
further demonstrates that the Ag+ absorbed at the interface between Pt and PVP rather than the 
repeat units of the polymeric PVP molecules. In a sense, the unique interface of Pt and PVP is 
specific to Ag+ binding. Taken together, the synergistic adsorption effect of the Pt fcc crystal 
structure and PVP is believed to be responsible for the specific and strong adsorption of Ag+ on 
the surface of PVP-capped Pt cubes. This adsorption of Ag+ blocks the active sites for catalysis 
and eventually inhibits the peroxidase-like catalytic activity of the Pt cubes. 
6.3 Conclusion 
In summary, we have demonstrated a facile colorimetric method for the detection of Ag+ 
with picomolar sensitivity. The high detection sensitivity relies on the ultrahigh peroxidase-like 
catalytic activity of PVP-capped Pt cubes and the specific, efficient inhibition toward this catalytic 
activity by Ag+. In addition to a high sensitivity, this colorimetric method also features simple 
operation, rapid execution, and cost effectiveness. We believe that the method presented here will 
find widespread use in monitoring and quantifying Ag+ in environmental scenarios. The concept 
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of taking advantage of the superior catalytic activities of nanoscale artificial peroxidases can also 
be extended to the detection and sensing of other critical ionic species.44, 45  
6.4 Materials and Experiment 
6.4.1 Chemicals and Materials 
Silver nitrate (AgNO3, ≥99.0%), sodium hexachloroplatinate(IV) hexahydrate 
(Na2PtCl6·6H2O, 98%), potassium bromide (KBr, ≥99%), poly(vinylpyrrolidone) (PVP, Mw ≈ 
55000), hydrogen peroxide solution (30 wt % in H2O), 3,3′,5,5′-tetramethylbenzidine (TMB, > 
99%), sodium acetate (NaOAc, ≥99%), acetic acid (HOAc, ≥99.7%), L-ascorbic acid (≥99%), 
gold(III) chloride trihydrate (HAuCl4·3H2O, ≥99.9%), sodium nitrate (NaNO3, ≥99%), silver 
trifluoroacetate (CF3COOAg, ≥99.9%), sodium citrate dihydrate (≥99%), citric acid (≥99.5%), 
sodium borohydride (NaBH4, ≥98%), and potassium chloride (KCl, ≥99%) were all obtained from 
Sigma-Aldrich. Ethylene glycol (EG) was obtained from J. T. Baker. All other reagents and 
chemicals were of at least analytical grade. All aqueous solutions were prepared using deionized 
(DI) water with a resistivity of 18.0 MΩ·cm. Tap-water samples were collected from a household 
water pipe in our laboratory. 
6.4.2 Synthesis of PVP-Capped Pt Cubes 
The synthesis of Pt nanocubes was the same as in Chapter 5. The concentration of final 
products in terms of Pt element was determined to be 1.68 mg/mL by inductively coupled plasma-
optical emission spectroscopy (ICP-OES). This Pt element concentration was converted to a Pt 
particle concentration of ∼2.01 × 1014 particles/mL or ∼3.34 × 10-7 M given that the shape and 
size of Pt particles (e.g., cubes with an edge length of 7.3 nm) had been resolved by TEM 
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(see Figure 6.1b). PVP-capped Pt cubes with average edge lengths of 6.2 and 9.5 nm (shown 
in Figure 6.5) were obtained by using the same procedure as for 7.3-nm Pt cubes except for 
changes in the amount of PVP from 40 mg to 8 and 200 mg, respectively. 
6.4.3 Standard Procedure for the Detection of Ag+ Using PVP-Capped Pt Cubes 
Before detection, Ag+ standards with various concentrations were prepared using 
AgNO3 as the source and 1.0 mM HOAc/NaOAc buffer (pH 6.0) as the sample matrix. Afterward, 
590 μL of Ag+standard or sample was mixed with 10 μL of PVP-capped Pt cubes (∼3.78 × 
1010 particles/mL) in a disposable plastic cuvette, and the mixture was incubated for 40 s at room 
temperature. Subsequently, 400 μL of substrate solution (5.0 M H2O2 and 2.0 mM TMB in 1.0 M 
HOAc/NaOAc buffer, pH 4.0) was added. After incubation of the reaction solution for 5 min at 
room temperature, its UV-vis spectrum, photograph, or both were taken. 
6.4.4 Synthesis of Other Nanostructures Shown in Figure 6.9 
6.5-nm PVP-Capped Pt Spheres 
The 6.5-nm PVP-capped Pt spheres were synthesized using the same procedure as for the 
7.3-nm PVP-capped Pt cubes except for the exclusion of KBr from the reaction solution. The final 
products were stored in 4 mL of DI water at a particle concentration of ∼5.38 × 1014 particles/mL 
or ∼8.94 × 10–7 M. 
5.0-nm Citrate-Capped Pt Spheres 
The 5.0-nm citrate-capped Pt spheres were synthesized according to a previously reported 
procedure with minor modifications.22 Briefly, 100 mL of 0.01% (w/v) Na2PtCl6·6H2O aqueous 
solution was heated to boiling under vigorous stirring, and then 2 mL of a solution containing 1% 
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sodium citrate and 0.05% citric acid was added. After 30 s, 1 mL of a freshly prepared solution 
containing 0.08% NaBH4 and 1% sodium citrate was quickly added to the above solution. The 
resultant mixture was kept boiling and stirring for 10 min and was then cooled to room temperature. 
The final products were stored in 10 mL of 0.1% sodium citrate solution at a particle concentration 
of ∼2.21 × 1014 particles/mL or ∼3.67 × 10–7 M. 
5.9-nm PVP-Capped Pd Cubes 
The 5.9-nm PVP-capped Pd cubes were synthesized using our previously published 
procedure with slight changes.23 In brief, 8.0 mL of an aqueous solution containing 105 mg of PVP, 
60 mg of AA, 4 mg of KBr, and 186 mg of KCl was hosted in a vial and preheated to 80 °C in an 
oil bath under magnetic stirring for 10 min. Subsequently, 3.0 mL of an aqueous solution 
containing 57 mg of Na2PdCl4 was injected with a pipet. After the reaction had proceeded for 3 h, 
the products were collected by centrifugation. The final PVP-capped Pd cubes were stored in 5.0 
mL of DI water at a particle concentration of ∼1.56 × 1015 particles/mL or ∼2.59 × 10–6 M. 
4.5-nm PVP-Capped Au Spheres 
Precisely 10.0 mL of an aqueous solution containing 1.05% (w/v) PVP and 0.25 mM 
HAuCl4 was hosted in a vial and stirred at room temperature. Subsequently, 0.5 mL of a freshly 
prepared solution containing 0.08% NaBH4 and 1% ascorbic acid was quickly added to the above 
solution. After the reaction had proceeded for 10 min, the products were collected by centrifugation. 
The final PVP-capped Au spheres were stored in 5.0 mL of DI water at a particle concentration of 
∼9.71 × 1013 particles/mL or ∼1.61 × 10–7 M. 
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6.4.5 Estimation of the Magnitude of Signal Diminishment (N) for the Proposed Method 
Here, detection of 0.5 nM Ag+ was chosen as a model for the estimation. The magnitude of 
signal diminishment of the detection system was estimated by comparing the amount of Ag+ in the 
system with the amount of colored products diminished relative to the blank (e.g., 0 nM Ag+). 
Known parameters: 
1) The Ag+ concentration: CAg+ =  0.5 nM 
2) The volume of Ag+ sample: VAg+= 590 μL  
3) The amount of Ag+ ions (nAg+): 590 μL × 0.5 nM = 2.95 × 10-13 mole 
4) The decrease of the absorbance at 653 nm of the detection solution: A0 – A0.5 = 0.0954 (see 
Figure  6.4e),  where A0.5 and A0  denote  the  absorbance  recorded  from  reaction  solutions  
containing 0.5 and 0 (blank) nM Ag+ 
5) The total volume of final reaction solution: V = 1000 μL  
6) The molar absorption coefficient of oxidized TMB at 653 nm: ε = 3.9 × 104 M-1‧cm-1 
Results: 
The path length of cuvette: b = 1.0 cm. The  decreased  concentration  of  oxidized TMB  
(∆CoxTMB,  relative  to  the  blank)  in  1000  μL solution toward 0.5 nM Ag+ could be calculated 
based on the Beer-Lambert law (A = εbC): ∆CoxTMB = (A0 – A0.5)/ (εb)   = 0.0954 / (3.9 × 104 M-
1‧cm-1 × 1 cm) = 2.4462 × 10-6 M. 
Therefore,  the  amount  of  diminished  oxidized  TMB  molecules  (noxTMB)  was  estimated  
to  be  2.45 × 10-9 mole (e.g., 2446.2 nM × 1000 μL). Finally, the magnitude of signal diminishment 
(N) could be estimated: N = noxTMB / nAg+ = 2.45 × 10-9 mole / 2.95 × 10-13 mole = 8.3×103. 
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6.4.6 Preparation of the Ionic Solutions 
The  ionic  solutions  labeled  with  #2-#31 in Figure  6.6  were  prepared  by  dissolving  
NH4Cl,  NaCl,  KCl,  LiCl,  BaCl2·2H2O,  CaCl2·2H2O, CdCl2, Co(NO3)2·6H2O, CuCl2·2H2O, 
FeSO4·7H2O, Mg(NO3)2·6H2O, MnSO4·H2O, NiCl2·6H2O, Pb(NO3)2, Zn(NO3)2·6H2O,  
Al(NO3)3·9H2O, CrCl3·6H2O, Fe(NO3)3·9H2O, NaF, NaCl, NaBr, NaNO3,  NaAc, Na2SO3,  
Na2SO4, K2CO3, Na3PO4, CuCl, PdCl2, and HgCl2, respectively,  in  DI  water.  All  the  chemicals  
were  analytical  grade  and  were  used  as  received  without further purification. 
6.5 Characterizations 
UV-vis spectra were measured using an Agilent Cary 60 UV-vis spectrophotometer. TEM 
images were recorded using a JEOL JEM-2010 microscope operated at 200 kV. The 
concentrations of Pt, Ag, and Pd ions were determined by ICP-OES (Perkin-Elmer Optima 7000 
DV spectrometer) and could be converted into particle concentrations of Pt and Pd nanoparticles 
by coupling with TEM imaging data. X-ray photoelectron spectroscopy (XPS) measurements were 
performed on an SSX-100 system (Surface Science Laboratories, Inc.) equipped with a 
monochromated Al Kα X-ray source, a hemispherical sector analyzer (HSA), and a resistive anode 
detector. The pH values of buffer solutions were recorded using an Oakton pH 700 benchtop meter. 
Photographs of the samples in cuvettes were taken using a Canon EOS Rebel T5 digital camera. 
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CHAPTER 7 A NON-ENZYME CASCADE AMPLIFICATION STRATEGY 
FOR COLORIMETRIC ASSAY OF DISEASE BIOMARKERSa 
7.1 Introduction 
Diagnostic technologies for the detection of disease biomarkers have become a critical 
component in biomedical research and clinical care.1-4 Over the past several decades, a variety of 
technologies based on different signal-transducer principles have been actively explored, with 
notable examples including fluorescent,5-7 chemiluminescent,8,9 colorimetric,10-12 
electrochemical,13,14 Raman,15-17 and plasmonic18,19 assays. Among them, enzyme-based 
colorimetric assays (in which the enzymes are pre-conjugated to bioreceptors and specifically 
generate a color signal by catalyzing chromogenic substrates) continue to attract increasing 
attention because of their simplicity and cost-effectiveness.20-22 In particular, they could be 
performed by less-trained personnel with low-cost devices, making them extremely desirable for 
diagnostics in resource-limited settings. 
Nevertheless, extensive application of colorimetric assays in clinical diagnosis is largely 
limited by their relatively low detection sensitivity. A general strategy to enhance the sensitivity 
is to amplify the color signal by assembling as many enzymes as possible on carriers (e.g., 
polymers and nanoparticles).23, 24 However, this strategy is ultimately confined by the loading 
amount of enzymes on a carrier with limited space and the steric hindrance.25 Recently, enzyme 
                                                          
aReprinted with permission from Chem. Commun. 2017, 53, 9055-9058  
Copyright © 2017 The Royal Society of Chemistry 
Haihang Ye contributed the conception and design of the related work, acquisition and 
interpretation of data, and preparation of the article. 
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cascade amplification has emerged to be a novel and efficient signal amplification strategy for 
sensitivity enhancement.26-32 A typical mechanism involves sequential cascade reactions catalyzed 
by enzymes – the products generated from a primary enzyme associated with bioreceptors catalyze 
the activation of a secondary enzyme, which in turn yields another product with a drastically 
increased amount. While this amplification technique is highly efficient, it is subject to a number 
of variables such as the enzymatic activity, stability, and activation conditions. In particular, the 
relatively poor stability of enzymes makes the enzyme cascade amplification system hardly 
survive in harsh environments, which is oftentimes the case for field work and point-of-care tests.33 
In this work, we report a non-enzyme cascade amplification (NECA) strategy for 
enhancing the sensitivity of a colorimetric assay. This strategy lies in the dense atom packing in 
silver (Ag) nanoparticles and the ultrahigh catalytic activity of platinum (Pt) nanocatalysts. The 
NECA assay adopts the classic ELISA platform,20 ensuring the simplicity of the assay without the 
involvement of additional equipment. Specifically, as shown in Figure 7.1, after antibody-
conjugated Ag nanoparticles are captured by biomarkers in a 96-well microtiter plate and the 
uncaptured ones removed, the nanoparticles are dissolved into individual Ag+ through chemical 
etching by H2O2.
34 The Ag+ could then effectively inhibit the catalytic activity of Pt nanocubes as 
artificial peroxidases, thereby largely eliminating the generation of blue colored product – oxidized 
TMB.35,36 Despite being miniature in size, Ag nanoparticles consist of thousands to millions of Ag 
atoms that can be conveniently released in the form of Ag+. For example, the Ag nanosphere of 20 
nm we used in this study (will be specified later) contains ∼2.5 × 105 Ag atoms. On the other hand, 
as demonstrated in our recent study,36 a single Ag+ could inhibit the generation of ∼104 oxidized 
TMB within several minutes owing to the superior catalytic activity of Pt nanocubes and the 
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efficient inhibition of Ag+ towards the catalytic reaction. Notably, the oxidized TMB possesses a 
large molar extinction coefficient (ε) at a level of 104 M-1‧cm-1,37 ensuring a distinct change in the 
color signal. Considering these two cascade processes together, the detection signal (refers to as 
the diminished color signal relative to a control) in the NECA system could be amplified by orders 
of magnitude. Significantly, both Ag nanoparticles and Pt nanocubes are made of inert noble 
metals with good stabilities, making the NECA system less vulnerable to the environment. 
 
Figure 7.1 Schematics showing the non-enzyme cascade amplification (NECA) strategy for the 
detection of disease biomarkers. 
7.2 Results and Discussion 
We first conducted a set of experiments to demonstrate the feasibility and optimize the 
conditions of the NECA system, in which the response of Ag nanoparticles with various amounts 
was investigated. Specifically, 50 μL of aqueous suspensions of citrate-capped Ag nanospheres 
with an average diameter of ∼20 nm (Sigma Aldrich, Figure 7.2a) were etched with 50 μL of 
H2O2 to form a Ag
+ solution. Then, to the etching solution, 20 μL of Pt nanocubes with an average 
edge length of 7.3 nm (100 pM in particle concentration, Figure 7.2b) and 100 μL of the TMB 
substrate solution were sequentially added. Here, the Pt nanocubes were synthesized the same as 
Chapter 5.35 The catalytic reaction was finally quenched by H2SO4, in which oxidized TMB was 
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converted to yellow-colored diimine with λmax ≈ 450 nm and ε = 5.9×104 M-1‧cm-1.38 We chose 
these Ag nanospheres for demonstration because (i) they could be easily functionalized with 
antibodies through electrostatic interactions;39 (ii) they could be prepared with good uniformities 
in terms of both shape and size, ensuring good reproducibility of the assay; and (iii) they are 
commercially available, making it convenient to assemble the assay system for practical use. After 
the systematic examination of various parameters (Figure 7.3), the optimal conditions for etching 
of Ag nanospheres were found to be 0.1 M H2O2, 37 °C, and 20 minute incubation, under which 
Ag atoms in the nanospheres were almost completely converted to Ag+. It should be emphasized 
that, while we adopted etching at 37 °C as a standard condition in this study, the etching efficiency 
at 22 °C was similar to the case of 37 °C (Figure 7.3c), indicating the potential use of the present 
system at room temperature. As shown in Figure 7.2c, the intensity of the color signal from the 
system decreased as the concentration of the Ag nanospheres increased. A linear relationship was 
found between the decrease of absorbance at 450 nm relative to the control (A0 - Ax) and the 
concentration of Ag nanospheres in the range of 0.5-8.0 fM (Figure 7.2d). It is worth noting that 
the decrease of the color signal was even evident when the concentration of Ag nanospheres was 
as low as 0.5 fM (corresponding to only ∼1.5×104 particles in a 50 μL suspension). In other words, 
a small amount of Ag nanospheres could induce a detectable color change, implying a high 
sensitivity of the system. These results clearly demonstrated the capabilities of signal amplification 
and quantification for the proposed NECA strategy. 
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Figure 7.2 Demonstration of the NECA system by varying the amount of Ag nanospheres in an 
aqueous suspension. (a) Scanning electron microscopy (SEM) image of the 20 nm Ag 
nanospheres; (b) TEM image of the 7.3 nm Pt nanocubes; (c) UV-vis spectra taken from the 
reaction solutions containing Pt cubes, TMB substrates, and Ag nanospheres of various 
concentrations after they had been etched by H2O2. The group of “0 fM Ag nanospheres” is 
referred to as “control”. The inset shows a typical photograph of the corresponding samples in 
cuvettes; (d) calibration curve of (c) that was generated by plotting the decrease of the absorbance 
at 450 nm relative to the control (A0 - Ax) as a function of the Ag nanosphere concentration. 
 
Figure 7.3 The effects of (a) H2O2 concentration, (b) etching time, and (c) temperature on the 
etching efficiency of Ag nanospheres by H2O2. The experiments were carried out by etching 50 
μL aqueous suspensions of 20 nm Ag nanospheres (~10 fM) with 50 μL of H2O2. The H2O2 
concentration was 0.1 M, etching time was 20 minutes, temperature was 37 °C, unless otherwise 
stated. The etching efficiency is defined as the amount of released Ag+ as a percentage of the 
amount of total Ag element in initial Ag nanospheres. 
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We then applied the NECA system to the detection of human PSA according to the 
principle shown in Figure 7.1. PSA is the key biomarker that indicates the recurrence of prostate 
cancer after treatment.40 It is pivotal to detect minute concentrations of PSA at early stages to 
improve the survival rates of patients who have undergone radical prostatectomy.40, 41 For 
comparison, we benchmarked the NECA assay against the conventional HRP based ELISA by 
using the same set of antibodies and materials. Herein, antibodies were conveniently 
functionalized on Ag nanospheres through a simple incubation process (see Section 7.4.4), 
ensuring the simplicity of the NECA assay. 
PSA standards of various concentrations were tested by both assays and quantified using a 
microtiter plate reader. For the NECA assay (Figure 7.4, blue), a quality linear relationship (R2 = 
0.999) in the range of 2-64 pg‧mL-1 of PSA was found by plotting the decrease of absorbance 
relative to the control (A0 - Ax) against PSA concentration. The coefficients of variation (n = 6) 
across the entire concentration range were determined to be <10%, indicating a good 
reproducibility of the assay. The limit of detection (LOD),42, 43 defined as the concentration 
corresponding to a signal that is three times the standard deviation of a zero calibrator, was 
calculated to be 0.165 pg‧mL-1. In comparison, a linear range of 200-6400 pg‧mL-1 and a LOD of 
16.0 pg‧mL-1 of PSA were determined for the conventional HRP ELISA based on its calibration 
curve (Figure 7.4, black). These results suggest that the NECA system could enhance the detection 
sensitivity by approximately 2 orders of magnitude as compared to conventional ELISA. 
Significantly, this substantial enhancement of the sensitivity does not compromise the simplicity 
of the colorimetric assay since the NECA system shares the same platform and a similar procedure 
with conventional ELISA. It is worth mentioning that the utilized amounts of Ag nanospheres and 
165 
 
Pt nanocubes were tiny based on the detection procedure (e.g., ∼2.0×10-6 and ∼1.0×10-8 gram per 
test, respectively). Therefore, even though precious noble metals are used in the NECA system, 
their costs in individual tests are negligible. 
 
Figure 7.4 Calibration curves of the NECA assay and HRP ELISA for PSA detection. The error 
bars indicate the standard deviations of six independent measurements. 
We also investigated the effect of Ag nanosphere size on the detection sensitivity of NECA 
for PSA. Specifically, we have examined the performance of two additional batches of Ag 
nanospheres from Sigma Aldrich (with average diameters of 10 nm and 40 nm, see Figure 7.5a, 
b) in detecting the PSA standards. The detection procedures were kept the same as the standard 
procedure used for the 20 nm Ag sphere, except for the substitution of 20 nm Ag spheres with the 
same amount of 10 nm or 40 nm Ag spheres. As shown in Figure 7.5c, d, the detection sensitivities 
of 10 nm and 40 nm Ag spheres were determined to be 0.195 pg‧mL-1 and 0.549 pg‧mL-1, 
respectively (vs. 0.165 pg‧mL-1 for 20 nm Ag spheres). It can be concluded that (i) decreasing the 
size of the Ag sphere from 20 to 10 did not cause an apparent change in the detection sensitivity. 
This observation might be explained by the argument that a 10 nm Ag sphere was more efficient 
in binding to the analytes. Therefore, even though a 10 nm Ag sphere contains smaller amount of 
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Ag element (Figure 7.1) compared to a 20 nm Ag sphere in the standard assay, their performances 
(e.g., detection sensitivities) in the NECA system were comparable. The decrease of sensitivity 
may be ascribed to the enhanced steric hindrance of antibodies labeled on Ag spheres.44,45 
 
Figure 7.5 Effect of Ag nanosphere size on the detection sensitivity of NECA for PSA. SEM 
images of Ag nanospheres with average diameters of (a) 10 nm and (b) 40 nm. Calibration curves 
of NECA assays when (c) 10 nm and (d) 40 nm Ag nanospheres shown in (a, b) were used. Error 
bars in (c, d) indicate the standard deviations of six independent measurements. 
To evaluate the stability of the NECA system, we heated the two critical components – Ag 
nanospheres and Pt nanocubes – at a high temperature (up to 90 °C) for 6 hours prior to the assay 
of a 10 pg‧mL-1 PSA standard. As shown in Figure 7.6, no significant change in both the detection 
sensitivity and reproducibility was observed for the NECA assay after the Ag and Pt particles had 
been treated with heat. This superior stability might be ascribed to the inherent inertness of noble 
metals.25 In this regard, the NECA system is expected to be more reliable for detection under 
extreme conditions compared to enzyme-based signal amplification techniques. 
  
167 
 
 
Figure 7.6 Stability test for the NECA system, in which the 20 nm Ag nanospheres (a) and 7.3 nm 
Pt nanocubes (b) were heated at different temperatures for 6 hours before they had been utilized 
for the NECA assay of 10 pg/mL PSA standards. 
It is worth emphasizing that the sensitivity of the NECA system could be further enhanced 
by coupling with other cascade mechanisms. For example, we have demonstrated that the 
sensitivity could be improved by the “silver enhancement” technique (Figure 7.7a), which is 
widely used in bioanalysis.46, 47 Herein, Ag nanospheres act as catalysts to reduce Ag+ (from 
AgNO3) to metallic Ag at room temperature in the presence of hydroquinone as a reducing agent. 
As shown by the SEM images in Figure 7.7b, the 20 nm Ag nanospheres were enlarged to ∼50 
nm during the silver enhancement process, with which the Ag content was greatly enriched. By 
coupling this technique to the NECA system, the LOD of the PSA assay was reduced to 0.031 
pg‧mL-1 as calculated on the basis of its calibration curve (Figure 7.7c). It can be concluded that, 
although the system has not yet been optimized for maximum Ag enrichment, an additional 5-fold 
enhancement in the sensitivity relative to the standard NECA assay could be achieved. 
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Figure 7.7 Silver enhancement technique coupled NECA assay. (a) Schematics showing the 
treatment of Ag nanospheres with silver enhancement; (b) SEM images of the 20 nm Ag 
nanospheres before and after silver enhancement; and (c) calibration curve of the silver 
enhancement technique-coupled NECA assay for PSA detection. 
Finally, in order to demonstrate the potential use of the NECA assay in clinical scenarios, 
we applied it to detecting human serum samples spiked with the PSA standard at different 
concentrations in the range of 5-50 pg‧mL-1. As shown in Table 7.1, the analytical recoveries 
(defined as the amount measured as a percentage of the amount of PSA originally added to a 
sample25) for the five PSA spiked human serum samples were determined to be in the range of 
92.46-104.31%. The coefficient of variation (n = 6) for all the samples was below 10.91%. We 
also benchmarked the detection against a commercial ELISA kit (Abcam plc., United Kingdom). 
As shown in Figure 7.8, the detection results from the NECA assay and the ELISA kit correlated 
very well with a correlation coefficient R2 = 0.993. These results indicated that the performance of 
the NECA system was essentially not compromised by the complex matrices in human serum, 
suggesting the potential application of this technique in clinical diagnostics. 
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Figure 7.8 Correlation analysis between the NECA assay and a commercial ELISA kit (ab188389, 
Abcam plc.) in quantifying PSA from five PSA-spiked serum samples. The error bars indicate the 
standard deviations of six independent measurements. 
Table 7.1 Analytical recoveries of the NECA assay in detecting PSA spiked human serum 
samples. 
PSA amount 
spiked 
(pg/mL) 
PSA amount 
measured (pg/mL) 
Coefficient of variations 
(%, n = 6)  
Recovery (%) 
5 4.68 10.91 93.62 
10 9.89 8.52 98.87 
20 20.86 4.22 104.31 
35 32.36 5.37 92.46 
50 49.76 2.78 99.52 
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7.3 Conclusion 
In conclusion, we have demonstrated a non-enzyme cascade signal amplification strategy 
for colorimetric assay of disease biomarkers with substantially enhanced sensitivity. This strategy 
was built by integrating two cascade processes – dissolution of nanoscale Ag particles to individual 
Ag+ and generation of colored molecules catalyzed by Pt nanocubes as artificial peroxidases. To 
our knowledge, such a non-enzyme cascade amplification strategy has never been demonstrated 
before. Significantly, this technique is compatible with the instrument and procedures of existing 
biosensing technologies, making it straightforward to employ for clinical diagnostics. The concept 
of non-enzyme cascade signal amplification presented here may open up a new avenue for the 
development of more sensitive and reliable diagnostic technologies. 
7.4 Materials and Experiment 
7.4.1 Chemicals and Materials 
Sodium hexachloroplatinate(IV) hexahydrate (Na2PtCl6·6H2O, 98%), potassium bromide 
(KBr, 99%), silver nitrate (AgNO3, ≥99.0%), hydroquinone (≥99%), polyvinylpyrrolidone (PVP, 
M.W. ≈ 55000), 3,3’,5,5’-tetramethylbenzidine (TMB, >99%), hydrogen peroxide solution 
(wt=30% in H2O), citrate-capped Ag nanospheres of different sizes, human prostate-specific 
antigen (PSA, ≥99%), acetic acid (HOAc, ≥99.7%), sodium acetate (NaOAc, ≥99%), bovine serum 
albumin (BSA, ≥98%), tween 20, sodium chloride (NaCl, ≥99.5%), potassium chloride (KCl, 
≥99%), sodium phosphate dibasic (Na2HPO4, ≥99%), potassium phosphate monobasic (KH2PO4, 
≥99%), dimethylformamide (DMF), human serum, and sulfuric acid (H2SO4, 95-98%) were all 
obtained from Sigma-Aldrich. Ethylene glycol (EG) was from J. T. Baker. mPEG-SH (M.W. ≈ 
5,000) was obtained from Laysan Bio, Inc. Rabbit anti- PSA polyclonal antibody (rabbit anti-PSA 
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pAb), mouse anti-PSA monoclonal antibody (mouse anti-PSA mAb), and commercial ELISA kit 
for PSA (product code: ab188389) were from Abcam plc. HRP-goat anti-mouse IgG conjugate 
and goat anti-mouse IgG were obtained from Thermo Fisher Scientific, Inc. 96-well microtiter 
plate (polystyrene, clear, flat bottom) was obtained from Celltreat Inc. All aqueous solutions were 
prepared using deionized (DI) water with a resistivity of 18.0 MΩ·cm. 
7.4.2 Synthesis of PVP-Capped Pt Cubes 
The synthesis of Pt nanocubes was the same as in Chapter 5. The concentration of final Pt 
nanocube suspension was estimated to be 334 nM (e.g., 2.01×1014 particles/mL), according to the 
ICP-OES analysis and TEM imaging.  
7.4.3 Demonstration of the Non-enzyme Cascade Amplification (NECA) System 
50 μL aqueous suspensions of citrate-capped 20 nm Ag nanospheres with different particle 
concentrations were mixed with 50 μL of 0.1 M H2O2 in a cuvette. After incubation at 37 °C in an 
oven for 20 min, the etching solution was taken out to room temperature. Then, to the etching 
solution, 20 μL of PVP-capped 7.3 nm Pt nanocubes (100 pM, in DI water) and 100 μL of TMB 
substrate solution (e.g., 4 M H2O2 and 1.6 mM TMB in 20 mM NaOAc/HOAc buffer, pH 4.0) 
were sequentially added. After incubation at room temperature for 20 min, the catalytic reaction 
was stopped by adding 20 μL of 2 M H2SO4, in which oxidized TMB was converted to yellow 
colored diimine with λmax ≈ 450 nm and ε = 5.9×104 M-1·cm-1. UV-vis spectra were then taken 
from the reaction solutions using a spectrophotometer. 
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7.4.4 Preparation of Ag Nanosphere-goat Anti-mouse IgG Conjugates 
A 5 μL aliquot of goat anti-mouse IgG (1 mg/mL, correspond to the "secondary antibody" 
in Figure 7.1) was mixed with 10 μL of mPEG-SH (10 μM) at room temperature. Then, 1 mL of 
Ag nanospheres (0.185 mM in Ag element) was added to the mixture and incubated at room 
temperature for 20 min, followed by the addition of 100 μL of BSA (1 wt%) and incubation at 
room temperature for another 20 min. The final conjugates were purified by washing twice with 
0.1 wt% BSA and stored in 10 mM phosphate buffered saline pH 7.4 (PBS) containing 10 wt% 
BSA and 0.05 wt% tween 20 at 4 °C for future use. 
7.4.5 NECA Assay of PSA 
In a standard NECA assay of PSA, 100 μL aliquots of rabbit anti-PSA pAb (5 μg/mL, in 
PBS, correspond to the "capture antibody" in Figure 7.1) was added to the wells of 96-well 
microtiter plate and incubated at 4 °C for 12 h. After being washed by washing buffer (PBS 
containing 0.05 wt% tween 20) for three times, the wells were blocked by 200 μL of blocking 
buffer (PBS containing 0.05 wt% tween 20 and 2 wt% BSA) and incubated at 37 °C for 1 h. Then, 
the wells were washed three times by washing buffer, followed by addition of 100 μL of PSA 
standards in dilution buffer (PBS containing 0.05 wt% tween 20 and 0.5 wt% BSA). After being 
shaken on a shaker at room temperature for 2 h, the wells were washed by washing buffer for three 
times. 100 μL of mouse anti-PSA mAb (2 μg/mL, in dilution buffer, correspond to the "detection 
antibody" in Figure 7.1) was added to the wells, followed by shaking at room temperature for 1 h. 
After the wells had been washed three times by washing buffer, 100 μL of Ag nanosphere-goat 
anti-mouse IgG conjugates (20 μg/mL in Ag elements) was added, followed by 1 h shaking at room 
temperature. After three times washing by washing buffer, 100 μL of H2O2 (0.05 M) was added to 
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the wells, followed by incubation at 37 °C for 20 min. Finally, 20 μL of Pt nanocubes (100 pM, in 
DI water) and 100 μL of TMB substrate solution (4 M H2O2 and 1.6 mM TMB in 20 mM 
NaOAc/HOAc buffer, pH 4.0) were sequentially added. After incubation at room temperature for 
20 min, the reaction was stopped by adding 20 μL of 2 M H2SO4. The absorbance of each well at 
450 nm was read using a microplate reader. PSA spiked human serum samples were measured by 
the same procedure for PSA standards as described above, except that the serum samples were pre-
diluted 2 folds by dilution buffer prior to detection. Note that the original serum sample (from 
Sigma Aldrich) does not contain detectable PSA as determined by a commercial ELISA kit (Abcam 
plc., United Kingdom). 
7.4.6 HRP ELISA of PSA 
The detection principle and procedure of HRP ELISA was similar to those of NECA assay 
except that the color signal was generated from HRP. In brief, after the capture antibodies, PSA, 
and detection antibodies had been adsorbed on the 96-well microtiter plate (using the same 
procedure for NECA assay), 100 μL of HRP-goat anti-mouse IgG conjugates (1 μg/mL, in dilution 
buffer) was added to each well. The plate was shaken at room temperature for 1 h and then washed 
three times by washing buffer. 100 μL of TMB substrate for HRP ELISA (1 mM H2O2 and 0.8 mM 
TMB in 20 mM NaOAc/HOAc buffer solution, pH 4.0) was added to each well, followed by 
incubation at room temperature for 20 min. The reaction at the wells were finally stopped by 20 
μL of 2 M H2SO4. The absorbance of each well at 450 nm was read using a microplate reader. 
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7.4.7 Silver Enhancement Technique-coupled NECA Assay of PSA 
The procedure of silver enhancement technique-coupled NECA assay of PSA was same as 
that of above mentioned standard NECA assay except for the involvement of a silver enhancement 
process before the step of Ag particle etching by H2O2. The silver enhancement was conducted by 
adding 50 μL of AgNO3 (0.1 mM, in DI water) and 50 μL of hydroquinone (0.1 mM, in DI water) 
to each well. After incubation at room temperature for 20 min, the wells were washed five times 
by DI water. 
7.5 Characterizations 
The UV-vis spectra were recorded using an Agilent Cary 60 UV-vis spectrophotometer. 
TEM images were taken using a JEOL microscope (JEM-2010) operated at 200 kV. Scanning 
electron microscopy (SEM) images were taken using a cold field emission high resolution 
scanning electron microscope (Hitachi S-4700) operated at 20 kV. To estimate particle 
concentrations, the Ag nanospheres and Pt nanocubes were dissolved to Ag and Pt ions by aqua 
regia. The concentrations of Ag and Pt ions were then determined using an inductively coupled 
plasma-optical emission spectroscopy (ICP-OES, PerkinElmer Optima 7000DV), which could be 
converted to the particle concentrations of Ag nanospheres and Pt nanocubes once the particle 
sizes and shapes had been resolved by TEM or SEM imaging. A microplate reader (PerkinElmer 
Victor 3 1420) was used to measure the absorbance at 450 nm for samples in microtiter plates. 37 
°C-incubation was conducted in an oven (Precision Scientific, Inc.). Microtiter plates were shaken 
on a Corning LSE digital microplate shaker. A benchtop meter (Oakton pH 700) was used to 
measure the pH value of buffer solutions. 
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CHAPTER 8 PLATINUM-DECORATED GOLD NANOPARTICLES WITH 
DUAL FUNCTIONALITIES FOR ULTRASENSITIVE COLORIMETRIC 
IN VITRO DIAGNOSTICSa 
8.1 Introduction 
In vitro diagnostic (IVD) tests are crucial for patients and physicians to make timely and 
optimal decisions for patient care and treatment.1-3 Colorimetric IVD, among many other types of 
IVD technologies, has received increasing attention in recent years due to its simplicity and cost 
effectiveness.4-10 The test results of colorimetric IVDs can be conveniently read out with the naked 
eyes and, if needed, quantified by an inexpensive and portable device.11 In particular, these 
features make colorimetric IVDs extremely desirable for field work and point-of-care tests that are 
urgently needed, especially in resource-limited settings. 
Au nanoparticles (AuNPs) as signal reporters have been widely used in colorimetric IVDs 
for decades because of their superior physicochemical properties.3, 12 First, they offer highly 
intense color signals (red, in most cases) owing to an optical phenomenon called localized surface 
plasmon resonance (LSPR).13-15 AuNPs of ∼40 nm show an absorption cross-section 5 orders 
larger than ordinary organic dyes.16 Second, they can be easily functionalized with biomolecules 
(e.g., antibodies and DNAs) by means of simple thiol-gold chemistry and/or electrostatic 
interactions.17-20 Third, they are made of an inert noble metal and thus are highly stable, enabling 
them to survive harsh environments. Moreover, they can be easily and reproducibly synthesized 
                                                          
aReprinted with permission from Nano Lett. 2017, 17, 5572-5579 
Copyright © 2017 American Chemical Society  
Haihang Ye contributed the conception and design of the related work, acquisition and 
interpretation of data, and preparation of the article. 
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in common chemical laboratories. The past few decades have witnessed a variety of AuNP-based 
IVD systems with home pregnancy test being one of the most familiar examples.3, 21-24 Despite the 
simplicity and practicality, it remains a challenge to substantially enhance the sensitivity of AuNP-
based colorimetric IVDs without adding complexity. Note that high detection sensitivity is critical 
to many important applications such as early detection of cancers and infectious diseases for which 
the concentrations of related biomarkers are very low.25, 26 Because the detectable color signal in 
AuNP-based IVDs originates from the plasmonics of AuNPs, the detection sensitivity is essentially 
confined by the inherent plasmonic activity. 
In this work, we report a novel strategy to circumvent such confinement of AuNP 
plasmonics and thus break through the detection limit barrier of associated colorimetric IVDs. 
Specifically, in this strategy conventional AuNPs are decorated with conformal, thin skins of Pt to 
form unique Au@PtnL core@shell NPs (Figure 8.1a). The number (n) of Pt atomic layers could 
be precisely controlled in the range of 1-10. We demonstrated that as long as the Pt shell is ultrathin 
(several atomic layers) the plasmonic property of the AuNP cores underneath Pt is well retained, 
making the resultant Au@PtnL NPs as red as the initial AuNPs (Figure 8.1b). On the other hand, 
Pt shells on the surface endow the Au@PtnL NPs with ultrahigh peroxidase-like catalytic activities, 
allowing them to rapidly generate blue-colored molecules by catalyzing the oxidation of TMB27 
by H2O2 in aqueous solution. It is worth mentioning that this catalytic reaction is extremely 
suitable for IVDs and has been widely used in commercial diagnostic kits mainly because (i) both 
TMB and H2O2 are cost-effective and nontoxic, (ii) the reaction can be conveniently conducted in 
aqueous system and at room temperature, and (iii) the blue-colored product [e.g., oxidized TMB 
(oxTMB) with λmax = 653 nm] has a large molar extinction coefficient.27 Significantly, the intensity 
180 
 
of blue color from catalysis is orders of magnitude stronger than that of the intrinsic red color from 
plasmonics, ensuring an enhanced detection sensitivity. These dual functionalities, plasmonics and 
catalysis, of the Au@PtnL NPs make them particularly suitable for colorimetric IVDs. They can 
offer two different detection alternatives: one produced just by the red color of interior AuNPs 
(low-sensitivity mode) and the second more sensitive blue color produced by the Pt shell through 
catalysis (high-sensitivity mode), achieving an “on-demand” tuning of the detection performance. 
It should be pointed out that the low-sensitivity mode is faster and more convenient than the high-
sensitivity mode because the latter involves an additional signal enhancement procedure (e.g., 5 
min TMB/H2O2 treatment process). In practical use, one will first perform the low-sensitivity 
mode. High-sensitivity mode is only needed when no signal is observed in low-sensitivity mode 
(for samples with low concentration of analytes or negative samples). Using lateral flow assay as 
a model IVD system, we demonstrated that the detection sensitivity could be enhanced by ∼100 
times as compared to conventional AuNPs as the benchmark. 
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Figure 8.1 Schematics showing (a) the fabrication of Au@PtnL NPs in which Pt atoms are 
deposited onto an AuNP to form a conformal, thin Pt shell with thicknesses of 1-10 atomic layers 
and (b) two types of color signal generated from Au@PtnL NPs under different mechanisms. In 
(a), the rate of atom deposition is controlled to be slower than that of surface diffusion 
(Vdep. < Vdiff.). 
8.2 Results and Discussion 
We started with the synthesis of Au@PtnL NPs that was conducted using seed-mediated 
growth. In a standard synthesis, an aqueous solution of Na2PtCl6 as precursor to Pt was injected 
slowly (1.2 mL/h, with a syringe pump) into a mixture containing ∼40 nm citrate-capped AuNPs 
with an overall spherical shape as the seeds, L-ascorbic acid as a reductant, and sodium citrate as 
a colloidal stabilizer, which had been preheated to 90 °C under magnetic stirring. We chose ∼40 
nm citrate-capped AuNPs as a model seed because they have been extensively used for various 
IVD systems.28-31 As shown by the TEM images in Figure S8.1 (Appendix F), the Au seeds 
displayed uniform spherical shapes and smooth surfaces. Most of them contained multiply twinned 
defects. Their average diameter was measured to be 40.2 nm by randomly analyzing 200 
particles. Figure 8.2a, b, respectively, shows typical low- and high-magnification TEM images of 
182 
 
the Au@PtnL NPs prepared from a standard synthesis. It can be seen that the spherical shape, 
smooth surface, and twin structures of the Au seeds were well retained after Pt growth, implying 
the involvement of a layer-by-layer growth mode. The average edge length of the Au@PtnL NPs 
was measured to be 42.1 nm, which was 1.9 nm greater than that of the initial Au seeds. Therefore, 
on average, the thickness of the Pt shell deposited on the Au spherical seed was about 0.95 
nm. Figure 8.2c shows a HAADF-STEM image of the same sample, from which the 3D spherical 
shape and smooth surface were more evident relative to the TEM images. The high-resolution 
TEM image of an individual particle (Figure 8.2d) reveals the continuous lattice fringes from Au 
core to Pt shell, indicating an epitaxial relationship between these two metals. 
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Figure 8.2 Morphological, structural, and compositional analyses of Au@Pt4L NPs that were 
prepared from a standard synthesis. (a, b) TEM images at two different magnifications. (c) 
HAADF-STEM image. (d) High-resolution TEM image of an individual particle. Inset shows a 
magnified image of the region marked by a white box. (e) EDX mapping image of an individual 
particle (red = Au, green = Pt). (f) Line-scan EDX spectra of elemental Au and Pt that were 
recorded from an individual particle (inset) along a direction as indicated by the black arrow. (g) 
XPS survey spectra of the Au@Pt4L NPs and initial AuNP seeds. (h) High-resolution XPS spectra 
of the Pt 4f region shown in (g). 
Because Au and Pt have similar atomic masses and lattice constants, it is almost impossible 
to resolve Pt from Au via electron microscopy.32 As such, the elemental distribution of Au and Pt 
in the sample was determined by energy-dispersive X-ray (EDX) mapping and line-scans analyses. 
From the EDX mapping image (Figure 8.2e), Au could only be observed in the interior (red) while 
Pt was distributed across the entire particle including the shell (green), suggesting an Au@Pt 
core@shell structure and the conformal coating of Pt on Au surface. The core@shell structure was 
further confirmed by the EDX line-scan profile recorded along a central axis direction of an 
individual sphere (Figure 8.2f), where the Pt trace dominated the shell region. To further confirm 
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Pt was conformally distributed on Au surfaces, those Au@PtnL NPs were etched with a chemical 
etchant of which strength is sufficiently strong to etch Au while too weak to react with Pt.33 As 
shown by the TEM images in Figure 8.3, most of the Au@PtnL NPs were intact after etching. Only 
∼2% of them was converted to thin nanoshells with a hollow interior. This result suggested that 
conformal Pt overlayers existed in most of the Au@PtnL NPs, which prevented the Au cores from 
being etched. For a small portion of Au@PtnL NPs that were not fully covered by Pt, Au cores 
were etched away, leaving only nanoshells of Pt. The surface properties of the Au@PtnL NPs were 
determined by X-ray photoelectron spectroscopy (XPS). It can be seen that the XPS survey 
spectrum of the Au@PtnL NPs was similar to that of the initial Au seeds, except for the appearance 
of Pt characteristic peaks (Figure 8.2g). This observation suggests that the surface ligands on 
AuNPs remain unchanged after they had been coated with Pt, which ensured the simplicity of 
antibody functionalization as discussed later. The high-resolution spectra of the Pt 4f peaks 
(Figure 8.2h) revealed the existence of three chemical states for Pt species, where the Pt0was 
dominant. 
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Figure 8.3 (a) Low- and (b) high-magnification TEM images of a sample that was prepared by 
etching the Au@Pt NPs shown in Figure 8.2 with a CTAB solution containing I– and Au3+ ions. 
In (a), black arrows indicate nanoshells with a hollow interior. By randomly analyzing ~500 
particles under TEM, the statistical data showed that most of Au@Pt NPs were intact after etching. 
Only ~2% of them were converted to nanoshells. 
To quantitatively determine the average number (n) of Pt atomic layers for the 
Au@PtnL NPs shown in Figure 8.2, the sample was subject to inductively coupled plasma-optical 
emission spectrometry (ICP-OES) analysis. The mass ratio of Au to Pt was measured to be 6.49:1. 
According to this ICP-OES data, the size of Au spherical seeds, and the densities of Au and Pt, the 
thickness of Pt shell was quantified to be 0.89 nm (see Figure S8.2 in Appendix F for details), 
which is in good agreement with the value of 0.95 nm measured from the change to average 
diameter by TEM. In the following discussion, Pt shell thickness is referred to the data from ICP-
OES because it averages over a much larger number of particles than TEM. Because a nanosphere 
of face-centered cubic structure tends to expose low-energy (111) surfaces,34, 35 for rough 
estimation here we assume Pt layers are spaced by Pt{111} planes with the interplanar distance of 
∼0.23 nm.36, 37 Thus, the average number of Pt atomic layers was ∼4 for this sample, so is denoted 
as Au@Pt4L NPs. 
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As demonstrated in our previous studies,38-41 so long as the deposition of Pt on Au was 
directed to follow a layer-by-layer mode, the thickness of the Pt shells could be conveniently 
controlled with atomic precision by simply adjusting the amount of Pt precursor introduced to the 
synthesis. The key to induce and maintain such layer-by-layer mode was to ensure a slow atom 
deposition relative to surface diffusion (Vdep. < Vdiff., see Figure 8.1a) so the Pt adatoms could 
spread across the entire Au surface, resulting in the formation of a conformal and smooth Pt 
coating.38 This argument was supported by our experimental result that Pt dendrites (Figure 8.4) 
instead of smooth shells were formed on Au seeds when the atom deposition rate was raised by 
increasing the injection rate of Pt precursor while all other conditions were kept unchanged. With 
this mechanistic understanding, we were able to finely tune the thickness of Pt shells from 1 to 10 
atomic layers that were confirmed by both electron microscopy imaging and ICP-OES analysis 
(see Table S8.1 in Appendix F). For example, Au@Pt2L NPs (Figure S8.3a in Appendix F) and 
Au@Pt7L NPs (Figure S8.3b in Appendix F), respectively, could be obtained by adjusting the 
amount of Pt precursor from 347 μL in a standard synthesis to 170 and 628 μL. 
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Figure 8.4 TEM image of Au-Pt bimetallic nanocrystals synthesized using the standard procedure 
for Au@Pt4L NPs except that the injection rate of Na2PtCl6 solution was increased from 1.2 to 120 
mL/h. Inset shows a corresponding 2D atomic model. 
We then evaluated the plasmonic properties of the Au@PtnL NPs (n = 0-10). Here, 
Au@Pt0L NPs correspond to the initial AuNP seeds. Figure 8.5a compares the appearance of 
aqueous suspensions of Au@PtnL NPs and initial Au seeds with the same particle concentration. 
An overall red color can be seen for all the samples, whereas the color intensity decreased with the 
increase of Pt atomic layers. Figure 8.5b shows the corresponding UV-vis spectra recorded from 
these samples. As the number (n) of Pt layers increased, the major LSPR peak at ∼520 nm 
broadened, together with an intensity decrease. Compared to initial Au seeds, the extinction at 520 
nm for the Au@PtnL NPs was decreased by ∼11% and ∼15%, respectively, when n = 2 and 4 (see 
inset of Figure 8.5b). At n = 10, the decrease was enlarged to ∼20%. Further increase of the Pt 
shell thickness led to the diminishment and eventual disappearance of the characteristic red color. 
For instance, the red color is barely detectable when the thickness of Pt shell reached 10 nm (about 
44 Pt atomic layers, see Figure S8.4 in Appendix F). These data demonstrate that the ultrathin 
coating of Pt (preferably several atomic layers) is critical to the retaining of plasmonic properties. 
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Figure 8.5 Plasmonic (a,b) and catalytic (c,d) properties of Au@PtnL NPs, where n denotes the 
number of Pt atomic layers (n = 0 corresponds to the initial AuNP seeds shown in Figure S8.1 in 
Appendix G). (a) A photograph taken from aqueous suspensions of Au@PtnL NPs with the same 
particle concentration. (b) Corresponding UV-vis spectra recorded from the samples in (a). Inset 
shows a plot of extinction at 520 nm (E520 nm) against n. (c) A photograph taken from reaction 
solutions (e.g., oxidation of TMB by H2O2) catalyzed by Au@PtnL NPs of the same particle 
concentration. In all measurements, the reaction time was fixed at t = 3 min. The blue color was 
originated from the oxidized TMB as the product (λmax = 653 nm). (d) A plot comparing the 
catalytic constant (Kcat) of different Au@PtnL NPs. Error bars in (b, d) indicate the standard 
deviations of three independent measurements. 
The peroxidase-like catalytic property of Au@PtnL NPs was investigated with the 
oxidation of TMB by H2O2 being as a model catalytic reaction.
42-44 As shown in Figure 8.5c, 
Au@PtnL NPs could rapidly generate a blue-colored product (e.g., oxTMB) through the catalytic 
reaction. The intensity of blue color increased as the number (n) of Pt layers increased and became 
saturated at n = 4. In contrast, the initial Au seeds (n = 0) could barely catalyze the reaction 
(Figure 8.5c). To quantify the catalytic efficiency, catalytic constant (Kcat) was determined 
through the apparent steady-state kinetic assay, as shown in Figure 8.6 for the sample of Au@Pt4L 
NPs.42, 45 As summarized by Figure 8.5d, Kcat for the Au@PtnL NPs (n ≥ 4) reached the regime of 
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106 s-1, which is several orders of magnitude higher than those of the initial AuNPs and natural 
peroxidases.42 
 
Figure 8.6 Kinetic assays of the Au@Pt4L NPs as catalysts for the oxidation of TMB by H2O2. The 
initial reaction velocity (ν) was measured in 0.2 M NaOAc/HOAc buffer pH 4.0, containing 2.0 
M H2O2, 6.32×10
-14 M Au@Pt4L NPs, and TMB of different concentrations at room temperature. 
(a) Plot of ν against TMB concentration; (b) Double-reciprocal plot generated from (a), with which 
the catalytic constant (Kcat) was determined. Error bars indicate the standard deviations of three 
independent measurements. 
To better understand the relationship between the structure of Au@PtnL NPs and their 
plasmonic and catalytic properties, we conducted preliminary theoretical calculations. We first 
performed finite-difference time-domain (FDTD) simulations to investigate the extinction cross-
section spectra of Au@PtnL NPs (n = 0-10).
46 The simulation results are shown in Figure 8.7. It 
can be seen that the AuNP seeds displayed a major LSPR peak at ∼532 nm. When they were 
coated with Pt of different atomic layers (n), their LSPR peak gradually blue-shifted and broadened 
as n increased. The peak intensity decreased rapidly as n increased from 0 to 4. Thereafter (n = 5-
10), the decrease of peak intensity slowed down. The overall trends of the changes in LSPR peak 
position, shape, and intensity agreed well with the experimental results shown in Figure 8.5b. In 
order to gain insight into the peroxidase-like catalytic activities of those Au@PtnL NPs, we 
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performed density functional theory (DFT) calculations to study the surface electronic structures 
of Pt overlayers on Au surface where the d-band center positions were derived. It is well 
documented that the d-band center of surface atoms of a transition-metal catalyst is a good 
measurement for its binding affinity toward adsorbates and therefore its catalytic activity.47-
50 Figure 8.8 shows the partial density of state (PDOS) profiles of 5d orbitals for the outmost 
atoms of Au(111) and Au@PtnL(111) (n = 1-10) surfaces. It can be seen that the d-band of Au(111) 
surface was narrower and had a much lower density near the Fermi level compared to those of 
Au@PtnL(111) surfaces. These results indicated that Au(111) was less catalytically active than 
Au@PtnL(111) surfaces,
51, 52 which is in good agreement with the experimental results shown 
in Figure 8.5c, d. For the Au@PtnL(111) surfaces with n = 1-10, significant change of d-band 
center positions was only observed when n increased from 1 to 3, as shown in Figure 8.8b, 
suggesting that the change of catalytic activity of Au@PtnL(111) should be obvious in the range 
of n = 1-3.47 This result is consistent with the experimental observations that the catalytic activity 
of Au@PtnL NPs drastically increased as n increased from 1 to 3 and tended to become saturated 
when n ≥ 4 (Figure 8.5d). 
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Figure 8.7  (a) FDTD-simulated extinction cross-section spectra of Au@PtnL NPs, where n denotes 
the number of Pt atomic layers (n = 0 denotes the initial AuNP seeds). (b) Plot of extinction cross-
section at 532 nm (ECS532 nm) against n. 
 
Figure 8.8 (a) Partial density of state (PDOS) profiles of 5d-orbitals for the outmost atoms of 
Au(111) and Au@PtnL(111) surfaces (n = 1-10). (b) Plot of d-band centers (relative to the Fermi 
level (EF)) of Au@PtnL(111) against n. Note the Fermi level is set as zero. In (a), the calculated d-
band centers are marked with white lines. 
It should be emphasized that even though Au@Pt core@shell nanostructures have been 
extensively reported in literature,53-57 most of those studies did not precisely control over the 
surface structure and shell thickness at the atomic level. Particularly, in most cases the deposition 
of Pt on Au seeds was not maintained along a layer-by-layer mode during the entire course of 
growth.40 As a result, Pt shells in the final products oftentimes took irregular morphologies. In the 
present work, Pt shells with a well-defined morphology and thickness of 1-10 atomic layers were 
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successfully coated on Au seeds, which allowed us to systematically investigate the structure–
property relationships from both experimental and theoretical angles. We believe the insights from 
this study will serve as a strong foundation to inspire future work. 
Because n = 4 for the Au@PtnL NPs well balanced the decrease of plasmonic activity and 
the increase of catalytic activity, the Au@Pt4L NPs (Figure 8.2) were chosen for subsequent 
studies. It should be emphasized that the intensity of blue color from catalysis was significantly 
higher than that of the intrinsic red color from plasmonics. Specifically, the molar extinction 
coefficient of the 40.2 nm AuNPs was determined to be ∼9.5 × 109 M–1 cm–1 (see Figure S8.5 in 
Appendix F for details), which is consistent with literature reports on 40 nm AuNPs.16, 58, 59 In 
contrast, the equivalent molar extinction coefficient (defined as the total light extinction of colored 
products catalyzed at t = 5 min) of the Au@Pt4L NPs was calculated to be ∼1.8 × 1013 M-1‧cm-
1 (see Figure S8.5 in Appendix F for details). To our knowledge, this value represents the record-
high extinction efficiency among all types of nanoparticles with similar size. Taken together, the 
color signal of ∼40 nm AuNPs could be enhanced by 3 orders of magnitude through a simple 
substrate treatment process (5 min, room temperature, and aqueous system), which forms the basis 
for exceptional detection sensitivity. Notably, this enhancement is expected to be more evident for 
AuNPs of smaller sizes since the molar extinction of AuNPs decreases at a fast rate proportional 
to the cube of particle radius.60 
Finally, we applied the Au@Pt4L NPs to lateral flow assay (LFA) of human PSA as a model 
cancer biomarker,61 according to the principle shown in Figure 8.9. LFA is one of a handful of 
point-of-care techniques that can claim to have taken tests out of the laboratory.62-65 AuNPs with 
tens of nanometers in size have been widely used in LFA as colorimetric labels for decades because 
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of their superior physicochemical properties.22, 66 While creative research effort continues to be 
invested into the improvement in detection performance for AuNP-based LFAs, there is still an 
unmet need for a broadly applicable methodology to provide ultralow detection limits. A 
transformative idea to enhance the detection sensitivity of LFA is to amplify the plasmonics of 
AuNPs. The most commonly used strategy for plasmonics amplification is to assemble numerous 
AuNPs on larger-sized carrier particles. For example, Xu and co-workers decorated silica rods of 
several micrometers with AuNPs.67 AuNPs (∼104) were assembled on a single silica rod. Owing 
to the increased AuNP density, the detection limit was lowered more than 10 times compared to 
conventional AuNP based LFA. Similarly, branched dendrimers as carriers also displayed 
enhanced color intensity.68 Despite these demonstrations, this strategy is limited by the loading 
capacity of a carrier and the bulkiness of the AuNPs-carrier complexes, which inhibit the particles’ 
migration within the strip thus exacerbating the steric effect for bioreceptor binding to analytes. 
Another notable strategy for plasmonics amplification is to enlarge the AuNPs on the test line 
through post gold or silver enhancement, in which the size and thus optical intensity of AuNPs is 
increased.69-71 This strategy is troubled by using large amounts of highly toxic Au3+ or Ag+. Both 
ions adversely affect the environment and have serious biological effects on human health.72-
74 Unless this issue can be addressed, it will be impractical to implement this method into LFAs, 
especially in nonlaboratory scenarios. Taken together, it remains a challenge to substantially 
enhance the sensitivity of AuNP-based LFAs that are presently confined by the inherent 
plasmonics of AuNPs. 
194 
 
 
Figure 8.9 Detection of PSA with conventional AuNP-based LFA (AuNP-LFA) and 
Au@Pt4L NP-based LFA (Au@Pt4L NP-LFA). (a) Schematics showing the principles of AuNP-
LFA and Au@Pt4L NP-LFA at low- and high-sensitivity modes (see Section 8.4.10 for details 
about the preparation of LFAs). (b) Representative photographs taken from the LFAs of PSA 
standards. The asterisks (*) indicate detection limits by the naked eyes. (c) Corresponding 
calibration curves of the detection results shown in (b). Error bars indicate the standard deviations 
of six independent measurements. Inset shows the linear range region of the Au@Pt4L NP-LFA at 
high-sensitivity mode. 
For direct comparison, we benchmarked the performance of Au@Pt4L NPs in LFA against 
initial ∼40 nm AuNPs by using the same set of antibodies and materials. Procedures for the 
Au@Pt4LNP- and AuNP-based LFAs were also kept the same except that an additional 
enhancement procedure (e.g., TMB/H2O2 treatment) was involved in the “high-sensitivity” 
Au@Pt4L NP-LFA (see Figure 8.9a). It is worth noting that Au@Pt4L NPs could be easily 
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functionalized with antibodies through a simple incubation process that is usually used for 
conventional AuNPs (Figure S8.6 in Appendix F for details).75, 76 This facile antibody 
functionalization of Au@Pt4LNPs could be ascribed to the existence of similar ligands on the 
surfaces as conventional AuNPs that had been demonstrated by the XPS data shown 
in Figure 8.2g. 
PSA standards with various concentrations were monitored in test strips. The detection 
results were recorded with a digital camera (Figure 8.9b) and were subject to quantification using 
Adobe Photoshop software (Figure 8.9c). It can be seen that intensities of red bands at the test line 
region for both AuNP- and Au@Pt4L NP-LFAs (“low-intensity mode”) were almost the same. The 
naked eye detection limit was about 2 ng‧mL-1 of PSA for both LFAs. This result suggests that the 
Au@Pt4L NPs could be utilized in the same fashion as conventional AuNPs without the 
compromise of performance. For Au@Pt4L NP-LFA at the “high-intensity mode”, blue/purple 
lines could be resolved for strips applied with PSA standards of concentrations as low as 20 pg‧mL-
1. It should be mentioned that a faint blue color was observed for the zero calibrator under high-
sensitivity mode. This background signal may be caused by the nonspecific binding of a small 
amount of Au@Pt4L NPs to the test line region, which were capable of catalyzing the formation of 
visible blue colored oxTMB molecules. Figure 8.9c compares the calibration curves of the three 
LFAs that were generated by plotting the color intensity at test line against the PSA concentration. 
In particular, a quality linear relationship (R2 = 0.996) in the range of 10-200 pg‧mL-1 PSA was 
observed for the “high-sensitivity” Au@Pt4L NP-LFA (inset of Figure 8.9c). The detection limit, 
defined as the concentration corresponding to a signal that is 3 times the standard deviation above 
the zero calibrator,77, 78 was calculated to be 3.1 pg‧mL-1 for the “high-sensitivity” Au@Pt4L NP-
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LFA. It is worth pointing out that this detection limit is even lower than what could be achieved 
by commercial enzyme-linked immunosorbent assay (ELISA) kit (4.9 pg‧mL-1, Abcam plc., 
United Kingdom, Figure 8.10), which involves complicated operation procedures and 
instruments. In comparison, the detection limits of the AuNP-LFA and “low-sensitivity” 
Au@Pt4LNP-LFA were determined to be 272 and 322 pg‧mL-1, respectively, based on their 
calibration curves (Figure 8.9c). These results demonstrated that Au@Pt4L NP could enhance the 
sensitivity of conventional LFA by ∼100 times, enabling it to rival the sensitivities of other 
sophisticated instrument-based IVD techniques (e.g., ELISA). Such a significant enhancement in 
sensitivity is only paid by a simple 5 min substrate treatment process at room temperature. It should 
be mentioned that the magnitude of color signal enhancement by Au@Pt4L NPs relative to 
conventional AuNPs in LFA test (∼100 times, Figure 8.9) was lower than the case when 
Au@Pt4LNPs were suspended in aqueous solution (∼1,000 times, see Figure 8.5 and Figure S8.5 
in Appendix F). Note in LFA test, Au@Pt4L NPs were immobilized and accumulated on a solid 
phase (e.g., nitrocellulose the membrane of test strip). Therefore, the relatively low signal 
enhancement in LFA test can be ascribed to the compromise of catalytic activity of Au@Pt4L NPs 
that was caused by (i) the same nanocatalysts-medicated catalytic reaction in a solid-solution phase 
is generally less effective than in a solution phase79 and (ii) the aggregation of Au@Pt4L NPs in 
LFA test strips reduced the total surface area of active Pt surface. 
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Figure 8.10 Calibration curve of a commercial PSA ELISA kit (Abcam plc., United Kingdom). 
Error bars indicate the standard deviations of six independent measurements. The limit of 
detection, defined as the concentration corresponding to a signal that is 3 times the standard 
deviation above the zero calibrator, was determined to be 4.9 pg‧mL-1. 
We also compared the performance of Au@Pt4L NPs in LFA of PSA standards with those 
of Pt dendrites coated AuNPs (e.g., the sample shown in Figure 8.4, which will be referred to as 
“Au@Ptdendrite NPs”) and PtNPs (Figure 8.11) with similar sizes and the same surface ligands (e.g., 
citrate). In the comparisons, all experimental conditions were kept unchanged except for the 
substitution of Au@Pt4L NPs with the same amount of Au@Ptdendrite NPs or PtNPs. As shown 
in Figure 8.12, the detection sensitivity of Au@Ptdendrite NP-LFA was comparable to that of 
Au@Pt4LNP-LFA in both low- and high-sensitivity modes. PtNPs were synthesized according to 
a previously reported procedure with slight modifications.80 As shown by the TEM image 
in Figure 8.11, the PtNPs displayed relatively irregular surface and broad size distribution 
compared to the Au@Pt4L NPs. Figure 8.13 shows the performance of those PtNPs in LFA of PSA 
standards. It can be seen that the detection sensitivity of PtNP-LFA was similar to that of 
Au@Pt4L NP-based LFA under high-sensitivity mode. However, under low-sensitivity mode, its 
detection sensitivity was several times lower than Au@Pt4L NP-LFA. This difference can be 
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ascribed to the fact that Au@Pt4L NPs with Au cores possess superior optical properties relative to 
the PtNPs of similar size.81 It should be emphasized that the Au@PtnL NPs presented in this work 
are much more uniform in terms of size, shape, and elemental distribution than the 
Au@Ptdendrite NPs and PtNPs. Accordingly, they are expected to provide better detection 
reproducibility.82 In addition, their properties (e.g., plasmonic and catalytic activities) were well 
understood at the atomic level. Therefore, we believe the Au@PtnL NPs are more suitable for 
biosensing applications, providing sensitive and reliable tests. 
 
Figure 8.11 TEM image of citrate-capped Pt nanoparticles. Inset shows the distribution of 
diameter for this sample. 
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Figure 8.12 Comparison of the performance of Au@Pt4L NPs (Figure 8.2) and Au@Ptdendrite NPs 
(Figure 8.4) in LFA of PSA standards. (a) Representative photographs taken from the LFAs of 
PSA standards. The asterisks (*) indicate detection limits by the naked eyes; (b, c) Corresponding 
calibration curves of the detection results shown in (a). Error bars indicate the standard deviations 
of six independent measurements. In (b, c), the data of Au@Pt4L NP-LFA was retrieved from 
Figure 8.9. 
 
Figure 8.13 Comparison of the performance of Au@Pt4L NPs (Figure 8.2) and PtNPs (Figure 
8.11) in LFA of PSA standards. (a) Representative photographs taken from the LFAs of PSA 
standards. The asterisks (*) indicate detection limits by the naked eyes; (b, c) Corresponding 
calibration curves of the detection results shown in (a). Error bars indicate the standard deviations 
of six independent measurements. In (b, c), the data of Au@Pt4L NP-LFA was retrieved from 
Figure 8.9. 
To demonstrate the potential clinical use of the “high-sensitivity” Au@Pt4L NP-LFA, we 
applied it to quantifying PSA from human plasma samples (from a healthy female donor, provided 
by the UP-Health System-Portage, Houghton, Michigan, United States) that had been spiked with 
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PSA at concentrations of 20-160 pg‧mL-1. The detection was benchmarked against a commercial 
ELISA kit. As summarized in Table 8.1, the analytical recoveries for Au@Pt4L NP-LFA in 
analyzing the five PSA spiked human plasma samples were determined to be in the range of 94.5-
106.6%. The coefficient of variation (n = 6) for all samples was below 7.3%. The detection results 
correlated well with the parallel tests by commercial ELISA kit with a correlation coefficient R2 = 
0.992 (see Table 8.1 and Figure 8.14). These data demonstrated that the performance of 
Au@Pt4L NP-LFA was not influenced by the complex matrices in human plasma, suggesting the 
feasibility of the new LFA in analyzing clinical samples. 
 
Figure 8.14 Correlation analysis between the Au@Pt4L NP-LFA and commercial ELISA kit in 
quantifying PSA from five PSA-spiked serum samples. Error bars indicate the standard deviations 
of six independent measurements. 
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Table 8.1 Performances of Au@Pt4L NP-LFA (high-intensity mode) and a commercial ELISA kit 
(Abcam plc., United Kingdom) in detecting PSA-spiked human plasma samples 
 
PSA amount spiked 
(pg‧mL-1) 
PSA amount 
measured  
(pg‧mL-1) 
coefficient of 
variations  
(%, n = 6) 
recovery  
(%) 
Au@Pt4LNP-
LFA 
20 18.9 7.3 94.5 
40 38.7 5.2 96.8 
80 76.9 6.2 96.1 
120 127.9 4.1 106.6 
160 163.4 5.1 102.1 
commercial 
ELISA kit 
20 18.4 3.6 92.0 
40 40.5 2.6 101.3 
80 82.3 3.3 102.9 
120 116.2 2.6 96.8 
160 157.6 3.1 98.5 
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8.3 Conclusion 
In summary, we have demonstrated a dual-functional AuNPs (with both plasmonic and 
catalytic activities) for colorimetric in vitro diagnostics with substantially enhanced detection 
sensitivity. Such dual-functional AuNPs were engineered by coating conventional AuNPs with 
ultrathin Pt skins of sub-10 atomic layers (e.g., Au@Pt NPs). The enhanced sensitivity is ascribed 
to the ultrahigh catalytic activity of the Au@Pt NPs that allows them to generate detectable color 
signal orders of magnitude stronger than the intrinsic color from plasmonics. Importantly, the 
Au@Pt NPs retain all the merits of conventional AuNPs, making it convenient and straightforward 
to employ them for clinical diagnostics. 
8.4 Materials and Experiment 
8.4.1 Chemicals and Materials 
Gold(III) chloride trihydrate (HAuCl4·3H2O, ≥99.9%), sodium citrate dihydrate (≥99%), 
L-ascorbic acid (AA, ≥99%), sodium hexachloroplatinate(IV) hexahydrate (Na2PtCl6·6H2O, 98%), 
hydrogen peroxide solution (30 wt% in H2O), 3,3',5,5'-tetramethylbenzidine (TMB, >99%), TMB 
substrate solution for membranes, sodium acetate (NaOAc, ≥99%), acetic acid (HOAc, ≥99.7%), 
human prostate-specific antigen (PSA, ≥99%), bovine serum albumin (BSA, ≥98%), potassium 
phosphate monobasic (KH2PO4, ≥99%), sodium phosphate dibasic (Na2HPO4, ≥99%), potassium 
chloride (KCl, ≥99%), sodium chloride (NaCl, ≥99.5%), sodium azide (NaN3, ≥99.5%), sodium 
carbonate (Na2CO3, ≥99.5%), sucrose (≥99.5%), cetyltrimethylammonium bromide (CTAB, 
≥99%) and Tween 20 were all obtained from Sigma-Aldrich. Monoclonal mouse anti-human PSA 
capture antibody (referred to as "anti-PSA CAb"), monoclonal mouse anti-human PSA detection 
antibody (referred to as "anti-PSA DAb"), and human PSA enzyme-linked immunosorbent assay 
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(ELISA) kit (ab188389) were obtained from Abcam plc.. Polyclonal goat anti-mouse IgG antibody 
(referred to as "anti-mouse IgG") was obtained from Thermo Fisher Scientific, Inc. Nitrocellulose 
(NC) membrane, glass fiber membrane, and absorbent pad were obtained from GE Healthcare. 
Polyvinyl chloride (PVC) backing card was obtained from DCN Diagnostics. All aqueous 
solutions were prepared using deionized (DI) water with a resistivity of 18.0 MΩ·cm. 
8.4.2 Preparation of ~15 nm Au Nanoparticles (AuNPs) To Be Used as Seeds for 
Preparing ~40 nm AuNPs 
~15 nm AuNPs were synthesized using the classical Frens’ method with minor 
modifications.S1 Briefly, 50 mL of HAuCl4 aqueous solution (0.01%, w/v) was added to a 100-
mL round-bottom flask equipped with a condenser and heated to boiling in an oil bath under 
magnetic stirring. Subsequently, 2 mL of sodium citrate aqueous solution (1%, w/v) was quickly 
added into the boiling solution with a pipet. The solution was kept boiling and stirring for 30 min 
until its color turned to red. After cool-down, the ~15 nm AuNPs as products were stored in dark 
at room temperature (~22 oC) for future use (~55 μg/mL in Au element). 
8.4.3 Preparation of ~40 nm AuNPs To Be Used as Seeds for synthesizing Au@PtnL NPs 
~40 nm AuNPs were synthesized according to a seed-mediated growth method with slight 
modifications, where above mentioned ~15 nm AuNPs were employed as the seeds. In brief, 1,700 
μL of the ~15 nm AuNPs was diluted to 20 mL with DI water, and hosted in a 50-mL round-
bottom flask at room temperature under magnetic stirring. Then, 10 mL of precursor aqueous 
solution containing 370 μL of HAuCl4 aqueous solution (1%, w/v) and 10 mL of reductant aqueous 
solution containing 0.6 mL of AA aqueous solution (1%, w/v) plus 0.3 mL sodium citrate aqueous 
solution (1%, w/v) were injected separately to the flask at a rate of 12 mL/h using a syringe pump. 
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Right after the complete injection of the two solutions, the mixture was heated to boiling in an oil 
bath under magnetic stirring for 30 min. Finally, the ~40 nm AuNPs as products were cooled down 
to room temperature and stored in dark at room temperature for future use (8.06×1010 particles/mL 
or 1.34×10-10 M). Note all particle concentrations in this study were determined by the combination 
of ICP-OES analysis and TEM imaging. See the section "Characterizations" below for details. 
8.4.4 Synthesis of Au@PtnL NPs 
In a standard synthesis of Au@Pt4L NPs, 8.0 mL of the ~40 nm AuNPs and 3,653 μL DI 
water were hosted in a 25 mL three-neck flask and preheated to 90 oC in an oil bath under magnetic 
stirring for 10 min. After the preheating, 347 μL of 1.0 mM Na2PtCl6 aqueous solution and 4.0 mL 
of 4.0 mM AA aqueous solution was injected separately into the flask at rates of 1.2 and 2.4 mL/h, 
respectively, using a syringe pump. The reaction was allowed to proceed for an additional 30 min 
after the complete injection of the Na2PtCl6 and AA solutions. Finally, the produced Au@Pt4L NPs 
were cooled down to room temperature and stored in dark at room temperature for future use 
(3.80×1010 particles‧mL-1 or 6.32×10-11 M). The procedures for synthesizing other Au@PtnL NPs 
(n: 1-10 Pt atomic layers) were similar to the standard procedure for Au@Pt4L NPs except for the 
variations of reagents listed in Table S8.1 (Appendix G). 
8.4.5 Synthesis of ~40 nm Pt nanoparticles (PtNPs) 
~40 nm PtNPs were synthesized according to a previously reported procedure with minor 
modifications. First, 100 μL of 0.4 M AA solution, 200 μL of 1% (w/v) sodium citrate aqueous 
solution, and 800 μL of 1.25 mM H2PtCl6 solution were added to a vial and mixed together. Then, 
the above mixture was incubated at 80 ℃ for 30 min. After being cooled down, the final products 
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(e.g., ~40 nm PtNPs) were stored in dark at room temperature for future use (2.19×1011 
particles‧mL-1 or 3.64×10-10 M). 
8.4.6 Steady-State Kinetic Assays 
All the steady-state kinetic assays were performed at room temperature (~22 oC) in cuvettes 
with a path length (l) of 1.0 cm by using 0.2 M NaOAc/HOAc buffer (pH 4.0) as the reaction 
buffer. Final particle concentrations of 6.32×10-14 M for all the Au@PtnL NPs and 6.70×10-12 M 
for the ~40 nm AuNPs were used for their corresponding kinetic measurements. The rest procedure 
for collection of Vmax and Km can be found in Chapter 3, Section 3.4.4. 
8.4.7 FDTD Simulations 
The finite-difference time-domain (FDTD) simulations were performed using FDTD 
Solutions 8.0 (Lumerical Solutions, Inc.) according to a previous report with minor 
modification.S7 During the FDTD simulations, an electromagnetic pulse with the wavelength 
range of 350-800 nm was launched into a box containing a target nanostructure. The targeted 
nanostructure was surrounded by a virtual boundary with an appropriate size. The nanostructure 
and its surrounding space were divided into 1-nm meshes. Finer meshes of 0.2 nm in size were 
added at nanostructure. The refractive index of the surrounding medium was set to be 1.33, which 
is the index of water. The nanostructures were modeled as a sphere, and the sizes of the 
nanostructures were set according to the average sizes measured from the TEM images. Typically, 
the diameter of the AuNPs (as the cores of Au@PtnL NPs) was set to be 40.2 nm, and the Pt-shell 
thicknesses of the Au@PtnL NPs were set to be 0.23 nm (n = 1), 0.46 nm (n = 2), 0.69 nm (n = 3), 
0.92 nm (n = 4), 1.15 nm (n = 5), 1.61 nm (n = 7), and 2.30 nm (n = 10). For all simulations, the 
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dielectric function of gold and platinum was represented with the fitting from Babar and Palik’s 
data, respectively. 
8.4.8 DFT Calculations 
All of the density functional theory (DFT) calculations were carried out using VASP codes. 
A projector augmented wave (PAW) pseudopotential was chosen to deal with the interaction 
between ion cores and valence electrons. The exchange-correlation effects between valence 
electrons were described by the Perdew-Burke-Ernzerhof (PBE) functional using the generalized 
gradient approximation (GGA). The Kohn-Sham wave functions for the valence electrons were 
expanded using a plane-wave basis set within an energy cutoff of 320 eV. The energy cutoff was 
increased to 400 eV to test for convergence, and the d-band centers were found to vary by less than 
0.01 eV. The Monkhorst-Pack scheme K-points grid sampling was set as 4 × 4 × 1 for the 
irreducible Brillouinzone. The conjugate gradient (CG) scheme was chosen as the minimization 
algorithm. Its iterative process was considered to be converged when the force on the atoms was 
less than 0.01 eV/Å, the energy change per atom was less than 1 × 10-5 eV.  
We first calculated the bulk crystal structure of Au and Pt, which gave the following lattice 
parameters: a = b = c = 4.1549 (Au) / 3.9665 (Pt) Å. This is in good agreement with the 
experimental parameters: a = b = c = 4.0783 (Au) / 3.9239 (Pt) Å. The Au(111) was simulated by 
the periodic (2 × 2) slab model. This model has 12 atomic layers. The slabs were separated by a 
15 Å thick vacuum, which is sufficient to screen the self-interaction effects of the periodic 
boundary conditions. Au@PtnL NPs were modeled with different Pt monolayers (1, 2, 3, 4, 5, 7, 
10) on the p (2 × 2) Au(111) slabs with the 12 atomic layers. The p (2 × 2) Pt(111) monolayers 
were constrained in the p (2 × 2) Au(111) surface. The atomic positions of the bottom six atomic 
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layers were fixed to simulate the bulk effects. 
8.4.9 Preparation of Anti-PSA DAb Conjugated Au@Pt4L NPs (Referred to as "Au@Pt4L 
NP-Anti-PSA DAb Conjugates") 
Au@Pt4L NP-anti-PSA DAb conjugates were prepared according to the reported methods 
with minor modifications. In brief, 10 mL of the as-synthesized Au@Pt4L NPs (6.32×10-11 M, in 
DI water) was initially adjusted to pH 9.0 using 0.1 M Na2CO3 aqueous solution under magnetic 
stirring. Then, 15 μL of anti-PSA detection antibody [2 mg‧mL-1 in 10 mM phosphate buffered 
saline (PBS, pH 7.4) buffer] was added into the particle suspension. After incubation at room 
temperature for 30 min, the reaction solution was put in a refrigerator overnight at 4 oC. 
Subsequently, 1 mL of blocking solution (10% BSA in PBS) was added to the reaction solution. 
After 1 h, the final products were collected by centrifugation, washed twice with PBS, and 
redispersed in 1 mL of PBS containing 5% sucrose, 5% BSA, 0.5% Tween 20, and 0.05% NaN3 
for future use.  
The procedure for preparing the AuNP-anti-PSA DAb conjugates was the same as that for 
Au@Pt4L NP-anti-PSA DAb conjugates except for the substitution of Au@Pt4L NPs with ~40 nm 
AuNPs at the same particle concentration. 
8.4.10 Preparation of Au@Pt4L NP-LFA Test Strips 
The LFA strips were prepared according to the reported procedure with minor 
modifications. A ZX1000 Dispensing Platform and a CM4000 Guillotine Cutter (BioDot Inc.) 
were used for the preparation. The Au@Pt4L NP-LFA strips consist of five components: a sample 
pad, a conjugate pad, a NC membrane with a test line and a control line, an absorbent pad, and a 
PVC backing card (see Figure 8.4a). The absorbent pad and PVC backing card were utilized 
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without any pretreatment. The sample pad was prepared by dipping a glass fiber membrane into 
PBS containing 5% sucrose, 5% BSA, 0.5% Tween 20, and 0.05% NaN3, followed by drying out 
at room temperature for 4 h. The conjugate pad was prepared by dispensing the as-prepared 
Au@Pt4L NP-anti-PSA DAb conjugates onto a glass fiber membrane at a speed of 25 μL/cm using 
a ZX1000 Dispensing Platform, followed by drying out at room temperature for 2 h. The NC 
membrane with the test and control lines was prepared by separately spotting anti-PSA CAb (1 
mg‧mL-1 in PBS containing 0.05% NaN3, for the test line) and anti-mouse IgG (1 mg‧mL-1 in PBS 
containing 0.05% NaN3, for the control line) onto a NC membrane at a jetting rate of 1 μL/cm 
using a ZX1000 Dispensing Platform. The two lines were positioned at a 5.0 mm interval. Finally, 
the sample pad, conjugate pad, NC membrane, and absorbent pad were sequentially assembled 
onto the PVC backing card with an overlap between them of ~2 mm, and cut into strips with a 
wide of 4 mm. The prepared Au@Pt4L NP-LFA strips were stored in refrigerator at -20 °C under 
dry condition for future use.  
The procedure for preparing AuNP-LFA strips was the same as that for the Au@Pt4L NP-
LFA strips except for the substitution of Au@Pt4L NP-anti-PSA DAb conjugates with AuNP-anti-
PSA DAb conjugates at the same particle concentration. 
8.4.11 Detection of PSA Using the Au@Pt4L NP-LFA 
100 μL PSA standards or human plasma samples were initially dispensed onto the sample 
pad of the Au@Pt4L NP-LFA strips and kept at room temperature for ~10 min until the flow is 
stopped. Note that plasma was pre-diluted 2 folds by dilution buffer (1% BSA in PBS containing 
0.05% Tween 20, PBST) prior to spiking of PSA and detection. Then, 100 μL of PBST was 
dispensed onto the sample pad and kept at room temperature for another ~10 min, in order to wash 
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away the excess Au@Pt4L NP-anti-PSA DAb conjugates. The photographs of the strips were taken 
with a camera (the "low-sensitivity" mode). For the "high-sensitivity" mode, an additional TMB 
substrate treatment process was applied: substrate solution (a mixture containing 6 μL of TMB 
substrate solution for membranes, 2 μL of 1.0 M NaOAc/HOAc buffer, pH 4.0, and 2 μL 10 M 
H2O2) were dispensed onto the control and test lines of each strip. After 5 min incubation at room 
temperature, the photographs of the strips were taken. For quantitative analysis (Figure 8.4c), all 
the photographs were imported to a computer and converted to 8-bit grayscale images using Adobe 
Photoshop. The arithmetic mean of pixel intensity within the test line regions was read as the color 
signal intensity. 
The procedure for the AuNP-LFA of PSA was the same as that for the "low-sensitivity" 
Au@Pt4L NP-LFA of PSA except for the exclusion of the TMB substrate treatment process. 
8.4.12 Detection of PSA Using a Commercial ELISA Kit 
The detection was carried out according to the assay protocol provided by Abcam plc.. 
Briefly, 50 μL of PSA standards or human plasma samples were initially added into appropriate 
wells. Note that plasma was pre-diluted 2 folds by dilution buffer (1% BSA in PBST) prior to 
spiking of PSA and detection. Then, 50 μL of PSA Capture Antibody and 50 μL of PSA Detector 
Antibody were added into each well. After gently shaking at room temperature for 1 h, the wells 
were washed three times with Wash Buffer PT, followed by the addition of 100 μL of TMB 
Substrate. After 10 min incubation at room temperature, 100 μL of Stop Solution was added into 
each well. The absorbance of each well at 450 nm was read using a microplate reader. 
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8.5 Characterizations 
The UV-vis spectra were recorded using an Agilent Cary 60 UV-vis spectrophotometer. 
The transmission electron microscope (TEM) images were taken using a JEOL JEM-2010 
microscope operated at 200 kV. High-resolution TEM images, HAADF-STEM images, energy 
dispersive X-ray (EDX) mapping, and EDX line-scan profile were acquired using a double Cs-
corrected JEOL ARM200F TEM at Brookhaven National Laboratory. The concentration of Au 
and Pt ions were determined using an inductively coupled plasma-optical emission spectroscopy 
(ICP-OES, PerkinElmer Optima 7000DV), which could be converted to the particle concentration 
of AuNPs and Au@Pt NPs once the particle sizes and shapes had been resolved by TEM imaging. 
The X-ray photoelectron spectroscopy (XPS) measurements were performed on a PHI Versa Probe 
III XPS system (ULVAC-PHI) using a monochromated Al Kα X-ray source (1486.6 eV). The LFA 
strips were prepared using a ZX1000 Dispensing Platform and a CM4000 Guillotine Cutter 
(BioDot Inc.). The absorbance of samples in microtiter plates was read using a PerkinElmer Victor 
3 1420 Multilabel Plate Reader. Microtiter plates were shaken using a Corning LSE Digital 
Microplate Shaker. pH values of buffer solutions were measured using an Oakton pH 700 
Benchtop Meter. Photographs of strips and samples in vials were taken using a Canon EOS Rebel 
T5 digital camera. 
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Figure S2.1 TEM image of Pd truncated octahedra with an overall spherical shape and an average 
size of 5.6 nm that served as seeds for the preparation of Pd-Ru core-frame octahedra and 
subsequent Ru NFs. The inset shows a HRTEM image recorded from an individual particle 
orientated along <110> direction. 
 
Figure S2.2 HRTEM image of an individual Pd-Ru core-frame octahedron orientated along <110> 
direction. 
. 
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Figure S2.3 Representative HAADF-STEM images of individual Ru NFs showing the imperfect 
octahedral shape of the sample. 
 
Figure S2.4 TEM images of the sample prepared using the same procedure for the Ru NFs shown 
in Figure 2.6 except for the reduction of Ru precursor by 50%. 
 
Figure S2.5 Additional TEM image of the Ru NFs at a lower magnification relative to the images 
shown in Figure 2.6. 
  
250 
 
APPENDIX C ADDITIONAL INFORMATION FOR CHAPTER 4 
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Figure S4.1 TEM image of Pd truncated octahedra with an average size of 5.6 nm that served as 
seeds for the preparation of Pd-Ir NPs. The inset is a 2D schematic model of the sample. 
 
Figure S4.2 Low magnification TEM image of Pd-Ir NPs shown in Figure 4.2b. 
252 
 
 
Figure S4.3 XRD patterns of the Pd seeds (Figure S4.1) and Pd-Ir NPs (Figure 4.1). Red bars: 
JCPDS no. 06-0598 (fcc Ir). Green bars: JCPDS no. 05-0681 (fcc Pd). 
 
Figure S4.4 Line-scan EDX spectra of elemental Pd and Ir that were recorded along a corner-to 
edge direction of the individual Pd-Ir NP shown in the inset. 
 
Figure S4.5 XPS analyses of the initial Pd seeds (Figure S1) and Pd-Ir NPs (Figure 4.1). (a) XPS 
survey spectra, in which the Ir 4f peak of the Pd-Ir NPs was labeled in red. (b) High-resolution 
XPS spectra of the Ir 4f region. 
253 
 
Figure S4.6 Schematics showing the rough estimation of a) the average number of GNPs in each 
GV (NGNPs per GV) and b) the average number of Pd-Ir NPs in each GV (NPd-Ir NPs per GV). A SEM 
image of GV is integrated to a). 
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Figure S5.1 FTIR spectra of pure PVP55 powder and dried PVP55-capped Pt cubes shown in 
Figure 5.1. 
 
Figure S5.2 TEM image of Pt nanocrystals that was prepared using the standard procedure for 
PVP55-capped Pt cubes shown in Figure 5.1, except for the absence of KBr. Scale bar in inset is 
10 nm. 
 
Figure S5.3 CTAB-capped Pt cubes that were synthesized using a previously reported protocol 
with minor modification. (a) TEM image, and (b) FTIR spectra taken from the CTAB-capped 
cubes and pure CTAB powder as reference. Inset in (A) shows a model of the cube, in which the 
bilayer of CTAB on the surface is highlighted.  
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Table S5.1 Comparison of kinetic parameters of various peroxidase mimics toward the oxidation 
of TMB by H2O2.  
Catalysts Size (nm) 
[E] 
(M) 
Km 
(M) 
Vmax 
(Ms-1) 
Kcat 
(s-1) 
Kcat-
specific 
(s-1nm-2) 
Ref 
PVP55-Pt 
cubes 
8.16 2.9×10-13 8.1×10-4 2.76×10-7 9.53×105 2.38×103 
This 
work 
PVP55-Pt 
cubes 
6.45 5.9×10-13 6.6×10-4 3.86×10-7 6.54×105 2.62×103 
This 
work 
PVP55-Pt 
spheres 
4.30 4.0×10-13 7.1×10-4 5.12×10-7 1.28×105 2.2×103 
This 
work 
Fe3O4 
particles 
300 
(diameter) 
1.1×10-12 9.8×10-5 3.4×10-8 3.0×104 0.11 1 
Pd cubes 
18 
(edge length) 
1.4×10-12 5.4×10-5 9.7×10-8 6.9×104 35 2 
Pd-Ir 
cubes 
19.2 
(edge length) 
3.4×10-14 1.3×10-4 6.5×10-8 1.9×106 8.6×102 2 
Ir particles 
1.5 
(diameter) 
2.0×10-9 2.0×10-5 1.1×10-7 56 7.8 3 
Ft-Pt 
particles 
1.87 
(diameter) 
4.2×10-8 2.2×10-4 3.2×10-4 7.6×103 6.8×102 4 
MnO2 
particles 
4.5 
(diameter) 
3.0×10-8 4.0×10-5 5.8×10-6 1.9×102 3.0 5 
Co3O4 
cubes 
20 
(edge length) 
3.4×10-10 1.0×10-4 6.3×10-8 1.8×102 7.2×10-2 6 
Graphene 
oxidea 
1 
(thickness) 
1.2×10-9  2.4×10-5 3.5×10-8 29 3.7×10-4 7 
Fe2O3 
particle 
~10 
(diameter) 
3.1×10-10 3.1×10-4 1.1×10-6 3.4×103 11 8 
Carbon 
 nanodotsb 
2.1 
(diameter) 
1.5×10-7  3.9×10-5 3.6×10-8 0.24 1.7×10-2 9 
PtPd-
Fe3O4 
particle 
~12 
(diameter) 
3.9×10-9 - 9.4×10-8 24 5.3×10-3 10 
Au@Pt 
rods 
~30×70 
(width×length) 
1.3×10-11 2.7×10-5 1.8×10-7 1.4×104 2.1 11 
Au@Pd 
particles 
~20 
(diameter) 
9.6×10-11 1.7×10-4 2.0×10-6 2.1×104 17 12 
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a Estimated from the mass concentration (40 µg/mL) and the hypothesis that each particle is an 
ideal disc with size of 100×1 nm (diameter × thickness). 
b Estimated from the mass concentration (1 µg/mL). 
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Table S6.1 Comparison of analytical performances of various fluorescent methods and the 
colorimetric method developed in this work in detecting Ag+. 
Method Detection probes 
LOD 
(nM) 
Assay time 
(min) 
Fluorescent 
methods 
DNA + Ru complex + quantum dots 100 40 
CdTe quantum dots 50 N/A 
DNA-based fluorogenic probe 32 10 
Silver DNAzyme 24.9 30 
DNA-Ag nanoclusters 10 N/A 
MoS2 nanosheets 10 10 
Cytidine-stabilized gold nanocluster 10 N/A 
MnO2 nanosheet + DNA 9.1 45 
Graphene oxide + fluorescent DNA 
probe 
5 7 
Fluorescent DNA probe 5 2 
ZnO/CdS@SiO2 core/shell 
nanocomposites 
3.3 N/A 
2-Aminopurine-modified DNA 
homopolymers 
3 10 
Carbon nanoribbons 1.73 30 
nano-graphite-DNA hybrid + DNase I 0.3 135 
i-Motif DNA + Cyanine dye 0.25 0.17 
Colorimetric 
method 
PVP-capped Pt cubes 0.08 6 
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Figure S8.1 (a) Low- and (b) high-magnification TEM images of AuNPs with an average diameter 
of 40.2 nm that served as seeds for the preparation of Au@PtnL NPs.
262 
 
 
Figure S8.2 Schematic showing the estimation of Pt shell thickness (x nm) for the Au@PtnL NPs 
shown in Figure 8.2. 
  
263 
 
 
Figure S8.3 TEM images of (a) Au@Pt2L NPs and (b) Au@Pt7L NPs that were synthesized using 
the standard procedure for Au@Pt4LNPs except that the total volume of Na2PtCl6 solution was 
adjusted from 347 µL to 170 and 628 µL, respectively. The number of Pt atomic layers was 
determined by ICP-OES. Insets show the distributions of diameter for both samples. 
 
Figure S8.4 Normalized UV-vis spectrum taken from an aqueous suspension of Au@Pt NPs with 
Pt thickness of ~10 nm. Inset shows a photograph of corresponding sample hosted in a glass vial. 
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Figure S8.5 Schematics illustrating the estimation of molar extinction coefficients for the 40.2 nm 
AuNPs (ɛAuNPs) and Au@Pt4LNPs (ɛAu@Pt4LNPs), as well as the magnitude of signal enhancement 
(N). Here, the ɛAu@Pt4LNPs is referred to as the equivalent molar extinction coefficient, which is 
defined as the total light extinction of colored products (e.g., oxTMB) catalyzed at t = 5 min. 
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Figure S8.6 Normalized UV-vis spectra of Au@Pt4L NPs before (dashed) and after (solid) they 
had been incubated with mouse anti-PSA monoclonal detection antibodies. The red shift of major 
peak implies the successful conjugation of antibodies on Au@Pt4L NP. 
Table S8.1 The dosages of reagents for the synthesis of various Au@PtnL NPs (n: 1-10 Pt atomic 
layers). 
Number (n) of Pt 
atomic layers 
Volume of 
AuNPs (mL) 
Volume of DI 
H2O (μL) 
Volume of 1.0 
mM Na2PtCl6 
solution (μL) 
Volume of 4.0 
mM AA 
solution (mL) 
1 8.0 3,916 84 4.0 
2 8.0 3,830 170 4.0 
3 8.0 3,743 257 4.0 
4 8.0 3,653 347 4.0 
5 8.0 3,562 438 4.0 
7 8.0 3,372 628 4.0 
10 8.0 3,073 927 4.0 
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